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Abstract 
Bacteroides fragilis NCTC 9343 is a Gram-negative anaerobic bacterium with genomic DNA of 5205 
Kb and a GC ratio of 43%. It is a commensal organism that can act as an opportunistic pathogen and 
is commonly present on the mucous membranes. It causes a variety of infections including intra 
abdominal infections, perirectal abscesses and decubitus ulcers. Enterotoxigenic forms are capable of 
causing diarrhoea in children and animals.  
Enterobacter cancerogenus ATCC 35316 is also a Gram-negative facultatively anaerobic bacterium 
with genomic DNA of 4602 Kb and a GC ratio of 55%. It is a naturally occurring human gut symbiont 
known to exhibit resistance to antibiotics like aminopenicillins. It has also been reported in cases of 
severe osteomyelitis and infections of bones and joints. 
This study aims to analyse the differential expression of proteins in the presence of mucin since it 
serves as the first site of adherence for the bacteria. The E. cancerogenus and B. fragilis proteins 
were extracted and separated by two dimensional electrophoresis from logarithmic phase cultures 
grown in semi-defined media enriched with or without porcine gastric mucin Types II and III. The gel 
images were analysed using Bio-Rad PDQuest, Ludesi Redfin and Nonlinear Dynamics SameSpots 
softwares. It was observed that the presence of mucin in the media affected the expression of a 
number of proteins in E. cancerogenus and B. fragilis cells. The protein spots of interest were excised, 
hydrolysed using trypsin and subjected to electrospray ionisation based LC-MS analysis in order to 
determine the identity of the digested proteins and obtain a better understanding of the interactions of 
B. fragilis and E. cancerogenus with mucin. 
 The outer membrane protein surface antigen X was found to be up-regulated in both mucin Type II 
and III enriched media in E. cancerogenus. Some of the other proteins that were differentially 
regulated in both E. cancerogenus and B. fragilis included the elongation factor Ts, malate 
dehydrogenase, triose phosphate isomerase and thiol peroxidase proteins indicating that these 
proteins may be associated with the ability of bacteria to grow in mucin and may be potential virulence 
factors. 
Genes encoding the proteins CAH06598 and CAH09443 from the glycoside hydrolase families 95 and 
97 in B. fragilis strain NCTC9343 were cloned, overexpressed and purified using nickel affinity and gel 
filtration chromatography. The enzymes were found to be active by performing fluorimetric assays 
using methyl-umbelliferyl sugar substrates. Diffracting crystals of CAH09443 were obtained from the 
PACT ANION screens containing polyethylene glycol and sodium malonate as a precipitant. Structure 
determination was achieved via molecular replacement using the glycoside hydrolase Family 97 α-
galactosidase, BtGH97b, from Bacteroides thetaiotaomicron as a starting model. The structure of 
CAH09443 was shown to be composed of a N-terminal β-super-sandwich domain and a canonical 
(β/α)8 barrel, similar to the two other glycoside hydrolase family 97 enzyme structures reported. 
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Abbreviation list 
APS    Ammonium persulphate 
bp   Base pair 
BSA   Bovine serum albumin 
CBM   Carbohydrate binding module 
CFE   Cell free extract 
Da   Dalton 
dNTP   deoxynucleotide triphosphate 
DTT   Dithiothreitol 
EDTA   Ethylene diamine tetraacetic acid 
GH   Glycoside hydrolase 
HEPES  N-[2-hydroxyethyl] piperazine-N‟-[2-ethanosulphonic acid] 
IMAC   Immobilised metal affinity chromatography 
IPTG   Isopropyl-β-D-thiogalactopyranoside 
kb   Kilobase pair 
LB   Luria Bertani 
PAGE   Polyacrylamide gel electrophoresis 
PCR   Polymerase chain reaction 
SDS   Sodium dodecyl sulphate 
TAE   Tris-acetate-EDTA 
TEMED  N,N,N‟,N‟-tetramethylethylene diamine 
TRIS   tris(hydroxymethyl)aminomethane 
v/v    volume per volume 
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w/v   weight per volume 
ACN   Acetonitrile 
ATP   Adenosine tri phosphate 
BHI   Brain Heart Infusion 
BPB   Bromophenol blue 
BPC   Base peak chromatogram 
CHES   N-cyclohexyl-2-aminoethane sulphonic acid 
DHAP   Dihydroxy acetone phosphate 
ESI   Electrospray ionisation 
EF   Elongation factor 
IAA   Iodoacetamide 
MES   2-(N-morpholino)-ethanesulphonic acid 
MPD   2-Methyl-1,3 propanediol 
MS    Mass spectrometry 
FA   Formic acid 
GDP   Guanosine di phosphate 
G-3-P   Glyceraldehyde-3-phosphate 
GTP   Guanosine tri phosphate 
IEF   Isoelectric focussing 
LC   Liquid chromatography 
CAZY   Carbohydrate active enzymes 
dCMP   deoxy cytidine mono phosphate 
MPD   2-methyl-1,3 propanediol  
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NAD   Nicotinamide adenine dinucleotide 
NADP   Nicotinamide adenine dinucleotide phosphate 
NCBI   National Centre for Biotechnology Information 
Omp   Outer membrane protein 
PEG   Polyethylene glycol 
PEG MME  Polyethylene glycol monomethyl ether 
PEPCK  Phosphoenol pyruvate carboxykinase 
PBS   Phosphate buffered saline 
PFL   Pyruvate formate lyase 
SOB   Super optimal broth 
SOC   Super optimal culture 
SSP   Standard spot numbers  
TIC   Total ion current  
TPI   Triose phosphate isomerase 
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4. General introduction 
The study aims at understanding the interaction between gut commensal bacteria 
and mucin. The GI tract is colonised by a number of bacteria which are opportunistic 
pathogens that can cause infection when the host immune system is impaired. This 
work mainly focuses on the gut infection causing bacteria, Enterobacter 
cancerogenus strain ATCC 35316 and Bacteroides fragilis strain NCTC 9343.  
 
4.1  Bacteroidaceae 
Based on the comparative analysis of the 16S rRNA sequences, Bacteroides 
species have been classified under the family „Bacteroidaceae‟ and phylum 
„Bacteroidetes‟.  They play an important role in the maintenance of human and 
animal health by colonising the intestine and forming an indigenous flora of the 
colon. They have been known to colonise the distal regions of the stomach where 
the gastric secretions are diluted and the hindgut beginning from the distal regions of 
the small intestine with increasing numbers in the terminal illeum and colon. They 
help in the fermentation of carbohydrates in the colon where the fermentation activity 
is very high at the caecum. As the carbohydrate sources become limited, the activity 
is slowed down in the transverse colon and directed towards protein fermentation 
(Smith et al., 2006).  
 
4.2 Introduction to Bacteroides fragilis 
Bacteroides fragilis is classified as a Gram-negative anaerobe which is included in 
the family of Bacteroideceae. They commonly occur on mucous membranes and are 
responsible for endogenous infections. Bacteroides species cause more than 50% of 
anaerobic infections. They normally range from 0.5 - 0.6 µm in diameter to 1.5 - 4.5 
µm in length and are found in nature as round ended bacilli (Fig. 1). They have a 
genome size of 5205 Kb with a guanine+cytosine (GC) ratio of 42% (Brook, 2006). 
They are opportunistic pathogens present in the gastrointestinal flora and cause a 
number of intra-abdominal infections. 
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Figure 1: An electron micrograph showing aggregates of B. fragilis. The bar 
refers to a size of 1µm (Ferreiraa et al., 2002). 
 
They have also been found to exhibit resistance to a variety of antibiotics including 
penicillin and the β-lactam antibiotics because they have the ability to produce the 
enzyme, β-lactamase which attacks the β-lactam ring within the antibiotic. They have 
also shown multidrug resistance to other antibiotics like clindamycin, tetracycline and 
metronidazole (Su & Honek, 2007). 
 
4.2.1 Types of Bacteroides fragilis infections 
B. fragilis is a Gram-negative bacterium that is capable of causing a variety of 
infections within the host. These include central nervous system infections, intra-
abdominal and pleuropulmonary infections, skin and soft tissue infections, female 
genital tract infections, bacteraemia, osteomyelitis, abscesses and septic arthritis 
(Pumbwe et al., 2006). B. fragilis is commonly present on the mucous membranes 
and causes a variety of infections including intra abdominal infections, perirectal 
abscesses and decubitus ulcers. The enterotoxigenic forms are capable of causing 
diarrhoea in children and animals (Nakano et al., 2007).  
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4.2.2  Uses of Bacteroides fragilis to man 
Bacteroides spp. are also beneficial to man in a number of ways. They are capable 
of producing certain vitamins like Vitamin K2 and menaquinone which are utilised by 
the human host. 
Anaerobic growth of Bacteroides species results in the production of a number of 
end products such as butyrate, acetate and propionate and this contributes to nearly 
70% of the energy source for enterocytes, a distinct type of epithelial cell that 
constitutes the innermost layer of the large and small intestine and helps to transport 
molecules into the tissues after breaking them down, present in the colon. 
They play a very valuable role in the enterohepatic cycles which include the bile acid 
recirculation and the bile acid transformation by producing the enzyme, bile salt 
hydrolase (BSH) (Stellwag & Hylemon, 1976).  
Bile acid recirculation involves the absorption of bile acids by the hepatocytes and 
this process is repeated several times within the intestine to make sure that the 
maximum amounts of nutrients are absorbed. The presence of anaerobic bacteria 
help to enhance this process (Hopley & Schalkwyk, 2006).  
Bile acid transformation also plays an important role in the regulation of bile and 
cholesterol in the system. The terminal ileum and large bowel are largely 
characterised by the presence of those anaerobes which enhance the deconjugation 
process (Hopley & Schalkwyk, 2006). They compete with other pathogens in the 
colon thereby developing a competition at food supply and receptor sites by 
producing acidic end products like acetic acid and lactic acid that lowers the pH of 
the environment. This regulates the bacterial growth in the intestine.  
 
4.2.3 General characteristics of Bacteroides fragilis 
The selective medium which can be used to distinguish B. fragilis is Bile esculin agar 
which has the presence of oxgall, ferric ammonium sulphate (colour change 
indicator) and an antibiotic, gentamycin. Gentamycin and oxgall act as inhibitors of 
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other facultative anaerobes and Gram-negative anaerobes. Esculin is hydrolysed by 
B. fragilis to produce dextrose and esculetin and this reacts with the salt to produce 
black complexes which get accumulated around the colony (Livingston et al., 1978).  
 
B. fragilis have the ability to exhibit haemolytic activity. Studies showed that the 
haemolytic activity diminished in the presence of oxygen or hydrogen peroxide and 
was controlled by the hlyA and B genes (Robertson et al., 2006). This was confirmed 
when haemolytic activity was observed in blood agar plates containing E. coli 
transformed with the hlyA and B genes. 
 
4.2.4 Cell wall structure of Bacteroides fragilis 
B. fragilis has a distinct outer capsular layer made up of polysaccharides A and B 
(Fig. 2) (Pruzzo et al., 1989). The capsular layer confers resistance to phagocytosis, 
assists in adherence to the host and also evades complement mediated lysis 
(Pumbwe et al., 2006). 
The second layer, termed as the lipopolysaccharide layer, projects out from the outer 
membrane of the lipid layer. This can be of varying thickness exhibiting a 
considerable level of toxicity and also functioning as an adhesive when contacted by 
host cells. 
They have the presence of fibrils which act as short fine appendages whose role in 
virulence is not yet determined even though it is suspected to be related to adhesion 
and biofilm formation. The next important component of the cell wall includes the 
outer membrane vesicles. They are known to produce endotoxins like 
neuraminidase, sialidase and fibrinogenolytic enzymes (Pumbwe et al., 2006). The 
fibrinogenolytic enzymes, chondroitin sulphatases and hyaluronidases are histolytic 
in nature and B. fragilis is also capable of producing antimicrobial chemicals, namely 
bacteriocins. Neuraminidase exhibits a hydrolytic activity on the mucin 
polysaccharide. One of the previous studies showed that neuraminidase activity 
plays a very important role in the successful survival of Bacteroides in mammalian 
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tissues thereby acting as one of the major virulence conferring antigens (Godoy et 
al., 1993). 
 
Studies suggest that B. fragilis produces outer membrane proteins which play an 
important role in maintaining the structure of the cell and the production of these 
proteins are controlled by a set of 4 omp genes (Wexler, 2002). 
 
 
              Figure 2:Cell wall structure of B. fragilis (Pumbwe et al., 2006) 
              Pe- periplasmic space, OM- outer membrane, L- side chains, A and           
              B- Capsular polysaccharides, Pi- Pilus, P- outer membrane porin,          
              EP- efflux pump, IM- inner membrane. 
 
4.2.5 Types of B. fragilis toxins  
 B. fragilis produces two main types of toxins,  
 The endotoxin from the outer membrane vesicles and  
 The enterotoxin whose production is controlled by the regulation of three bft 
genes, I, II and III. They can cause diarrhoea within the host by damaging the 
tight junctions of the intestine. Actin cytoskeleton rearrangement of the 
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epithelial cells causes a leakage in the internal contents of the intestine 
(Nakano et al., 2007).  
 The bft genes also induce a fluid secretion in the intestinal epithelia  (Pumbwe 
et al., 2006).  
 B. fragilis  also produces proteins termed as bacteriocins which inhibit the 
growth of other bacteria by targeting their RNA polymerase thereby providing 
the bacteria a better chance of survival during competition from other 
pathogens (Stein, 1998). 
 
4.2.6  Bacteroides fragilis virulence factors 
Some of the virulence factors produced by B. fragilis include capsules where 
capsulated strains have been shown to be more virulent in nature (Pruzzo et al., 
1989). They produce several extracellular or membrane bound enzymes like 
collagenases, fibrinolysin, proteases, lipases, ribonucleases and deoxyribonucleases 
involved in tissue degradation and destruction. The other virulence factors are the 
oxygen scavenging enzymes namely superoxide dismutases, catalases and 
peroxidases which enable the bacteria to survive in the presence of oxygen or in 
aerobic environments (Namavar et al., 1991). They produce endotoxins that are 
transported to the target host sites and induce complement activation. The capsular 
polysaccharides inhibit phagocytosis and induce abscess formation, the charged 
surface ligands help in adherence and bacterial interaggregation sometimes 
promoting the formation of biofilms of the same or different bacterial communities. 
The IgA protease causes impairment of secretory and mucosal immunity and 
heparinase promotes coagulation with tissue ischemia. Some strains of bacteria are 
capable of producing β-lactamases which confer resistance to β lactam antibiotics. 
Bacteriocins and other secondary metabolites including fatty acids, hydrogen 
sulphide and ammonia competitively inhibit the growth of normal flora (Stein, 1998).  
Studies in Bacteroides forsythus have revealed the presence of a S-layer which is a 
unique surface structure that has been known to be involved in virulence. They help 
in the adherence of the bacterial cells to the host, surface recognition and resistance 
to phagocytosis. The S-layer ranges in size from 40-200 kDa in size and is 
composed of regularly aligned glycoprotein subunits. These proteins could contribute 
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to the ability of the bacteria to adhere and form biofilms on the surface of teeth 
resulting in dental plaque (Sabet et al., 2003).    
B. fragilis can exist in both capsulated and non-capsulated forms but the capsulated 
forms tend to have a higher degree of virulence conferring capacity. Their capsules 
contain two different types of polysaccharides called A and B which are linked 
together by oppositely charged groups and they confer resistance to the organism 
against the host defences (Pantosti et al., 1993).  
They also produce a number of virulence conferring enzymes which include 
neuraminidase, hyaluronate lyase, DNase, phosphatase and rare fibrinolysins. They 
produce the enzyme heparinase which may result in vascular thrombosis (Hopley & 
Schalkwyk, 2006). They also produce a toxin called fragilysin that is a zinc 
metalloprotease, 20 kDa in molecular weight. This damages the tight junctions of the 
intestine resulting in the destruction of enterocytes due to its cytotoxic effects and 
fluid secretion (Fasano & Nataro, 2004). 
 
4.2.7 Treatment of Bacteroides fragilis infections 
A number of normal antibiotics can be used for the treatment of B. fragilis infections 
like metronidazole, chloramphenicol, moxalactam, ceftriaxone, clarithromycin, 
cefoperazone, cefotaxine, ceftazidime, sparfloxacin, carbapenems and clindamycin 
(Katsandri et al., 2006). However, recent studies showed that certain strains of B. 
fragilis exhibit resistance to carbapenem by producing a β-lactamase enzyme, 
carbapenemase. This was found to be induced by the activation of the cfiA gene with 
or without the insertion sequence elements indicating that this gene may be involved 
in the development of antibiotic resistance in Bacteroides (Edwards & Read, 2000). 
They also exhibited a resistance percentage of 0.8 and 1.3 for antibiotics imipenem 
and meropenem, respectively (Edwards & Read, 2000).   
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4.3 Enterobacteriaceae 
Enterobacter species are capable of causing a number of infections ranging from 
bacteraemia, lower respiratory tract infections, skin and soft tissue infections to 
endocarditis, urinary tract infections, intra abdominal infections and post surgical 
wound infections. One of the major characteristic of Gram negative bacteria is their 
ability to produce lipopolysaccharides. Enterobacteriaceae produce 
lipopolysaccharides which are composed of three parts namely the oligomeric 
repeating O polysaccharide units, a core and lipid A. The core links the O 
polysaccharide units to the lipid A and this causes the lipopolysaccharide to remain 
anchored to the cell envelope. O polysaccharides exhibit structural variation which 
induces inflammatory responses in the host. The toxin is also capable of causing 
sepsis within the host which later leads to the development of Enterobacter 
bacteraemia characterised by cyanosis (Janda & Abbott, 2006). Biochemical 
characteristics reveal that these bacteria are straight rods, Gram negative, 
facultatively anaerobic and exhibit both respiratory and fermentative type of 
metabolism. They are citrate positive, indole negative and are chemoorganotrophic 
in nature (Bergey & Holt, 1994). 
 
4.3.1 General virulence factors of Enterobacter species 
 Some of the major virulence factors associated with Enterobacter species are the 
mannose sensitive haemagglutinins (MSHA) type 1 or 3, siderophores, toxins and 
outer membrane proteins. The MSHA are putative fimbriae of 35 kDa size and have 
a receptor site that is recognised as a high mannose oligosaccharide. Siderophores 
have been known to be associated with invasive systemic infections. E. cloacae 
produces hydroxamate siderophore aerobactins that may be associated with 
invasive diseases whereas E. coli has been known to produce a 72 kDa aerobactin 
associated protein. Certain non-aerobactin hydroxamate compounds have also been 
found to be infrequently expressed in Enterobacter species. Details about their role 
in pathogenicity remain unknown (Keller et al., 1998). Enterobacter species also 
produce toxins like α- haemolysin which have a glycine rich motif and exhibit 
cytotoxic activity against human erythrocytes and leukocytes. Molecular 
characterisation of invasive infections caused by E. cloacae showed an up-regulation 
34 
 
of the outer membrane protein OmpX suggesting that this could be a potential 
virulence factor, 17 kDa in size. It was observed that an up-regulation of ompX was 
accompanied by a down-regulation of other outer membrane porins OmpF and 
OmpC and may be associated with the ability of the organism to exhibit resistance to 
β-lactam compounds. Bacterial strains lacking the omp X gene were constructed to 
study their role in pathogenicity and it was observed that these proteins increased 
the infection rate by 10 fold in non mutant strains (Janda & Abbott, 2006). 
 
4.3.2 Enterobacter cancerogenus 
Enterobacter cancerogenus is also a Gram-negative facultatively anaerobic 
bacterium that is a naturally occurring human gut symbiont. They have a GC ratio of 
55% with a size of 4602 Kb and are known to exhibit resistance to antibiotics like 
aminopenicillins. They have also been reported in cases of severe osteomyelitis and 
infection of bones and joints and belong to the CDC Enteric group 19. 
This bacterium was formerly known as Erwinia cancerogena and several 
morphological, physiological and biochemical studies revealed that E. cancerogena 
was not a member of the genus Erwinia but was included in the genus Enterobacter. 
E. cancerogenus are capsulated, motile straight rod shaped bacteria with 
peritrichous flagella. E. cancerogena was found to exhibit 75% phenotypic similarity 
to Erwinia carotovora and 92% phenotypic similarity to Enterobacter nimipressuralis. 
Hence it was proposed that E. cancerogena  could be moved to the genus 
Enterobacter based on phenotypic characterisation.(Dickey & Zumoff, 1988). 
 They are commonly found in nature and occur as commensals but when the host 
immune system is impaired they are capable of causing infections which make them 
opportunistic pathogens. Five cases of infection were reported in 1997. E. 
cancerogenus was identified from blood culture tests where wound infections and 
septicaemia occurred following environmental exposure of wounds from traumatic 
events or injuries in adults (Abbott & Janda, 1997).  
Studies revealed that E. cancerogenus was formerly known as Enterobacter taylorae 
after being moved from the genus Erwinia. Based on the evidence obtained from the 
study of the biochemical and physiological properties of E. taylorae, it was proposed 
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that the organism needed to be included in the Enterobacteriaceae family. They 
were able to ferment glucose to produce gas and showed 84- 95% similarity to 
ATCC 35317 strain (Farmer et al., 1985).There was a very strong relation between 
these two bacteria where they had a high degree of DNA relatedness. Since no 
difference could be ascertained between these two species, it was accepted that E. 
cancerogenus was a senior synonym of E. taylorae (Grimont & Ageron, 1989). 
Even though it is known that these bacteria are capable of causing infections and 
occur predominantly as gut microbiota, details regarding their virulence factors or 
mode of action are not available. Several cases of infection have been reported 
since 1987 and the bacteria have been included in the Proteobacteria division and 
isolated mainly from human faeces. Infections occurred following a traumatic injury 
and the bacterium was found to exhibit resistance to aminopenicillins (Garazzino et 
al., 2005). Four cases of nosocomial infections were reported in 1989 where all the 
cases described localised infection following open fractures, wounds or abrasions. 
The cases reported were bacteraemia, pneumonia and urinary tract infections. The 
bacteria were also found to produce β-lactamases showing resistance to antibiotics 
like penicillin and cephalosporins. Administration of cephalosporin prophylactically 
during cardiac surgery induced a drastic increase in the number of Enterobacter 
species in the intestine of the patient (Rubinstien et al., 1993). Another reported case 
of E. taylorae infection was osteomyelitis in a patient following an open fracture 
wound being infected (Westblom & Coggins, 1987). The most recent occurrence of 
E. cancerogenus infection was reported in 2005 where the infection occurred 
following a multiple bone fracture with abundant environmental exposure (Garazzino 
et al., 2005).  
 
4.3.3 Enterobacter species attachment to intestinal cells 
The outer membrane protein A has been known to play an important role in the 
attachment of E. sakazakii to the epithelial cells of the intestine of human hosts 
according to previous studies (Nair & Venkitanarayanan, 2007). Even though no 
reports are available regarding the attachment of E. cancerogenus to intestinal 
epithelial cells, E. cloacae which belongs to the same genus has been known to be 
associated with host intestinal tissues and mucin (Schierack et al., 2007).  
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4.3.4 Antibiotic treatment 
The commonly used antibiotic treatment for Enterobacter infections includes 
carbapenems and cefepime. Cross transmission contributes to some of the major 
factors that result in the spread of the bacteria. They have been predominantly found 
in intensive care units especially if infection control is poor.  
 
4.4 Epithelial cells of the intestine and their role in protection against 
antigens 
There are three types of cells that are produced to confer resistance to bacteria. This 
includes the goblet cells that produce proteoglycans and glycoproteins in the form of 
viscous mucin that covers the entire surface of the wet intestinal epithelial layer; the 
M cells that help to transport antigens from the exterior into the lymphoid tissue. This 
assists the host in identifying bacterial antigens and preparing the immune system. 
The third type of cells includes the Paneth cells that produce intra epithelial 
lymphocytes and antibacterial proteins that act against exogenous bacteria (Wilson, 
2002). Intestinal cells also protect themselves against bacteria by shedding off the 
surface epithelia that fill up with keratin. This sloughing off of the outer layers results 
in the removal of adhered bacteria which get flushed away. Mucosal epithelia also 
have the ability to produce proteins that recognise lipopolysaccharides present 
exogenously. This may be produced due to continual exposure to certain specific 
surface components of bacteria or for identification of potential antigens (Laux et al., 
2005). 
The entire length of the gastrointestinal tract consists of the intestinal epithelial cells 
with the outer protective mucous membrane. The upper part of the tract has been 
known to be colonised by aerobic bacterial flora since the oxygen concentration of 
the intestine decreases from the duodenum to the colon. The lower part of the 
intestinal tract is colonised by the anaerobic flora. Variations in pH and nutrition can 
affect the microflora balance and also determines the general metabolism of the 
body. Changes in microflora of the gastrointestinal tract have been known to result in 
metabolic disorders (Serino et al., 2009).  
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4.5  Mucin 
Mucin is a heavily glycosylated protein with a high molecular weight. Mucin forms a 
major component of the body secretions which include the mucous and secretions of 
the mucous gland, the saliva and secretions of the salivary gland, fibres of the 
tendons and the connective tissue. It is albuminoid in nature with a ropy appearance 
and possesses heavy glycosylation (Dekker et al., 2002). Mucins contain 
hydrophobic membrane spanning domains that enable them to be retained within the 
plasma membrane making them membrane bound. 
They generally form aggregates of proteins which are about 1-10 million Daltons and 
are known to contain neuraminic acids in their side chains (Dekker et al., 2002). 
They have the ability to resist proteolysis and act as the first line of defence against 
infection.  
 
4.5.1 Structure of mucin 
Mucin consists of a number of monomeric units that are linked by O and N linked 
oligosaccharides. Fig. 3 represents the mucin monomers linked together in an 
oligomeric gel and Figs. 4 and 5 represent the N and C termini of individual mucin 
monomers with N and O linked oligosaccharide units, cysteine knot and disulphide 
rich domains containing disulphide bonds. The disulphide rich domain is also termed 
as the D domain (Refer to Fig. 5) (Wilson, 2002). Porcine gastric mucin is 
predominantly made up of O-linked oligosaccharides and mucin side chains contain 
a number of groups attached to them including sulphates, neuraminic acids, sialic 
acids and so on.  
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Figure 3: A number of mucin monomers linked together in an oligomeric gel 
 
 
 
Figure 4: Structure of mucin showing the dimer domain 
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Figure 5: Oligomeric structure of mucin focussing on the monomer linkages and 
bonds (Wilson, 2002). 
 
Mucins are of two main types namely soluble mucins and membrane mucins. 
Soluble mucin secretion associated with the respiratory tract is known to be encoded 
by a cluster of 18 genes that results in the formation of heavily glycosylated 
disulphide bond rich glycoproteins in the mucous in man (Rose & Voynow, 2006).  
Membrane mucins are highly diverse structurally and functionally and contain a 
transmembrane domain that enables them to associate with the cell surface thereby 
acting as the first line of defense and can mediate transport of solutes. Examples of 
membrane mucin include the mucin encoded by the muc1 and muc4 genes. They 
function as anti-adhesive agents that prevent cell-cell, cell-molecular interactions. 
They also act as modulators of cell signalling pathways where muc1 encodes for 
mucin that act as docking protein and muc4 encodes mucin that acts as a modulator 
of receptor tyrosine kinase ErbB2 (Zhang et al., 2006).  Sialomucin complexes have 
the ability to act as anti-adhesive agents by disrupting cell-matrix interactions and 
have been overexpressed in cancer cells (Komatsu et al., 1997). This demonstrates 
the role of mucin and its protective functions within the host. 
N-LINKED 
OLIGOSACC
HARIDES 
LINKS TO NEXT 
MONOMER 
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A study was conducted to study the variation of mucin distribution in the gut. The 
four main parts that were studied were the small intestine, caecum, colon and 
luminal contents and three types of mucin were found to predominantly occur in 
them. These were classified as neutral mucins, sialomucins and sulphomucins of 
which sialo and sulphomucins were found to be acidic in nature and sulphomucins 
were sulphated. It was found that conventional rats produced higher amounts to 
mucin with higher villi and deeper crypts in the small intestine when compared to 
germ free rats indicating that exposure to bacteria may be one of the main reasons 
for the production of mucin. It was also observed that conventional rats had 
decreased amounts of neutral and sulpho mucins in the intestine indicating that 
bacteria could have a higher hydrolytic activity on them when compared to 
sialomucins that exhibit higher resistance (Meslin et al., 1999). This could explain the 
presence of bound sialic acids in the partially purified and crude extracts of mucin 
from the porcine intestine. 
The synthesis of mucin is controlled by a set of mucin genes termed muc. Mucin 
monomers are linked to form aggregates. They have specific non-covalent and 
intermolecular disulfide bonds to link them. The central region of the gene encodes 
the synthesis of hundreds of O-linked oligosaccharides of varying lengths whereas 
the N and C terminals have a much lesser level of glycosylation. The central region 
also possesses 10-80 repeating units of serine or threonine amino acid residues as 
shown in the figure below  (Salyers et al., 1977).    
 
 
Figure 6: Structure of the mucin gene „muc‟   
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4.5.2 Sugar composition of mucin 
Some of the oligosaccharides which have been released upon breakdown of mucin 
include 2-acetamido-2-deoxy-α-D-galactopyranosyl (1→3)-[α-L-fucopyranosyl-
(1→2)]-deoxy-β-D-galactopyranosyl-(1→3)-[N-glycoylneuraminyl-(2→6)]-2-
acetamido-2-deoxy-D-galacitol, N-glycolylneuraminyl→N-acetylgalactosaminitol, N-
acetylgalactosaminitol. Other oligosaccharides include GlcNAcβ( 1-3)GalNAc-ol, 
Galβ (1-4)GlcNAcβ (1-3)GalNAc-ol, Galβ (1-4)GlcNAcβ (l-3)4Galβ (l-4)GlcNAcβ (1-
3)GalNAc-ol, Galβ (1-4)GlcNAcβ (1-3)GalNAc-ol, GalNAcα(l-3)Galβ (1-4)GlcNAcβ (l-
6), and GalNAcα(l-3)Galβ (l-4)GlcNAcβ (1-3)Galβ (l-4)GlcNAcβ (l-3)Galα(l-
4)GlcNAcβ (l-3)GalNAc-ol irrespective of the source of mucin (Podolsky, 1985). 
   
The saccharide composition of mucin depends upon the part of the body where it 
might be produced, nutrition and several other factors including the environmental 
conditions. Studies were performed in porcine submaxillary mucins based on their 
ability to inhibit human A- anti A haemagglutination. The breakdown of the complex 
polysaccharide into oligosaccharides was studied and the resulting oligosaccharides 
were grouped from I to V. The study aimed at determining the type of mucin 
oligosaccharides that was found to be active in inhibiting haemagglutination 
(Carlson, 1968). Breakdown of mucin resulted in the release of the monosaccharide, 
2-acetamido-2-deoxy-D-galacitol (N-acetylgalactosaminitol), a pentasaccharide, 2-
acetamido-2-deoxy-α-D-galactopyranosyl (1→3)-[α-L-fucopyranosyl-(1→2)]-deoxy-β-
D-galactopyranosyl-(1→3)-[N-glycoylneuraminyl-(2→6)]-2-acetamido-2-deoxy-D-
galacitol. The other reduced oligosaccharides released include N-acetylglucosamine, 
N-glycolylneuraminyl→N-acetylgalactosaminitol and N-acetylgalactosaminitol 
(Carlson, 1968). 
Similar studies were performed in cervical mucin and it was found to contain neutral, 
sialylated and sulphated oligosaccharides including fucose, galactose, N-
acetylgalactosamine, N-acetylglucosamine, N-acetyl-galactosamine and so on. A 
neutral tetrasaccharide and an acidic trisaccharide were also isolated. It has been 
observed that there is a high degree of heterogeneity in mucins derived from various 
parts of the body like bronchial mucin, colonic mucin, cervical mucin, gastric mucin 
and so on (Yurewicz & Moghissi, 1981). 
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Previous studies performed in colonic mucin showed the release of sugars like 
galactosamine, galactose, glucosamine, sialic acids, fucose, mannose and glucose 
(Podolsky & Isselbacher, 1983).   
 
4.5.3 Functions of mucin 
Mucins are present in various parts of the body and play a very important role by 
acting as protective barriers of the host against pathogenic bacteria. Intestinal mucin 
helps the system internally by protecting the walls against the acvtivity of strong 
digestive enzymes. They lubricate the walls of the intestine, exhibit surface 
hydrophobicity and can reduce the absorption of toxins (Lugea et al., 2000).  Innate 
mucosal defense involves two main components; mechanisms that are involved in 
preventing the invasion of bacteria and their toxins and the second mechanism 
involved the rapid regeneration of the mucosal layer by repairing damages and 
defects. They work in conjunction with the tight junctions of the intestine controlling 
the passive diffusion of solutes beneficial to the host while regulating the entry of 
bacterial toxins and antigens (Blikslager et al., 2007). Even though it is known that 
the epithelial cell layer of the intestine secretes the mucin glycoproteins that form a 
viscoelastic gel, functional evidence of their protective functions are limited and not 
available in detail. Recent studies have revealed the presence of a distinctive and 
highly conserved structural motif containing 3 small proteins called the trefoil 
peptides. The goblet cells secreted these proteins and they were found to span the 
entire length of the gastrointestinal tract. The three proteins were designated as PS2, 
SP and the Intestinal trefoil factor (ITF) of which the first two were found to occur 
predominantly in the mucosa of the stomach, mouth, hepatobiliary duct and the 
pancreatic duct whereas the intestinal trefoil factor was found to be predominant in 
the small and large intestinal mucosa. These proteins contain a highly conserved 6 
cysteine residue motif that form three intrachain loops with disulphide bond 
interactions.  It has also been suggested that the occurrence of secondary structures 
of these proteins on the mucosal layer could confer resistance to the digestive 
activity of a variety of protease enzymes. This helps to maintain the intestinal walls 
structurally and functionally intact from the activity of proteases (Podolsky, 1999). 
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4.5.4 Mucin degradation by bacteria 
Bacteria have the ability to produce a variety of enzymes that degrade the mucin 
glycoproteins. This enables them to adhere efficiently to the host and thereby cause 
infection within the host. The glycoside hydrolases produced by bacteria, cleave the 
carbohydrate chains in mucin and hydrolyse them to produce monosaccharide units. 
These monosaccharides are then used by the organism as a source of energy and 
nutrition (Roberton & Stanley, 1982). 
Mucin, being the main component of mucosal surfaces acts as a point of adherence 
for the bacteria where they grow upon the glycoside residues of the complex 
glycoprotein oligomer by producing glycoside hydrolases and this leads to further 
damage of the mucosal surface and impairment of the membrane function (Salyers 
et al., 1977). B. fragilis has also been known to ferment mucin to release sulphates 
which favour the growth of other sulphate reducing bacteria. They break down 
sulphates into sulphides which can be toxic to the human system and this suggests 
that B. fragilis may possess sulfatase activity (Willis et al., 1996).   
Mucin, a high molecular weight glycoprotein that is heavily glycosylated and 
phosphorylated acts as a potential target for commensal bacteria like sulphate 
reducing bacteria which metabolise the sulphates and phosphates to produce 
sulphide ions and toxic hydrogen sulphide. This alters the environment in the gut and 
encourages the growth of other intestinal infection causing bacteria. According to 
previous studies, the sulphation of the gastrointestinal tract increases from 1-3% in 
the stomach to 3-5% in the colon (Willis et al., 1996). The intestinal microflora 
depend upon the type of nutrition and it has been observed that changes in nutrition 
can affect metabolism and cause an imbalance or change in the microflora of the 
gut. The other factor that contributes to the type of microflora present in the gut is the 
oxygen concentration. The upper part of the gastrointestinal tract is colonised by 
aerobic flora whereas the lower part of the gut is colonised by anaerobes. This may 
be due to the decrease in concentration of oxygen from the duodenum to the colon 
(Serino et al., 2009). Evasion of the host immune system results in the development 
of an infection. Previous studies have shown that micro-organisms have the ability to 
colonise the reproductive tract by producing enzymes like mucinases and sialidases 
which degrade the protective mucin layers in the cervix (Wiggins et al., 2001). 
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Some of the reasons for the colonisation of mucosal surfaces by bacteria may be 
due to chemotaxis and motility. Previous studies have shown that mutants lacking 
motility and chemotactic abilities exhibited reduced virulence (Laux et al., 2005). 
Bacterial flagella can function as adhesins too. Adherence of bacteria to the mucous 
layer receptors prevents their adherence to the cell receptors of the intestine. But the 
process behind how this adherence enhances colonisation is not known. Hence the 
cell surface structures that are expressed in bacteria during colonisation play an 
important part in understanding the mechanism of pathogenesis  (Laux et al., 2005). 
The B. fragilis genes BF0855 and BF3763 which were cloned and expressed in E. 
coli encoded the putative expression of the enzymes α-fucosidase and α-
glucosidase respectively. These enzymes have the ability to hydrolyse 
oligosaccharides into simple sugars like glucose or galactose and may play an 
important role in the degradation of complex polysaccharides like mucins. These 
enzymes may be associated with the differential expression of proteins in mucin 
enriched media and was one of the main reasons for their purification and 
characterisation in this study.    
The study of the genome of organisms is termed as „genomics‟ and the sequencing 
of genomes forms the basic blue print behind the study of proteins.  There may be 
several modifications, interactions and other complex structures formed by proteins 
but all of these may be linked to the genome through various factors like the 
environment (Zivy & de Vienne, 2000). 
 
4.6 Proteomics 
Proteomics is a field of science that merges the study of genes and proteins 
employing technologies such as two dimensional gel electrophoresis and mass 
spectrometry. It is basically a genomic study of the functions and expression of 
proteins where the two dimensional gel electrophoresis is used to measure the 
expression of a protein and mass spectrometry is used in protein identification and 
characterisation. The advancements in the field of genomics has led to the more 
frequent employment of proteomics to study proteins/enzymes, and has led to 
advancements in antibacterial drug discovery, identification of drug targets and the 
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mechanisms of resistance exhibited by bacteria  and various other characteristics 
related to it (Brotz-Oesterhelt et al., 2005).  
The term „proteome‟ has been derived from the terms „protein‟ and „genome‟. There 
are several factors that can influence the proteome of an organism, namely stress, 
culture conditions, environment, metabolism, temperature, drugs, illness and so on. 
The genome encodes the cell specific expression of proteins based on the effect of 
these factors. Protein modifications also act as important factors that contribute to 
the functions of a cell and the study of all the proteins produced by a particular 
species in an environment is collectively termed as proteomics. The five major 
aspects that contribute to research in proteomics include mass spectrometry based 
proteomics, proteome-wide biochemical assays, systematic structural biology and 
imaging techniques, proteome informatics and clinical applications of proteomics 
(Tyers & Mann, 2003). Proteomics serves as a tool in studying post translational 
modifications that alter physical and chemical properties of proteins including folding, 
conformation, stability and functions. Proteomic techniques like stable isotope 
labelling and novel mass spectrometric peptide sequencing can be used to 
characterise modifications in proteins like phosphorylation or in membrane proteins. 
Proteomics has also been used as a valuable tool in the identification of protein 
isoforms in eukaryotes (Blakeley et al., 2010). Alternate splicing of mRNAs result in a 
major difference between the sequences of genes present and the translated protein 
isoforms that can be of varying complexities. Protease associated degradation of 
proteins acts as an important factor in regulating signalling pathways and other 
physiological processes where selective affinity purification and tandem mass 
spectrometric analysis of resulting peptides can be used to study the processing 
events that may be taking place during cell signalling (Xu et al., 2009). 
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4.7 Transcriptomics 
Analysing or studying proteins that are expressed in a cell through the mRNA 
present in the cell is called transcriptomics. Transcriptomics forms the link between 
proteomics and genomics since messenger RNA is the link between genes and 
proteins (Hegde et al., 2003). Transcriptomics works based on the principle that 
genes showing similarities in their expression patterns may be functionally related 
too and hence it may be of importance to study the genes that control these 
expression profiles. Mutations in gene sequences can be used to study their 
potential as prospective drug targets, determining the functions of DNA sequences 
with no known activity based on their similarity to other conserved genes that may be 
homologous in nature (Twyman, 2003).   
 
 4.8  Two dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
This technique plays as a major role in the separation of mixtures of proteins. It is 
mainly composed of two techniques namely isoelectric focussing (IEF) and sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE). 
IEF is the first dimensional separation of the protein based on the net charge that it 
possesses. A high voltage is applied to the proteins of interest which are to be 
separated and an immobilised pH gradient technique is used in the separation of 
proteins using specific reagents. Proteins usually possess a charge and tend to 
migrate towards the oppositely charged electrode in the presence of an electric field. 
When a positively charged protein migrates towards the cathode, it passes through 
an increasing pH gradient which causes an overall decrease in the charge of the 
protein. Eventually, the protein reaches a pH region that corresponds to its 
isoelectric point where the net charge becomes zero and migration stops. This 
results in the formation of a protein band at that particular point. Following the 
separation based on charges, they are then run on a second dimension SDS-PAGE 
where the separation is based on the molecular weight and size. This technique 
employs the use of a denaturing anionic detergent, sodium dodecyl sulphate, in the 
effective separation of proteins (Gorg et al., 2004). The anionic detergent confers a 
negative charge to the protein in proportion to its length by wrapping itself around the 
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polypeptide backbone. When an electric field is applied, the proteins migrate towards 
the positive electrode. The size of the pores in the polyacrylamide gel are user-
defined and differentially retard the migration of proteins based on their size. Smaller 
protein molecules tend to travel farther down the gel when compared to larger 
protein molecules that remain closer to the point of origin resulting in effective 
separation of proteins. Therefore, by combining the separation of proteins based on 
their charge, or isoelectric point, and size, or relative molecular mass, differential 
expression studies can be performed. 
Previous proteomic studies have been done in analysing the oxidative stress 
response in B. fragilis since they are known to be strict anaerobes and it was found 
that these bacteria are capable of inducing OxyR regulon genes that respond to the 
presence of oxygen or hydrogen peroxide in the environment and this might play an 
important role in their ability to survive within the tissues in the colon  (Rocha et al., 
2003).  
 
4.9 Mass spectrometry 
Separation of molecules on the basis of their mass to charge ratio following 
ionisation is called mass spectrometry where a mass spectrum is generated based 
on the intensity of ionisation. The detected spectrum is then compared to a standard 
database to determine the identity of the complex peptide mixture. The sample is 
first passed through the ioniser that charges the molecules and the ions that are 
generated, enter the analyser where the ions are separated in vacuum. The 
individual ions from the analyser are then passed on to the detector where a 
spectrum based on the intensity of the ions is generated. The height of the peak in a 
spectrum is referred to as intensity. Mass spectrometry acts as a major tool in 
genomics and proteomics where complex molecules and protein mixtures can be 
identified and analysed (Liebler, 2002). Identification of proteins from a database is 
called peptide mass fingerprinting (PMF) or peptide mass mapping. Some methods 
of analysis also involve the comparison of a theoretical calculated spectrum of a 
database to an experimental spectrum generated from the mass spectrometer.  One 
of the common methods used for the identification of proteins is the tandem mass 
spectrometry which consists of two phases. The first phase constitutes the ionisation 
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of peptides to produce a spectrum that is used for peptide mass fingerprinting. Some 
of the peaks from this spectrum are selected based on the intensity and subjected to 
the second phase of dissociation. The ions are transmitted through a high pressure 
region of the tandem mass spectrometer containing gas molecules. The gas 
molecules collide with the ions and further fragment them into ions of varying 
masses called collision induced dissociation (CID) (Liptak, 2005). Since 
fragmentation can occur between any two residues along the peptide, differing 
masses of ions are generated and can be termed as b and y ions (Refer to Figs. 7 
and 8). These ions are then mapped to their respective proteins using a database 
like MASCOT (Johnson, 1987). 
 
Figure 7 represents the fragment ions in an MS/MS spectrum (Anon, 2010) 
 
 
Figure 8 shows the structures of six singly charged sequence ions (Anon, 2010). 
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4.10 Glycoside hydrolases 
Glycoside hydrolases or glycosidases are enzymes that catalyse the hydrolysis of 
sugars and other complex polysaccharides into smaller and simpler sugar units by 
hydrolysing their glycosidic linkages. These simple sugars or end products help in 
carbohydrate metabolism and are used as a source of carbon and energy in bacteria 
and higher animals. Glycosidases in association with glycosyltransferases, form the 
main machinery for the synthesis and breakdown of glycosidic bonds. They are 
produced as extra and intracellular enzymes in bacteria that help to acquire nutrients 
by breaking down complex compounds into simple sugars. Within the intestinal tract, 
they are capable of degrading carbohydrates like lactose, starch, sucrose and 
trehalose. 
Glycoside hydrolases can be classified based on the stereochemical outcome of 
their hydrolysis reactions as inverting or retaining mechanisms. They act on oligo 
and polysaccharide chains by hydrolysing the glycosidic linkages in the non-reducing 
end or the middle of the chain. Hence this can be used to classify them as exo-acting 
or endo-acting glycoside hydrolases. The exo-acting enzymes are capable of 
cleaving residues from the ends of the polysaccharide chains whereas endo-acting 
enzymes remove residues from the middle or internal positions in a random manner 
resulting in several oligosaccharides of different sizes. They have also been 
classified on sequence based methods where sequence similarity acts as a major 
factor. This series of sequence based classification of enzymes allows the prediction 
of their mechanism of hydrolysis, active site residues and possible substrates that 
can confer this activity. The CAZy website enzyme database is regularly updated 
and classifies enzymes based on their sequence and three dimensional structural 
similarities. The glycosidase sequence analysis and three dimensional structure 
comparison has led to the generation of a hierarchial classification of these glycoside 
hydrolases (http://www.cazy.org/fam/acc_GH.html). 
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4.10.1 Inverting mechanism in glycoside hydrolases 
Reactions involving the inverting mechanism of hydrolysis of carbohydrates employ 
the use of two enzymatic residues where one acts as an acid and the other acts as a 
base. The reaction occurs in the presence of carboxylic acid at the active site. This 
type of catalysis can be termed as a general acid base assisted catalysis method 
(Sinnott, 1990). 
 
Figure 9: Figure showing the catalytic mechanism in glycoside hydrolases 
(http://www.cazy.org/fam/ghf_INV_RET.html) 
 
 
 
Figure 9.1: Figure showing the inverting mechanism of hydrolysis. Enzyme 1 acts as 
a base and the enzyme 2 acts as an acid by donating protons. 
 
 
4.10.2 Retaining mechanism in glycoside hydrolases 
The retaining mechanism involves a 2 step reaction and each step results in an 
inversion of compounds. There are two enzyme carboxylic acid residues present 
where one acts as a nucleophile and the other acts as an acid or base by donating 
or accepting protons respectively. When the nucleophile attacks the anomeric centre 
in the first step, a glycosyl intermediate is formed. The acidic carboxylate acts as a 
proton donor and assists the reaction. The second step involves the hydrolysis of the 
Enzyme 2 
Enzyme 1 Enzyme 1 
Enzyme 2 
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glycosyl enzyme intermediate by the deprotonated acid carboxylate which acts as a 
base to produce the hydrolysed product. The reaction also involves the use of a 
nucleophilic water molecule. The following figure represents the inverting and 
retaining mechanism of glycoside hydrolase enzymes. 
 
 
Figure 9.2: Figure showing the retaining mechanism of hydrolysis. The enzyme 1 
acts as a nucleophile and the enzyme two acts as an acid or a base. A glycosyl 
enzyme intermediate is formed before the substrate is converted into the hydrolysed 
product. 
 
4.10.3 Carbohydrate active enzymes (CAZy) based classification of enzymes 
The CAZY website classifies enzymes into five main categories namely glycoside 
hydrolases (GHs), polysaccharide lyases (PLs), glycosyltransferases (GTs) and 
carbohydrate esterases (CEs) and carbohydrate binding modules (CBMs). Substrate 
specificity and molecular mechanisms contribute to some of the main factors 
considered for classification. The relationship between sequences and their folding 
similarities led to the consideration of amino acid sequence similarities as a major 
Enzyme 1 
Enzyme 2 
Enzyme 2 
Enzyme 1 
Enzyme 2 
Enzyme 1 
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factor. The active sites remain highly conserved and are maintained with integrity 
even though the structures of enzymes may differ due to evolutionary divergence. 
The families have also been grouped into „clans‟ based on the strong conservation of 
the folds of proteins even though sequences were not found to be as conserved as 
the folds of proteins. This grouping of families into clans would help to overcome 
structural and sequential resemblances or relatedness of enzymes to more than one 
family. The other factor that supported the grouping of families into clans was the 
improved sensitivity of sequence comparison methods. As of May 2009, 115 families 
of enzymes have been identified and classified in the CAZY website 
(http://www.cazy.org/fam/acc_GH.html). 
 
4.10.4  Active site topology 
Glycoside hydrolases have the presence of specific active sites based on the 
position of hydrolysis of the polypeptide chain. These may be of three types namely, 
the pocket site which is characteristic of exo enzymes, the cleft structure that occurs 
in endo enzyme hydrolysis and the tunnel topology in exo enzyme hydrolysis (refer 
to the Fig. 10). While the pocket topology binds to the ends of the polysaccharide 
chains, the cleft topology binds chains randomly within a cleft. The tunnel topology 
being very similar to the cleft topology has additional polypeptide loops which are 
present on the top of the cleft giving it a tunnel like appearance. The end of the 
polypeptide chain enters the tunnel and the digested peptides are released out at the 
other end. In the case of the cleft active site, random hydrolysis of the polypeptide 
chain results in the release of oligosaccharides or various lengths (Davies & 
Henrissat, 1995). 
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Figure 10: Figure showing the active site topology in glycoside hydrolases (Davies & 
Henrissat, 1995) 
 
Figure 10.1: Pocket topology. Coloured area indicates the substrate binding site of 
the enzyme. 
 
 
Figure 10.2: Cleft topology. Coloured area indicates the substrate binding site of the 
enzyme. 
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Figure 10.3: Tunnel topology. Coloured area indicates the substrate binding site of 
the enzyme. 
 
4.10.5  Genomes of B. fragilis and E. cancerogenus 
Completed published sequences of the genome of a number of different bacteria are 
readily available online. As of 11th May, 2009, 992 genomes have been published 
and are available via the Gold genome database. The online database reports 2523 
ongoing bacterial genome sequencing projects along with 1029 eukaryotic genomes 
and 96 archael ongoing projects. The total number of ongoing genome projects has 
been reported to be 4807 when compared to 2006 when it was 2172 
(http://www.genomesonline.org/gold.cgi). 
 The sequencing of genomes provides important information regarding the function 
of proteins. Once a genome is sequenced, the DNA is annotated as putative open 
reading frames (ORFs) containing information about the coded regions including 
exons, introns, promoters and so on (Zhang, 2006). Based on the translation of 
these ORFs, proteins or amino acid sequences can be obtained and searched 
against a sequence database to determine a list of proteins with the highest scores. 
Protein hits that show a very high degree of similarity or homology indicate a 
functional similarity between the two proteins. This can also be used to study the 
similarities and relationships between different bacterial species. Some of the 
problems that may be associated with this approach are that one particular gene 
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could encode for more than one protein and this could create confusion during 
analysis (Pennington & Dunn, 2001). 
The genome of B. fragilis NCTC 9343 has been sequenced and published by the 
Sanger Institute (http://www.sanger.ac.uk/Projects/B_fragilis/). The genome of E. 
cancerogenus ATCC 35316 is still being sequenced and is available through the 
NCBI website but work is still ongoing. The sequencing information is available from 
the Washington University or through the Gold genomes online database 
(http://www.genomesonline.org/gold.cgi?want=Bacterial+Ongoing+Genomes). 
Genomes of various species of Bacteroides namely B. vulgatus, B. diastonis were 
compared with B. fragilis and B. thetaiotomicron in a study. The conserved gene sets 
were grouped into Clusters of orthologous groups. Gut associated Bacteroidetes 
proteomes showed the predominant expression of conserved genes in carbohydrate 
transport and metabolism followed by cell wall or membrane or envelope biogenesis. 
The shared proteome of Bacteroidetes showed the expression of genes involved in 
amino acid transport and metabolism followed by translation, ribosomal structure and 
biogenesis genes (Xu et al., 2007).     
 
4.10.6  Glycoside hydrolase families GH95 and 97 and the putative 
activity of their enzymes 
The GH95 BF0855 gene encodes for a conserved hypothetical protein containing 
755 amino acids with a molecular weight of 86 kDa. The CAH06598.1 protein 
exhibits putative α1-2, L-fucosidase and α-L-fucosidase actvitiy and the catalytic 
nucleophile is asparagine that is activated by aspartic acid residues (Cerdeno-
Tarraga et al., 2005).  The catalytic proton donor has been identified to be glutamic 
acid residues. Previous structural studies of these enzymes in Bifidobacterium 
bifidum have shown that the enzyme has a high degree of similarity to the 
immunoglobulin Ig domains with similar folding patterns. They possess α/α six barrel 
or catalytic TIM type barrel domain and are active against substrates like 2‟-
fucosyllactose and lacto-N-fucopentaose I (Katayama, 2004) .  
The GH97 BF3763 gene encodes for a putative export protein containing 649 amino 
acids with a molecular weight of 74 kDa. The CAH09443.1 protein is known to be a 
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putative α-glucosidase or α-galactosidase. Enzymes that exhibit inverting 
mechanisms of catalysis contain glutamic acid as nucleophiles and those that exhibit 
retaining mechanisms of catalysis possess aspartic acid residues as nucleophiles 
(Gloster et al., 2008). Previous studies of the starch utilisation system in Bacteroides 
thetaiotomicron showed an inversion mechanism of catalysis liberating a β-anomer 
of glucose (Kitamura et al., 2008). The possess α/β eight barrel or catalytic TIM 
barrel type domains and the amino acids of the active site are located at the C-
termini of the β-strands. These proteins exhibit a high degree of similarity to proteins 
of other families that exhibit a retaining mechanism of glycoside bond hydrolysis 
(Naumoff, 2005). 
 The BF0855 gene from B. fragilis NCTC 9343 which was cloned and expressed in 
E. coli with a putative activity of α-L-fucosidase or 1, 2 α-L- fucosidase catalyses the 
reaction between α-L- fucoside and water resulting in the formation of L- fucose as 
an end product. These enzymes belong to the family of glycoside hydrolases that 
hydrolyse O and S glycosyl compounds and are also known as α-L- fucoside 
fucohydrolase. It is involved in n- glycan and glycan structure degradation and may 
be involved in the degradation of mucin by bacteria. 1, 2-α-L- fucosidase catalyses 
the following reaction: 
Methyl- 2- para- L- fucopyranosyl- β- D- galactoside + H2O ↔ L- fucose + methyl β- 
D- galactoside. 
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5 Aims of the study 
This study aims at understanding the differences in protein expression in E. 
cancerogenus ATCC 35316 and B. fragilis strain NCTC9343 in mucin-supplemented 
media in comparison to basic semi-defined media containing glucose as the 
carbohydrate source. These are commensal organisms that act as opportunistic 
pathogens and can cause infections within the host when the immune system is 
impaired. 
Two dimensional gel electrophoresis technologies would be employed, where the 
proteins were first separated in the first dimension based on their charge and pH 
using isoelectric focussing and then separated using the second dimension 
polyacrylamide gel electrophoresis based on their molecular weight. Protein 
expression profiles would be generated for both bacteria grown in the presence and 
absence of mucin and compared. Comparative analysis of gels would be used to 
determine the protein spots that show a differential expression in the presence of 
mucin.  
The protein spots of interest will be excised and subjected to in-gel trypsin digestion 
where the peptides produced from the degradation of proteins would be analysed 
using a nano flow liquid chromatography coupled mass spectrometer. This would 
help to identify the protein based on the mass spectrum (m/z ratio) generated from 
the MS-MS fragmentation of peptide ions. The identification of the differentially 
expressed proteins may provide an insight into the indirect association of bacteria 
and their colonisation of mucin. It may also be interesting to use mucin-coated cell 
culture plates to study the interaction between bacteria and mucin in the presence of 
a host immune response.  
This study also aims to express, purify and crystallise the proteins CAH06598 and 
CAH09443 from the glycoside hydrolase families 97 and 95 in B. fragilis strain NCTC 
9343 which produce the enzymes with the putative functions of α-fucosidase and α- 
glucosidase respectively. The recombinant enzyme activity was analysed against 
different chromophoric and fluorogenic substrates. Crystallisation of proteins would 
be useful in determining its three dimensional structure and obtain a detailed 
understanding of its active sites. 
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6.  Materials for the Proteomics experiment 
  
6.1  Culture Conditions 
Bacteroides fragilis strain NCTC 9343 and Enterobacter cancerogenus ATCC 35316 
were cultured in Columbia agar plates (CBA). A single colony from the plate was 
used to inoculate 20 mL of sterile anaerobic broth media (Bac T/ ALERT SN). The 
medium was incubated overnight in an anaerobic chamber at 37 °C. A loopful of the 
liquid culture was used to streak a CBA plate (Figure 3). The purity of the subculture 
was confirmed by Gram staining which showed Gram-negative rods. 
 
6.2  Anaerobic chamber 
The bacteria was cultured and maintained in an anaerobic chamber that was flushed 
with 80% nitrogen gas, 10% carbon dioxide and 10% hydrogen (Cox & Mangels, 
1976). 
 
6.3  Minimal media used for the growth of B. fragilis 
Minimal media used for the growth of B. fragilis according to the method of Varel and 
Bryant (1974) 
 
Per 100 ml     
Glucose          0.5 g 
Mineral solution1                                       5.0 mL 
Hemin solution2                                        0.1 µL 
Resazurin solution3                                  0.1 µL 
Volatile fatty acid solution4                       0.45 mL 
Vitamin B solution5                                 0.5 mL 
FeSO4-7H2O                                       0.4 mg 
6 mM (NH4)2SO4                                5.0 mL 
Casitone (Difco)                                   0.2 g 
Amino acid mixture6                              20 mL 
2.5% (w/v) Cysteine-HCl solution     2.0 g 
8% (w/v) Na2CO3 solution              5.0 mL 
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 The medium was made up with distilled water and autoclaved before use. The pH of 
the medium was adjusted to 7.0 and all components were added before autoclaving 
except sodium carbonate and cysteine. The medium was incubated overnight in the 
anaerobic chamber at 37oC in the absence of oxygen before inoculation of starter 
cultures. 
 
6.3.1     Stock solutions 
 
6.3.1.1 Mineral solution1 
Per litre 
KH2PO4                                     18 g 
NaCl                                            18 g 
CaCl2-2H2O                                0.53 g 
MgCl2-6H2O                                0.4 g 
MnCl2-4H2O                                0.2 g 
CoCl2-6H2O                                0.02 g 
 
6.3.1.2 Hemin stock solution2 
A stock concentration of 0.1% (w/v) of hemin solution was obtained by dissolving 0.1 
g of hemin in 1 mL of 0.1 M sodium hydroxide and then diluted to 100 mL with 
distilled water and appropriate dilutions of the stock were added to obtain a final 
concentration of 0.0001% (w/v) of hemin solution.  
 
6.3.1.3 Resazurin solution3 
A stock concentration of 0.1% (w/v) of resazurin solution was prepared by dissolving 
0.1 g of resazurin in 100 mL of sterile 18.2 MΩ/cm and appropriate dilutions of the 
stock were added to obtain a final concentration of 0.001% (w/v) of resazurin 
solution.  
 
 
6.3.1.4 Volatile fatty acid solution4 
Per 100 mL 
Acetic acid                                36 mL 
Isobutyric acid                           1.8 mL 
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n-Valeric acid                             2.0 mL 
DL-2 Methylbutyric acid            2.0 mL 
Isovaleric acid                           2.0 mL 
 
6.3.1.5 Vitamin B solution5 
Per 100 mL 
Thiamin-hydrochloride                       20 mg 
Calcium-D-pantothenate                   20 mg 
Nicotinamide                                     20 mg 
Riboflavin                                          20 mg 
Pyridoxine-HCl                    20 mg 
p-aminobenzoic acid                         1 mg 
Biotin                                                 0.25 mg 
Folic acid                                           0.25 mg 
Vitamin B12                                       0.1 mg 
 
6.3.1.6 Amino acid mixture6 
Per 50 mL 
L-histidine-hydrochloride      25 mg 
L-tryptophan        25 mg 
Glycine        25 mg 
L-tyrosine        25 mg 
L-arginine-hydrochloride      50 mg 
L-phenylalanine       50 mg 
L-methionine        50 mg 
L-threonine        50 mg 
L-alanine        50 mg 
L-lysine        75 mg 
L-serine        75 mg 
L-valine        75 mg 
L-isoleucine        75 mg 
L-proline        75 mg 
L-aspartic acid       75 mg 
L-leucine        100 mg 
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L-glutamic acid       224 mg 
 
6.4 Semi defined growth media 
Per 100 mL 
Casitone                                           0.5 g 
Yeast extract                                    0.5 g 
Ammonium sulphate                        0.08 g 
Salts solution A*                              0.04 mL 
Salts solution B *                             0.005 mL 
Hemin solution                               0.01 mL 
Glucose                                          0.5 g 
Sodium carbonate                         0.8 g 
Cysteine-HCl                                 0.05 g 
 
The medium was adjusted to a pH of 7 and all components were added before 
sterilisation except glucose and Na2SO4.  Sterile glucose and sodium carbonate 
solutions were prepared separately and added aseptically to the medium. The 
medium was incubated overnight at 37 °C in the anaerobic chamber before 
inoculation with the starter cultures. The hemin solution was prepared by dissolving 
50 mg of hemin in 1 ml of 0.1 M NaOH which was diluted with distilled water to 100 
mL. In 100 mL of the mucin supplemented semi-defined media, 0.5 g of mucin Type 
II or III were added to the media in addition to 0.5 g of glucose and autoclaved. The 
0.5 g refers to the total amount weighed out and added rather than the concentration 
of sugars in mucin. 
Sigma-Aldrich porcine gastric mucin Type II and Type III were used in the 
proteomics experiments. A quantity of 0.5 per of the glycoprotein was weighed out 
and added to 100 mL of the semi-defined medium and dissolved by vigorous 
shaking. Mucin was added to the semi-defined medium just before autoclaving and 
care was taken to avoid inhaling the chemical dust. 
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6.4.1 Stock solutions 
 
6.4.1.1 Salts solution A 
 
Per litre 
CaCl2                                     0.2 g 
MgSO4                                   0.2 g 
K2HPO4                                 1.0 g 
KH2PO4                                 1.0 g 
NaCl                                       2.0 g 
NaHCO3                                 10.0 g 
 
6.4.1.2  Salts solution B 
Per litre 
FeSO4-7H2O                           2.0 g 
CoCl                                         0.08 g 
 
 
6.5 Gram staining reagents 
Crystal violet        5 mL 
 Gram‟s iodine       5 mL 
 Acetone        5 mL 
Safranin solution       5 mL 
 
 
6.6 SDS-PAGE Loading buffer 
Per 10 mL 
60 mM Tris Base pH 6.8                   0.6 mL 
50% (w/v) glycerol                             5 mL 
10% (w/v) sodium dodecyl sulphate (SDS)   2 mL 
14.4 mM β-mercaptoethanol          0.5 mL 
1% (w/v) Bromophenol blue (BPB)              1 mL 
 
Stored as 1 mL aliquots at -20 °C 
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6.7 Protein size standards 
High molecular weight standard (M.W. 36, 45, 55, 66, 84, 97, 116 and 205 kDa) 
Low molecular weight standard (M.W. 20, 24, 29, 36, 45 and 66 kDa) 
To obtain a final concentration of about 2.0-3.5 mg/mL, the lyophilised standards 
were reconstituted in 100 µL of 18.2 MΩ/cm water and aliquoted out in 4 µL 
quantities into 1.5 mL microcentrifuge tubes and stored at -20°C. Refer to appendix 
D for the list of proteins used as a source for producing these size standards. 
 
6.8 Buffers and solutions used for the Proteomics experiment   
 
6.8.1 Cell resuspension buffer 
The cell resuspension buffer has the same recipe as that of the phosphate buffered 
saline (6.8.2) 
 
6.8.2 Phosphate buffered saline (PBS) 
Per litre (pH 7.0) 
NaCl                                                     8 g 
KCl                                                        0.2 g 
KH2PO4                                                0.2 g 
Na2HPO4-12H2O                                  1.44 g 
 
6.8.3 Lysis solution 
Per 10 mL 
Urea                                                      4.8 g 
 3-[(3-Cholamidopropyl) dimethylammonio]-2-hydroxy-1-propane sulphonate 
(CHAPS)                                              0.4 g 
The solution was made up in a sterile universal and aliquoted out into 
microcentrifuge tubes in 1 mL quantities. This was then stored at -20°C and 2 µL of 
IPG buffer was added to every 100 µL before use. 
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6.8.4 Rehydration solution (for IPG strips pH 3-10 or 4-7) 
Per 10 ml 
Urea                                                        4.8 g 
CHAPS                                                   0.4 g 
1% (v/v) BPB                                          20 µL 
 
1% (w/v) bromophenol blue solution was prepared by dissolving 1 g of bromophenol 
blue dye in 100 mL of 18.2 MΩ/cm water. 
The rehydration solution was divided into 700 µL aliquots and stored at -20°C. Prior 
to use, 14 µL IPG buffer (pH 3-10 or 4-7) and 1.4 mg of ditiothreitol (DTT) was added 
to each tube to give a final concentration of 2% (v/v) and 0.2% (w/v) respectively. 
 
Isoelectric focusing or the first dimension separation of proteins was carried out 
using a Multiphor II electrophoresis system involving the use of other components 
listed in the Appendix section B. 
Main parts include the anode and cathode electrodes, tray and electrode holder, dry 
strip aligners, IEF electrode strips. 
 
6.8.5 Equilibration solution 
Stock solution: 
Per 200 mL 
1.5 M Tris-HCl (pH 8.8)                             10 mL 
Urea                                                           72 g 
Glycerol                                                      69 mL 
SDS                                                            2 g 
1% (v/v) BPB                                              200 µL 
The stock solution was stored at -20°C in 20 mL aliquots. 
 
6.8.5.1 Equilibration buffer with DTT 
Per 20 mL 
Equilibration stock solution                        20 mL 
DTT                                                            0.2 g 
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6.8.5.2  Equilibration buffer with Iodoacetamide (IAA) 
Per 20 mL 
Equilibration stock solution                         20 mL 
Iodoacetamide (IAA)                                  0.9 g 
 
6.9 Second dimension-SDS-PAGE 
The SDS-PAGE was performed using a Protean II XL 2-D cells (Bio-Rad). 
4 mm xi clamp notch vs 13 mm XL clamp notch 
19 mm xi spacer vs. 8 mm XL spacer 
181 mm xi core gasket vs. 198 mm XL core gasket 
153 mm xi comb vs. 184 mm XL comb 
The main parts include tank and lid, central cooling core, casting stand, sandwich 
clamps, alignment card and combs.  
 
Small gels- glass plate sizes were 10.1 X 8.2 cm 
Large gels- glass plate sizes were 20 X 20 and 20 X 22 cm separated by spacers of 
1.5 mm 
 
6.9.1 14% (w/v) Resolving gel components 
18.2 MΩ/cm water                                                          58 mL 
1.5 M TRIS-HCl, pH 8.8                                                  37.5 mL 
10% (w/v) SDS stock                                                      1.5 mL 
40% (v/v) solution (37.5:1 acrylamide: bisacrylamide)    52.2 mL 
10% (w/v) APS                                                                750 µL 
N, N,N‟,N‟-Tetramethylethylenediamine (TEMED)           75 µL 
 
6.9.2 4% (w/v) Stacking gel components 
18.2 MΩ/cm water                                                          12.85 mL 
0.5 M TRIS-HCl, pH 6.8                                                  5 mL 
10% (w/v) SDS stock                                                      200 µL 
40% (v/v) solution (37.5:1 acrylamide: bisacrylamide)   1.95 mL 
10% (w/v) ammonium persulphate (APS)           100 µL 
TEMED                                                                           20 µL 
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1% (w/v) BPB                                         20 µL 
 
6.9.3 Agarose sealing solution 
Per 20 mL 
Running buffer (1 X)                                                     19 mL 
Agarose                                                                        0.1 g 
1% (w/v) BPB                                                                40 µL 
 
Protein size standards were the same as those mentioned in the above sections 
(Refer to Appendix D for details). 
 
6.9.4 Staining and destaining solutions 
 
6.9.4.1 Colloidal Coomassie blue stock 
Per litre 
Ammonium sulphate                             100 g 
Phosphoric acid                                     20 mL 
Coomassie blue G 250                      1 g 
 
20 mL of 18.2 MΩ/cm was used to dissolve 1 g of Coomassie blue G 250. A 20 mL 
solution of phosphoric acid was used to dissolve 100 g of ammonium sulphate and 
18.2 MΩ/cm water was added if necessary. The two solutions were then mixed 
together and made up to 1 litre with 18.2 MΩ/cm water. 
The stock solution was stored at room temperature until use. 
 
6.9.4.2 Fixing solution (Colloidal Coomassie blue staining) 
Per litre 
Methanol                                                     500 mL 
Glacial acetic acid                                       120 mL 
 
6.9.4.3 Staining solution (Colloidal Coomassie blue staining) 
The stock solution was shaken well to suspend the Coomassie blue stain and four 
parts of the Coomassie stock was diluted with one part methanol before use. 
  
67 
 
 
6.9.4.4  Fixing solution (Fluorescent staining) 
Per litre 
Ethanol                                           400 mL 
Acetic acid                                      100 mL 
 
6.9.4.5 Staining solution (Fluorescent staining) 
A 10 X concentration of the Bio-Rad FlamingoTM fluorescent gel stain was diluted to 
a 1 X working concentration of the solution with 18.2 MΩ/cm. 
 
6.9.5 Visualisation of the stained gels 
The Bio Rad Chemi doc XRS (Quantity One TM software, Resolution: 1392 X 1040 
pixels) was used to capture images of the gel using UV transillumination for 
fluorescence stained gels and the GS-800 densitometer (Resolution: 1360 X 1024 
pixels) was used to scan Coomassie blue stained gels. Hard copies of the gel were 
printed out using the Mitsubishi Video Copy Processor attached to it. 
 Image acquisition for Coomassie blue stained gels was carried out using Bio-Rad 
GS-800 image densitometer and further analysis was done using the PDQuestTM 
Advanced v 8.0 software. Hard copies of the gel were produced using the Mitsubishi 
Video Copy Processor (K65HM-CE / High density type, 110 cm X 21 m). The raw 
image data which was obtained from scanning the gels using the GS-800 
densitometer (Bio-Rad Quantity One TM software) was uploaded into the other two 
softwares, Ludesi Redfin and Non-linear Dynamics Progenesis SameSpots and used 
in analysis. 
 
6.10 Digestion of proteins for Mass Spectrometric analysis 
 
6.10.1 Protein digestion in solution 
 
6.10.1.1 Dissolve solution 
Per 100 mL 
SDS                                                         0.1 g 
Tris base                                                   6.06 g 
Dithiothreitol (DTT)                                      77.1 mg 
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The solution was adjusted to a pH of 8 using HCl and stored at room temperature. 
 
6.10.1.2 Trypsin stock (1 µg/µL) (Promega and NEB) 
Vial containing the lyophilised powder was stored at -20°C 
Trypsin lyophilised powder 20 µg/mL         100 µg 
Glacial acetic acid (50 mM)                                    100 µL 
 
The trypsin powder was dissolved in 50 mM glacial acetic acid and stored at -20°C 
for upto 1 month or at -80°C for a long term. 
 
6.11 In-gel protein digestion reagents 
 
6.11.1  100 mM NH4HCO3 
Per 10 mL 
NH4HCO3                                             79 mg 
 
6.11.2  50 mM   NH4HCO3 
Per 10 mL 
100 mM NH4HCO3                               5 mL 
 
6.11.3  Trypsin solution (20 µg/mL) 
Per 100 µL 
1 µg /µL trypsin stock                               2 µL 
50 mM NH4HCO3                                   98 µL 
 
6.12 Buffers used in LC-MS analysis 
 
6.12.1  Start buffer A 
Per 100 mL 
LC-MS Grade Water                              95 mL 
LC-MS Grade Acetonitrile                       5 mL 
Formic acid                                             0.1 mL 
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6.12.2  Start buffer B 
Per 100 mL 
LC-MS Grade Acetonitrile                      95 mL 
LC-MS Grade Water                              5 mL 
Formic acid                                            0.1 mL 
 
The solution was made up fresh before use. 
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7 Methodology used for the proteomics experiment 
 
7.1 Growth study in B. fragilis 
Ampules of B. fragilis were ordered from the National Collection of Type Cultures 
(NCTC) and used to inoculate the anaerobic basal broth media and incubated in the 
anaerobic chamber at 37°C overnight. The bacteria were sub cultured in Columbia 
blood agar media or brain heart infusion broth media.  
The initial growth curve experiment was carried out by growing the bacteria in 
minimal medium whose components have been mentioned in the Materials section 
6.3. But since the growth in the medium was not found to be reasonable enough for 
analysis, a semi defined medium was used. The components of the media varied 
with respect to yeast extract being used as the source of vitamin B. The medium was 
autoclaved before use and incubated overnight in the anaerobic chamber before 
inoculation. Mucin and glucose were weighed out and added at 0.5 g per 100 mL to 
the semi-defined growth media. 
The semi defined media supported quicker growth of bacteria. Experiments were 
performed by using different carbon sources. 
The culture was incubated at 37°C in the anaerobic chamber. The anaerobic 
condition within the chamber was monitored by using resazurin indicator strips that 
turned pink in the presence of oxygen in the chamber environment. Refer to 
Appendix E1 for details. 
 
7.2 Growth curve studies 
Small volume (20 mL) overnight starter cultures were used to inoculate large 
volumes (450 mL) of the media and the optical density of the media were monitored 
at various time intervals by measuring the absorbance at 600 nm and plating out 
serial dilutions of the culture. The time periods that were used to monitor the growth 
in E. cancerogenus  were 0 h, 2 h, 3 h, 4 h, 5h, 6 h, 7 h, and 8 h whereas the time 
periods in B. fragilis were 0 h, 4 h, 6 h, 21 h, 22h, 23 h, 24 h, 25 h, 26 h, 27 h, 28 h, 
29 h, 30 h, 31h, 46 h, 47h.The growth of B. fragilis in the medium was found to be 
slower and hence more time points were monitored. For each and every time point, 
the culture was mixed well and 1 mL was transferred into a plastic cuvette with a 
sterile pipette tip. The OD was measured at 600 nm using a Cecil 
Spectrophotometer. 100 µL of the culture was spread out onto a sterile CBA agar 
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plate and incubated overnight at 37°C. 1 mL of the culture was used to perform 
appropriate serial dilutions into test tubes containing 9 mL of sterile distilled water. 
Care was taken to maintain aseptic conditions within the chamber while performing 
the experiment. All experiments were performed in triplicates and the average values 
were calculated. Growth curves were plotted out to determine the phase of growth of 
the bacterium.  
7.3 Two dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
methodology 
Two dimensional gel electrophoresis comprised of a series of steps from the growth 
of bacteria, protein extraction and one dimensional iso-electric focussing to the two 
dimensional separation of proteins using SDS-PAGE. The methodology has been 
explained in detail in the following sections. 
 
7.4 Growth of E. cancerogenus and B. fragilis in semi defined media 
A loopful of the glycerol stock was used to streak out a plate of Columbia blood agar 
medium and incubated overnight at 37°C in an anaerobic chamber.  
A single colony of the bacteria from the culture plate was used to inoculate 450 mL 
of the semi-defined medium supplemented with and without mucin the following day. 
The semi defined medium was incubated overnight in the anaerobic chamber before 
inoculation. The culture was incubated in the anaerobic chamber till the optical 
density reached a value of 0.7 at 600 nm.  
 
7.5 Protein extraction 
A volume of 100 mL of the culture was then centrifuged at 4000 x g for 30 min at 
4°C. Following this, the pellets were resuspended in 5 mL of PBS and washed at 
4000 x g for 10 min at 4°C. The washing step was repeated 3 times and the final 
resuspension step was performed in 1 mL of PBS buffer. To 2 µL of IPG buffer pH 4-
7 or 3-10, 100 µL of lysis solution stock was added to prepare the lysis solution and 
100 µL of this was added to each of the samples. The pellets were then ultra-
sonicated on ice for 1 min at 10 s intervals and then centrifuged at 14000 x g for 30 
min at 4°C. The pellets were then discarded and the supernatant was transferred 
into clean 1.5 mL microcentrifuge tubes. 
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The cell free extract was subjected to removal of contaminants using the 2D clean 
up kit. It also helped to get rid of residual polysaccharides. To 100 µL of the cell free 
extract, 300 µL of precipitant solution was added and incubated on ice for 15 min. 
 
To this, 300 µL of the co-precipitant was added and vortexed well before centrifuging 
it for 5 min at 14000 x g. The supernatant was discarded and 40 µL of the co-
precipitant was added to the pellets and incubated on ice for 5 min. This was then 
centrifuged at 14000 x g for 5 min and the supernatant was discarded. 25 µL of 18.2 
MΩ/cm water was added and vortexed well. To this, 1 mL of chilled wash buffer and 
5 µL of wash additive were added before incubating the tubes at -20°C for atleast 30 
min. The tubes containing the proteins could be stored at -20°C for a maximum of 
one week with minimal protein loss. The solution was centrifuged at 14000 x g for 5 
min after which the supernatant was removed and the pellets were allowed to dry for 
half a min. 
The pellets were re-suspended in 350 µL of rehydration solution containing 0.001 g 
of DTT, 4 µL of BPB, 7 µL of IPG buffer and 350 µL of the rehydration stock solution. 
The solution was vortexed and centrifuged at 14000 x g for half a min to remove the 
insoluble residue and the solution was transferred into the wells of the reswelling 
tray.  
IPG strips of 11 cm length, 3.3 mm width and 0.5 mm thickness (pH 3-10 or 4-7) 
which were stored in the freezer at -20°C were taken and the plastic was removed 
from its surface. The strips were layered in the wells of the reswelling tray in such a 
way that the gel end of the strip was facing the rehydration solution and the positive 
end of the strip was located at the lower end of the reswelling tray. Once the strips 
were layered in the wells, the surfaces of the strips were covered with Dry strip cover 
fluid and left to rehydrate overnight at room temperature. 
 
 
 
 
 
 
 
 
73 
 
7.6 Iso-electric focussing 
 
The temperature was maintained at 20°C 
pH 
intervals 
Step Voltage 
(V) 
Time (h) kVh Current 
(mA) 
Power 
(W) 
4-7 1 500 0:01 - 2 5 
 2# 500 6:00 3.0 2 5 
 3 3500 1:30 3.0 2 5 
 4 3500 8:00 30 2 5 
                                         Total:         15:31         
# This step was included only when the Multiphor II Electrophoresis system was left 
running overnight since this is an optional step. 
Table 1: Table showing the parameters used in isoelectric focussing, pH 4-7 
 
pH 
intervals 
Step Voltage 
(V) 
Time (h) kVh Current 
(mA) 
Power 
(W) 
3-10 1 500 0:01 - 2 5 
 2 3500 1:30 3.0 2 5 
 3 3500 6:00 22.0 2 5 
                                            Total:         7:31 
Table 2: Table showing the parameters used in isoelectric focussing, pH 3-10 
 
The Multiphor II from Amersham Biosciences was used to run the 1st dimension 
isoelectric focussing.  
Two electrode contact strips of 11 cm were cut out and moistened with 1 mL of 18.2 
MΩ/cm water. The Dry strip cover fluid was poured on to the cooling plate and the 
Drystrip tray with its anode at the upper end [red] and the cathode at the lower end 
[black] was placed on it. The cathode and anode ends were connected to the 
Multiphor II isoelectric focussing unit. About 15 mL of the Dry strip cover fluid was 
poured on the tray and the Dry strip tray aligner was placed on it with the groove side 
facing upwards. Care was taken to avoid formation of air bubbles while aligning the 
dry strip tray on the cover fluid since it could affect the thermal contact. The 
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rehydrated Dry strip gels from the reswelling tray were removed and placed parallel 
to each other along the lanes of the tray with their gel side facing upwards. The 
cathodic and anodic ends of the strips along with the gel surface were kept in contact 
by the moistened electrode strip. The electrodes were placed and pressed down on 
these electrode strips. The cover fluid was poured over the strips to immerse them 
completely and a programmed EPS 3501 XL power supply (Amersham Biosciences) 
was switched on. The Techne Circulator C-100 with a TECAM Heat exchanger was 
used to maintain a temperature of 20°C throughout the process of separation. The 
gels were left to run for atleast 8 h and the strips were stored at -80°C in plastic 
petridishes until use. The parameters used in running the IEF strips have been 
detailed in Tables 1 and 2. 
 
 
7.7 Casting of SDS-PAGE gel 
Two glass plates of size 20 X 20 cm and 20 X 22 cm were wiped clean with 50% 
ethanol. The glass plates were aligned parallel to each other with a spacer of 1 mm  
thickness placed in between them around the edges. Single screw clamps were 
used to clamp the plates together tightly and the whole set up was mounted on a 
rubber gasket placed on a casting stand. 
 
A 12% (w/v) resolving gel was prepared as mentioned in the materials section and 
the solution was degassed for 30 min after which it was pipetted out into the space 
between the glass plates upto about 4 cm from the top of the smaller plate. The 
surface of the solution was overlayed with 18.2 MΩ/cm water and allowed to 
polymerise for 45 min atleast. After the gel was set, the overlayed water was poured 
out and a clean filter paper was used to remove any residual liquid. 
 
A 4% (w/v) stacking gel acrylamide solution was prepared and layered on top of the 
resolving gel solution. A comb containing a long 17 cm well and a small size 
standard well measuring 1.5 mm in thickness was immediately inserted into the gap 
between the plates. Care was taken to avoid formation of air bubbles by inserting the 
combs at an angle. This was allowed to polymerise for 30 min at least. Once set, the 
combs were removed and the surface of the gel was rinsed with copious amounts of 
18.2 MΩ/cm water to get rid of any gel debris or unpolymerised acrylamide. 
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The frozen IPG strips were equilibrated with 0.1 g of dithiothreitol (DTT) in 10 mL of 
the equilibration stock solution by gentle rocking on a shaker for 15 min. The 
equilibration step was repeated again with 0.45 g of iodoacetamide (IAA) instead of 
DTT. IAA was dissolved in 10 mL of the equilibration stock solution and the strips 
containing the gel were gently rocked on a shaker for 15 min.  
The strips were placed on a filter paper moistened with 18.2 MΩ/cm water to drain all 
the excess liquid. Approximately 1 cm of plastic from the negative edge of the strip 
was cut off in order to obtain a suitable length. The strips were layered on the top of 
the gel and liquid agarose sealing solution was poured in between the glass plates 
allowing it to cool down. Care was taken to ensure that the strips were placed with 
their gel side facing the smaller glass plate. 
 
The gels containing the strips were loaded onto the SDS PAGE electrophoresis unit 
by assembling them on a cooling core which was gently immersed at an angle into a 
gel tank containing about 2.0 L of running buffer.  Protein size standards of 8 µl were 
loaded into the respective wells of each gel present on either side of the cooling 
core. Running buffer was also used to fill up the upper compartment containing the 
electrodes. 
 
The second dimension was run in the electrophoresis unit where the lower and 
upper parts of the tank were filled with the running buffer. A current of 8 mA was 
applied to two gels and the process was normally complete in about 4 h which was 
indicated by the bromophenol blue dye that ran down the gel and started to come off. 
Throughout the separation process, the cooling core was maintained at a 
temperature of 10°C using the Techne Circulator C-100 with TECAM Heat 
Exchanger 1000. 
 
On completion of the process, the clamps were removed and the gels were 
transferred to large storage containers and 250 mL of the fixing solution was added 
to it. The gels were fixed for about 1 h with gentle rocking. 
The fixing solution was replaced by 250 mL of the Coomassie blue staining solution 
which was left rocking on a shaker overnight at room temperature.  
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Following this, the gels were destained using 18.2 MΩ/cm water for 4-6 h and the 
images were scanned and analysed using the PDQuest software. The raw image 
data obtained from scanning the gels using GS-800 Bio Rad densitometer was 
uploaded and used in analysis in the Redfin and SameSpots softwares. 
 
7.8 Fluorescent staining 
Attempts were also made to use fluorescent staining for visualising gels containing 
protein spots. Once the second dimension run was complete, the gels were left 
overnight in the fluorescent stain fixing solution with gentle rocking on a laboratory 
rocker. The gels were transferred to the staining solution the following day and 
allowed to stain from 3 to 8 h. The gels were stored in special storage boxes 
wrapped with aluminium foil to avoid contact with sunlight.  
 
 
7.9 Visualisation of the stained gel  
The Bio Rad Chemi doc XRS (Quantity One TM software) was used to capture 
images of the gel using UV transillumination. Hard copies of the gel were printed out 
using the Mitsubishi Video Copy Processor attached to it.  
 
7.10 Gram staining procedure 
7.10.1  Heat fixed film preparation 
A droplet of water was spread on to the surface of a clean glass slide with the help of 
a sterile plastic loop. A single colony of the bacteria was picked from a fresh culture 
plate with another sterile loop and mixed gently with the droplet of water and allowed 
to dry at room temperature. The slide was heat fixed by passing it through a Bunsen 
flame. Care was taken to avoid heating the slide too much since it could result in the 
charring of proteins. The slide was allowed to cool after heat fixation and subjected 
to Gram staining. 
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7.10.2  Gram staining 
 The heat fixed slide was flooded with methyl violet stain for 30 s. The stain was 
poured off after 30 s and the slide was flooded with Gram‟s iodine using a Pasteur 
pipette. The slide was left for 30 s with Gram‟s iodine on it and then gently rinsed off 
with tap water. Following this, the decolourising agent, acetone was used to flood the 
slide for just a few seconds (3-4 s) and washed off instantly in running tap water. The 
slide was finally flooded with Safranin stain for 30 s. The slide was rinsed off with tap 
water and dried with a blotting paper. Once the slide was completely dry, it was 
observed under the microscope using the oil immersion lens (X 100).  
 7.10.3 Expected Result 
The presence of violet or deep purple stained cells indicate that the bacteria may be 
Gram positive and the presence of red, pink or orange cells indicate that they are 
Gram negative in nature. 
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Figure 11: Methodology used for the analysis of spot data 
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7.11 PDQuest analysis 
 
7.11.1  Acquiring images 
The Bio-Rad GS-800 image densitometer was used for scanning and obtaining 
images of the 2D gels. Atleast 6 gel images were generated from every condition in 
order to ensure reproducibility of results. The cultures were grown in 450 mL 
volumes and separated out into 4 samples (Figs. 20.1-20.4, 21.1-21.4, 22.1-22.4, 
23.1-23.4, 24.1-24.4, 25.1-25.4) of 100 mL volume each when they reached the 
appropriate optical density. A second lot of 450 mL cultures were grown 
independently to process the rest of the 2 or 3 samples (Figs. 20.5-20.7, 21.5-21.6, 
22.5-22.8, 23.5-23.6, 24.5-24.6, 25.5-25.6)). Proteins were extracted from these 
biological replicates and 100 µL of the cell free extract from each sample was 
processed separately using the 2D Clean up kit. Hence 4 samples of the cell free 
extracts used in sequential optimisation experiments were from the same pool of 
material whereas the other 2 were from a separate culture. The PDQuest TM software 
uses Bio-Rad imaging services to convert the signals from biological samples into 
digital data. The gel was initially 'Preview' scanned and specific sections of the gel 
which contained all the protein spots were framed and acquired. Fig. 9 shows the 
steps involved in the processing of data.  
All the gels were scanned at the same time and care was taken to keep the frame 
dimension the same in all the cases. Once scanned, the images were saved and 
copies were printed out using the Mitsubishi Video Copy Processor. The gels can be 
cropped or rotated according to the crop and rotation tools on the Image menu. 
PDQuest was used as the default software for analysis based on the Student t-test. 
 
7.11.2  Spot detection 
The spot detection wizard was used to start up an experiment and step wise analysis 
of the gels was carried out. The spot detection wizard was used to detect spots on 
the gels. A template gel was selected and parameters were generated based on the 
smallest, faintest and the largest spot identified in it. The set parameters were used 
to scan every gel accordingly since gels show a high degree of variability with 
respect to streaking, intensity or clarity. The spot detection wizard was set to identify 
Gaussian, salt and pepper noise characteristics and filter them using a 7 X 7 pixel 
size filter dimension based on the individual noise pixels in the gel. Other features 
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including subtracting backgrounds and speckles detection were also enabled to 
make the detection process more efficient. 
Once the gels were filtered and smoothed to clarify all the spots including fuzzy, 
streaked or overlapping spots, three dimensional spots called Gaussian spots were 
created. All types of analysis were then performed on the Gaussian image which 
contained the Gaussian spots that were precisely identified and quantified. Three 
types of images were created during spot detection namely the original 2D scan, the 
filtered image and the synthetic Gaussian image. The Gaussian spots were indicated 
on the gels using crosshairs that was located at spot centres and spot ellipses that 
encircled the spot shape.  
 
7.11.3  Editing spots 
Editing of spots involved several features including adding, removing, combining or 
changing spot boundaries. All the editing was performed on the Gaussian image. 
Since the same parameters were used to identify spots in all the gels, some spots 
seemed to have been missed out. In certain cases, air bubbles or stain marks were 
identified as spots. Hence all the gels were reviewed manually to minimise errors. 
The spot adding tool was used to add spots to the Gaussian image and the spot 
removal tool was used to remove incorrectly identified or positioned spots.  
Other tools include the spot combining tool which is used to combine spots that have 
been identified to be different and the changing boundary tool which helps with the 
altering of spot boundary either by removing or moving them around. 
 
7.11.4  Matching spots 
Setting up an experiment automatically results in the generation of a matchset once 
the spots on the gels have been detected. Further grouping of the gels based on the 
various media conditions in which they were grown was also performed. The three 
main groups were the Media without mucin, Media with Type II mucin and media 
with Type III mucin. The gels could be matched manually or automatically. 
Automated matching was performed with a 50% restriction where the master image 
was matched to all the other images. The master image contained all the spots from 
all the gels mapped to it. However, a classic manual match was also performed after 
the automated match in order to minimise errors during matching. Landmarking was 
the first step performed which involved choosing reference spots to align and 
81 
 
position gels for matching. Once the landmarks are selected, an automatic match of 
all the spots is performed. The remaining spots can be reviewed individually and 
either matched or simply added to the master. 
 
7.11.5  Data Analysis 
Upon completion of the matching, an experiment summary report can be obtained 
from the analysis menu. The report shows the number of spots identified in each gel 
including its group details, match rates 1 and 2. Match rate 1 shows the percentage 
of matched spots relative to the total number of spots on the gel. Match rate 2 shows 
the percentage of matched spots on the gel relative to the total number of spots on 
the master gel. 
 
Standard spot numbers (SSP) are assigned automatically to all the spots. These are 
generated by the software when the standard gel is divided into rows and columns 
with each section having the same number of spots. The spots in a section are 
numbered sequentially and the first two digits of the SSP number indicate the X and 
Y coordinates of that section. The spot review tool was used to study the histograms 
of all the spots in a matchset. The spot quantities, intensities, location and the 
number of gels showing expression of a protein can be identified using this tool. The 
highlighted spot can be compared between all the gels and match modifications can 
also be made. The histograms of interest can be selected and used to create 
analysis sets. 
 
The scatter plot analysis shows the relatedness between two gels or two groups in a 
matchset. The quantity of each spot in the first gel is plotted along the X axis against 
the quantity of spots in the second gel. The slope of the scatter plot shows the 
degree of similarity. The closer the value is to 1.00, the stronger the relatedness 
between the gels.  
 
From the reports menu, quantity and quality tables can be obtained where the spot 
quality report shows a range of values from 0 to 100 based on the Gaussian fit, X 
and Y streaking , overlap and linear range of the scanner. 
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7.11.6  Normalization 
Normalization refers to the process where quantitative data from different gels are 
adjusted in order to compare different samples to one another. Variations in gels 
occur due to a number of factors which include handling and pipetting errors, loss of 
sample during loading, low cell density or inconsistent staining. Hence this process 
helps to compensate for non expression related variations in spot intensity. 
The normalization formula: 
Normalized spot quantity= Raw spot quantity X Scaling factor X Pipetting error 
compensation factor/ Normalization factor. 
Where raw spot quantity refers to the intensity of each spot, scaling factor refers to a 
constant value defaulted as 106 parts per million (ppm) and the normalized quantity 
is multiplied to it. 
 
The normalization factor was calculated for each gel based on „total quantity in valid 
spots‟ method where the raw quantity of a spot in a gel was divided by the total 
quantity of all the spots in each gel included in the master.  
All the spots which showed variations in expression in at least 6 gels were selected 
for analysis using LC-MS. Further, spots that showed expression in all three 
conditions were also selected for analysis. 
 
7.11.7  Consensus 
Group consensus was used to find potential spot detection errors and use the spot 
matching information uniformly across a set of gels in replicate group. The 
consensus tool helps to edit and match spots across specific gels, replicate groups 
or all the gels in a matchset. The ambiguous spots could be identified from the 
consensus analysis and matched to one or more spots on other gels. Once updated, 
the results are added to the spot review analysis report.  
 
7.11.8  Gel analysis software 
Apart from the PDQuest TM Advanced software, the Ludesi Redfin software and the 
Non linear Dynamics Progenesis SameSpots software were also used to compare 
and analyse the spot data. Spot data and match result tables have been attached to 
the Appendix F. Redfin software uses the Analysis of variance (ANOVA) and 
principal component statistical analysis (PCA) for summarising the spot data in E. 
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cancerogenus and B. fragilis whereas a cluster analysis is used to describe the 
same data in Progenesis Samespots software. Study of gels using three different 
software packages was performed to determine the reliability and reproducibility of 
analyses data from PDQuest, Redfin and SameSpots rather than depend just on the 
data obtained from PDQuest analysis.  The differentially expressed spot 
identification criteria included a significant p value of 0.05 or less and a fold change 
of 1.0 or more. 
 
7.11.8.1  Redfin analysis of 2DE gels 
The six main steps used in the analysis of data using the Redfin software included 
the pre-processing of images, choosing of a warp reference image, warping of all the 
gel images, creation of a fusion image, detection of spots and generation of spot 
borders. Completion of all the above mentioned steps provided a series of results 
showing the experiment overview, statistics used, details of filtered spots including 
details on its p value (p values< 0.05 are considered to be significant), presence (set 
as 100%), volume and fold change with respect to all the three different growth 
conditions. 
 
 The pre-processing of images involved an initial quality control check on the gels 
based on a number of factors to determine its suitability for analysis. The image 
editor was used to further crop, flip or rotate images as necessary. The step 
involving the creation of a fusion image is automated and involves transferring of the 
detected spots and their borders on to every individual image for quantification. This 
step ensures 100% matching and helps to get rid of cracks or other damages to the 
image. The „‟less-more‟‟ slider helps to optimise the number of spots detected on a 
gel and the „‟loose-tight‟‟ slider helps to determine the spot boundaries.  
 
Redfin analysis of spots also supports the categorisation of data into multiple groups 
to facilitate comparison. Once the reference image is selected and warped, global 
and local spot editing tools can be used to edit the spots on the gel. Once the spot 
borders are detected, an analysis report is generated containing the entire list of 
spots detected. The spots of interest are then filtered out by setting a p value filter of 
<0.05, a fold change of 1.0 and an expression volume of 100%. The filtered spots 
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could then be exported as a .pdf or .xls document. Spots of interest can be viewed 
using a 2D and 3D montage or statistically analysed. 
 
7.11.8.2  SameSpots analysis of 2DE gels 
The steps used in the analysis of data using the Progenesis SameSpots included the 
initial quality assessment followed by the alignment of images. The initial quality 
assessment step also helps to prevent positional errors with tools for cropping, 
flipping or rotating images. This software uses an automated image alignment 
system in order to minimise the repeated editing and re-matching of images. 
The pre-filtering step of analysis involved the filtering out of damaged, noisy and 
spots from the edges of the images. This was followed by appropriate grouping of 
gels based on their growth conditions to study differential expression and an 
automated gel analysis involving spot detection, background subtraction, 
normalisation and matching was performed.  
 
The analysis provides a review of results containing a list of spots from which the 
spots with relevant p values (<0.05) were selected. Fold change of 1.0 or more can 
also be used to select relevant spots since fold change is calculated by subtracting 
the highest and the lowest mean values and this is added on to the mean value of  
the third group. They provide a 2D and 3D montage view of spots to be able to study 
them better. 
 
Apart from analysis of variance, this software also uses other statistical applications 
like PCA analysis, correlation analysis and power analysis for describing the data 
obtained from the experiment. PCA analysis helps to determine the variation in 
expression based on the levels of spot expression spread out across all the gels. 
The correlation analysis helps to determine the degree of relatedness between two 
sets of data. Normalised spot expression volumes with a value closer to 1 indicate a 
higher correlation when compared to lower correlation spots which have a value 
closer to -1. The results of the correlation analysis are visually presented using 
dendrograms. Based on the variations in expression, difference between mean 
groups and sample size, the power value is calculated. The larger the difference 
between the group means, the more significant the power value of the spot. Usually 
a power value of 0.8 or more is categorised as a relevant spot. The data is presented 
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as average values based on the differential expression of spots in three different 
conditions of growth. The spots of interest could then be selected and used to 
generate a report for future use.  
 
 
7.12 Preparation of protein spots for analysis using the Mass spectrometer 
The spot outlines of interest were cut out using a scalpel and the gel bits were stored 
in silanised 0.5 mL tubes at -20°C until use. 
 
The Coomassie blue stain was removed from the gel slice by adding 100 µL of 100 
mM NH4HCO3 and 60 µL of acetonitrile and shaken for 30 min. The same washing 
process was repeated at least 3 times in order to get rid of the stain completely. 
Following this, the gel slices were dehydrated by adding 50 µL of ACN and incubated 
in room temperature for 5 min. The same process was repeated again. The gel 
slices containing the proteins were dried using the centrifugal evaporator for 15 min 
at room temperature. In the meanwhile a 20 µg/mL concentration of trypsin solution 
was prepared in 50 mM NH4HCO3 solution and 25 µL of the trypsin solution was 
added to each of the tubes. The tubes were incubated on ice for 30 min and 30 µL of 
50 mM NH4HCO3 was added to cover the solution before incubating it at 37°C in a 
waterbath overnight. 
 
The following day, 30 µL of a 50% (v/v) ACN and 5% (v/v) formic acid solution was 
added to stop the reaction and the tubes were shaken for 30 min. The solution 
containing the digested peptides were removed and stored in a clean 
microcentrifuge tube. A 30 µL solution containing 83% (v/v) ACN and 0.1% (v/v) 
formic acid was added to the tubes containing the gel slices and shaken for 30 min 
to remove all the remaining digested peptides which were then pooled into tubes 
containing the initial collection of digested peptides. 
 
7.13 Liquid chromatography 
Liquid chromatography experiments were performed using the Dionex Ultimate 3000 
nano LC system which consists of a pump that regulates the flow of buffers, 
temperature compartment that is maintained at 60°C while running samples, the 
autosampler that is attached to the syringe facilitating injection of the samples from 
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the multi-well plate and the UV detector that shows the absorbance values of 
samples at 254 nm. Separation of samples was carried out using a 200 µm X 5 cm 
long monolithic column made up of polystyrene divinyl benzene polymers. The 
peptide elution gradient was set in such a way that the first 0-0.5 min was used to 
perform equilibration and injection at a 100% Buffer A concentration. The elution of 
peptides occurred between 0.5 and 16 min of the gradient where the concentration 
of acetonitrile was gradually increased by pumping Buffer B to a 100%.  The column 
was washed and prepared for the loading of the next sample during the last 6 min of 
the gradient (Total 22 min gradient). 
 
The nano LC system is coupled to a HystarTM Bruker Daltonics ESI Ion trap MS 
system which carries out the MS/MS fragmentation of peptides. 
 
 
7.14 Mass spectrometric analysis 
The microcentrifuge tubes containing the digested peptides were freeze dried 
completely and then resuspended in 10 µL of the start buffer A. The solution was 
then pipetted into the respective microtitre well for performing an LC-MS analysis.   
 
The HCTUltra was used as the ion trap system with the ESI source. In order to 
create a stable spray with high ionisation yields, optimised ESI conditions were used. 
Identification experiments were performed at a flow rate of 3 µL/min with a nebulizer 
pressure of 15 psi and a drying gas flow rate of 5 L/min at a drying gas temperature 
of 300°C.  
 
7.14.1  Tuning 
Optimising the voltages that guide the flow of ions along the CapExit, Skimmer, 
Octopoles, Lenses and Tap Drive help to achieve maximum signal intensity called 
tuning. The Smart parameter setting was used for qualitative analysis and this was 
done using a standard compound. The target mass was set to 622.03 m/z. Tuning 
solution that was used in our experiments was 20% (w/v) acetonitrile. 
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7.14.2  Parameter settings for peptide mapping 
The Standard enhanced scan mode was used to obtain MS spectra in the order of 
singly, doubly and triply charged precursor ions. The Ion Charge Control (ICC) target 
was set to 200.000. Scan range was 300-2000 m/z for MS and the average was set 
to 5 (Low concentration samples required higher average numbers whereas low 
average numbers were set to complex samples).  
The Octopole 1 DC was set to 8.0 V. All ions above the intensity threshold were 
selected in the Auto MS (n) precursor selection analysis. Singly and doubly charged 
ions were detected whereas other mass ranges were excluded as being 
contaminants. 
The compound spectra generated from the Auto MS (n) were exported to the 
Biotools software as *.mgf files and then database searched through Mascot. 
Ion chromatograms from data processing included the UV chromatogram, BPC All 
MS and the TIC All MSn. The MS/MS ion search was used to connect to the Mascot 
search where the query file peptides were compared to the peptides present in the 
database to determine the identity of the protein. 
 
The username, email and an appropriate search title were filled in the search box. 
The taxonomy used for carrying out the searches was „Eubacteria‟ since the protein 
spots were cut out from gels expressing Gram negative bacterial culture proteins. 
The enzyme used was trypsin and the database normally used to conduct the 
searches was NCBI. The global modifications were set to a default of 
Carbamidomethyl (C) and the variable modifications were set to Oxidation (M). The 
missed cleavages were set to 2 and the charge state to doubly and triply charged 
ions. The mass tolerance was set to 1.7 Da, MS/MS tolerance to 0.5 Da and the 
output was set to 50 proteins. The results were saved by clicking on the „get hits‟ 
option. (Refer to section G1 of the Appendix for more details) Random matching 
results could also provide false positive results and hence certain criteria were set up 
to segregate false positives from correct identifications. This included selection of 
results where the protein score was more than 40 and at least 2 peptides matched to 
the query sequence. 
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8. Materials used for the cloning, purification and structural studies of 
glycoside hydrolase enzymes from families 95 and 97 in B. fragilis 
 
8.1 Liquid media 
Unless stated otherwise, all media were prepared using distilled water, and sterilised 
by autoclaving. In cases where solutions could not be autoclaved, they were filter-
sterilised using 0.2 µm Ministart® filter units (Sartorius) and stored in sterile plastic 30 
mL containers.  
Liquid media were stored at room temperature, and solid media at 4°C. All 
adjustments to the pH of solutions are stated under the list of components, and were 
achieved using HCl or NaOH. 
 
8.2 Solid media 
Columbia blood agar containing 5% (v/v) horse blood 
Per 100 mL 
Columbia agar powder                          3.7 g 
Horse blood                                           5 mL 
 
To 95 mL of distilled water, the agar powder was added and mixed well before 
autoclaving. The medium was then allowed to cool to about 50°C and 5 mL of horse 
blood was added to it and mixed gently. This was aseptically poured into labelled 
Petri dishes and allowed to set for 30 min. The horse blood was aliquoted out in 5 
mL quantities, stored in the freezer at -20°C and thawed before use. 
 
8.3 Plasmid vectors and competent cells used for cloning 
The plasmid vector used was pET-YSBLIC which was a modified form of the pET-
28a vector developed in the University of York to allow ligation independent cloning 
(LIC) with over expression of proteins in BL21 strains. Refer to Appendix C for 
details. 
The vector has the presence of a hexa-histidine tag at the N-terminal end that helps 
in easy purification of proteins using the immobilised metal affinity chromatography 
column. 
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The chemically competent cells used for the transformation were TOP10 E. coli cells 
and E. coli strain BL21 respectively. 
 
8.4 Luria-Bertani (LB) broth 
Per 1000 mL 
Tryptone                                            10 g 
Yeast extract                                     5 g 
NaCl                                                  10 g 
pH 7.0 
 
8.5 LB agar 
Per 100 mL 
LB broth                                              100 mL 
Agar (bacteriological agar N° 1)         2 g 
 
The medium was autoclaved to make the agar soluble and then poured into Petri 
dishes when cooled to about 55°C. 
 
8.6 Selective media 
The antibiotic used in the selective medium was kanamycin where a stock 
concentration of 10 mg/mL was prepared in 18.2 MΩ/cm water and stored at -20°C 
in the freezer. A 1 in 100 dilution was used as the working concentration making it 50 
µg/mL.   
 
Isopropylthio-β-D-galactoside (IPTG) was used as an inducer in LB medium at a final 
concentration of 240 µg/mL and this was prepared from a stock concentration of 24 
mg/mL dissolved in sterile 18.2 MΩ/cm water. 
 
8.7 Cryogenic storage of bacterial stocks 
The B. fragilis stock was stored at -80°C after mixing 0.5 mL of an overnight 
anaerobic basal broth culture with 0.5 mL of sterile 50% (v/v) glycerol. 
Per 100 mL 
100% (v/v) glycerol (Fisher)      50.0 mL 
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8.8 SOB broth 
Per 100 mL 
Tryptone                                      2.0 g 
Yeast extract                              0.5 g 
5 M NaCl                                    0.2 mL 
1 M KCl                                      0.25 mL 
4 M MgCl2-6H2O                        0.25 mL 
4 M MgSO4                                0.25 mL 
The solution was adjusted to a pH of 7.0 and autoclaved before use. MgCl2-6H2O 
and MgSO4 were prepared and autoclaved separately and then aseptically added to 
the solution. 
 
8.9 SOC broth 
Per 100 mL of the SOB broth 
1 M D (+) glucose (filter sterilised)        2.0 mL 
 
8.10 NZY Enrichment broth 
Per litre 
NZ Amine                                    10 g 
Yeast extract                               5 g 
NaCl                                            5 g 
MgSO4.7H2O                               2 g 
The solution was adjusted to a pH of 7.5 before autoclaving. 
 
8.11 NZY supplement 
Per 45 mL 
1 M MgCl2-6H2O                                     12.5 mL 
1 M MgSO4                                              12.5 mL 
20% (w/v) D (+) glucose                           20 mL 
 
 
The solution was filter sterilised and 0.45 mL of the NZY supplement was added to 
10 mL of the NZY broth to make up the NZY+ enrichment broth aseptically.  
 
91 
 
8.12 TE buffer 
Per litre 
0.5 M Tris-base pH 7.5                20 mL 
0.5 M EDTA pH 8.0                      2 mL 
The buffer was adjusted to a pH of 7.5 
 
 
8.13 Starter cultures for auto-induction media 
Per 10 mL 
Water                                                      9.55 mL 
1M MgSO4                                              20 µL 
1000 x metals                                          2 µL 
40% (w/v) glucose                                   125 µL 
25% (w/v) aspartate                                 100 µL 
50 X M                                                      200 µL 
kanamycin                                               100 µL 
 
8.13.1  ZYM-5052 auto-induction media 
Per 500 mL 
ZY                       478.5 mL 
1M MgSO4                                         1 mL 
1000 X metals                                    0.5 mL 
50 X 5052                                           10 mL 
50 X M                                                 10 mL 
kanamycin                                            5 mL 
 
8.13.2  Stock solutions 
 
8.13.2.1 50 X M 
Per 100 mL 
Na2SO4 (anhydrous)                            3.6 g 
NH4Cl    (anhydrous)                           13.4 g 
KH2PO4 (anhydrous)                           17.0 g 
Na2HPO4 (anhydrous)                         17.7 g 
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The salts were sequentially dissolved in distilled water and autoclaved before use. 
 
8.13.2.2 1000 X metals 
Per 100 mL 
Sterile 18.2 M Ω/cm water                   36 mL 
0.1 M FeCl3-6H2O                                50 mL  
(Dissolved in 100-fold dilution of HCl, approximately 0.12 M HCl and filter sterilised 
using 0.2 µm filters) 
1 M CaCl2 (anhydrous)                        2   mL 
1 M ZnSO4-7H2O                                1   mL 
0.2 M CoCl2-6H2O                                1   mL 
0.1 M CuCl2-2H2O                                2   mL 
0.2 M NiCl2-6H2O                                 1   mL 
0.1 M Na2MoO4-5H2O                           2   mL 
0.1 M Na2SeO3-5H2O                             2   mL 
0.1 M H3BO3 (anhydrous)                       2   mL 
 
All the solutions were made separately and autoclaved unless stated otherwise. 
 
20 mL of a 25% (w/v) aspartate solution was prepared and the pH was adjusted to 
7.0 by neutralisation with NaOH and autoclaved separately. 
 
 
 
8.13.2.3 50 X 5052 
Per 100 mL (The compounds were sequentially dissolved in distilled water) 
Glycerol                                             25 g 
Glucose                                             2.5 g 
α-lactose                                           10 g 
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8.13.2.4 ZY 
Per litre (sequentially dissolved in distilled water) 
Tryptone                                             10 g 
Yeast extract                                       5 g 
 
 
8.13.3  PASM-5052 SeMet-labelling auto-induction media 
Per 500 mL 
Water                                                    450.3 mL 
1 M MgSO4                                           1 mL 
1000 X metals                                       0.5 mL 
50 X 5052                                          10 mL 
20 X P                                                25 mL 
17 amino acid mix                              10 mL 
25 mg/mL methionine                         0.2 mL 
25 mg/mL selenomethionine               2.5 mL 
100 µM vitamin B12                           0.5 mL 
kanamycin                                          5.0 mL 
 
8.13.4  Stock solutions  
 
8.13.4.1 20 X P 
Per 100 mL (sequentially dissolved in water) 
(NH4)2SO4 (anhydrous)                     6.6 g 
KH2PO4 (anhydrous)                         13.6 g 
Na2HPO4 (anhydrous)                       14.4 g 
 
 
8.13.4.2 17 amino acid mix (17 aa mix) 
Per 100 mL (sequentially dissolved in water) 
Alanine                                                1 g 
Arginine-HCl                                        1 g 
Asparagine-H2O                                  1 g 
Aspartate                                             1 g 
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Na glutamate                                       1 g 
Glutamine                                            1 g 
Glycine                                                1 g 
Histidine-HCl-H2O                               1 g 
Leucine                                                1 g 
Isoleucine                                             1 g 
Lysine-HCl                                            1 g 
Phenylalanine                                       1 g 
Proline                                                   1 g 
Serine                                                    1 g 
Threonine                                               1 g 
Tryptophan                                             1 g 
Valine                                                     1 g 
 
The amino acids were dissolved by continuous stirring and also heating with the 
Bunsen when necessary. The solution was made up to a pH of 7.0 by neutralisation 
with NaOH, filter sterilised using 0.2 µm filters and stored at 4°C until use. 
 
8.13.4.3 Methionine and Selenomethionine solutions 
20 mL of a 25 mg/mL solution of methionine solution was prepared and autoclaved 
before use. 
5 mL of a 25 mg/mL L (+)-selenomethionine solution was made up just prior to use 
and filter sterilised using a 0.2 µm filter. 
20 mL of a 100 µM solution of Vitamin B12 was prepared by filter serilisation using a 
0.2 µm filter and stored at 4°C until use. 
 
 
8.14 Protein extraction and purification solutions and buffers 
 
8.14.1  Cell resuspension buffer in protein extraction 
Per litre (pH 7.4) 
HEPES                                   4.76 g 
NaCl                                       29.22 g 
imidazole                               0.68 g 
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8.14.2  Nickel column purification resin 
Fast flow chelating sepharose from GE Healthcare 
 
8.14.3  Gel filtration purification resin 
HiLoad 16/60 Superdex 200 prep grade (All the resins were stored in 20% (v/v) 
ethanol)  
 
8.14.4  Buffers used for nickel affinity purification 
 
8.14.4.1 Start buffer 
Per litre (pH 7.4) 
HEPES                                 4.76 g 
NaCl                                     29.22 g 
imidazole                             0.68 g 
 
8.14.4.2 Elution buffer 
Per litre (pH 7.4) 
HEPES                                4.76 g 
NaCl                                    29.22 g 
imidazole                            34 g 
 
8.14.5  Buffers used for gel filtration purification 
Per litre (pH 7.4) 
HEPES                                4.76 g 
NaCl                                    11.9 g 
 
8.14.6  Buffer exchange buffers 
The proteins were concentrated using 30 kDa concentrators. 
 
For CAH06598 and CAH09443 
Per litre (pH 7.4) 
HEPES (5 mM)                         0.595 g 
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8.15 Crystallisation screens and reagents 
The screen compositions for the various conditions used for the preparation of 
crystal trays have been included in the Appendix H. 
 
 
8.16 Chemicals and solutions used for SDS-PAGE 
 
8.16.1  Resolving gel (12% (w/v) acrylamide) 
40% (w/v) solution (37.5:1 acrylamide: bisacrylamide)       3 mL 
Buffer B                                                                               2.5 mL                                                                        
18.2 MΩ/cm water                                                              4.5 mL               
10% (w/v) ammonium persulphate (APS)                           50 µL 
Tetramethylethylenediamine  (TEMED)                              10 µL 
 
8.16.2  Buffer B 
Per 100 mL 
2 M Tris-base pH 8.8                                                       75 mL                                                     
10% (w/v) sodium dodecyl sulphate (SDS)                     4.0 mL 
 
8.16.3  Stacking gel (4% (w/v) acrylamide) 
40% (w/v) solution (37.5:1 acrylamide: bisacrylamide)       0.5 mL 
Buffer C                                                                               1 mL                                             
18.2 MΩ/cm                                                                       2.5 mL 
10% (w/v) APS                                                                     30 µL                                                             
TEMED                                                                                10 µL 
 
 
8.16.4  Buffer C 
Per 100 mL 
1 M Tris-base pH 6.8                         50 mL 
10% (w/v) SDS                              4 mL 
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8.16.5  Running buffer for SDS-PAGE 
Per litre 
Tris-base                                         30.3 g 
Glycine                                          144 g 
SDS                                              10 g 
 
The pH of the solution was adjusted to 8.8 before the addition of SDS and the 
running buffer was made up at a 10 X stock concentration which was diluted at 1:10 
before use with distilled water. 
 
8.16.6  SDS-PAGE Loading buffer 
Per 10 mL 
60 mM Tris-base pH 6.8                    0.6 mL 
50% (w/v) glycerol                             5 mL 
10% (w/v) SDS                                   2 mL 
14.4 mM β-mercaptoethanol             0.5 mL 
1% (w/v) bromophenol blue               1 mL 
 
Stored at 1 ml aliquots at -20°C 
 
8.16.7  SDS-PAGE solubilisation buffer 
Per 10 mL 
SDS-PAGE loading buffer                 7.6 mL 
urea                                                  2.4 g 
Stored at 4°C 
 
 
8.16.8  Coomassie Blue staining solution 
Per litre 
Coomassie Blue R-250                    1 g 
glacial acetic acid                           100 mL 
methanol                                         450 mL 
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Coomassie blue gel staining solution can be filtered through a filter paper and re-
used. 
 
8.16.9  Destaining solution for gels 
Per litre 
glacial acetic acid                            100 mL 
methanol                                         100 mL 
 
The Coomassie blue gel destaining solution can be filtered through a filter paper 
funnel containing activated charcoal and re-used once the stain is removed. 
 
8.16.10 Bradford assay 
Bradford‟s reagent solution                   200 µL 
Bovine serum albumin solution at various concentrations ranging from 0.1 mg/mL to 
1 mg/mL. 
Protein solution to be assayed           20 µL 
 
8.17 Solutions used for enzyme assay 
 
8.18 Stock solutions 
20 mM solution of HEPES pH 7.4                                 25 mL 
10 mg/mL solution of BSA                                             20 mL 
10 mM 4-methylumbelliferyl α-D-glucoside                    10 mL            
10 mM 4-methylumbelliferyl α-L-fucoside                       10 mL           
50 mM 4-nitrophenyl α-D-glucoside                               10 mL 
50 mM 4-nitrophenyl α-L-fucoside                             1 mL 
50 mM 4-nitrophenyl β-D-maltoside                           1 mL 
10 mg/mL α-glucosidase   (Recombinant protein purified from the study) 100 µL                                  
10 mg/mL α-fucosidase (Recombinant protein purified from the study) 100 µL    
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8.19 Reagents for agarose gel electrophoresis 
 
8.19.1  TAE Running buffer (50 X stock) 
Per litre 
Tris-base (ultra-pure)                             242 g 
17.51 M glacial acetic acid                    57.1 g 
0.5 M EDTA pH 8.0                           100 mL 
 
A 1: 50 dilution of this buffer is used for making agarose gels and for running gels in 
the electrophoresis tanks.  
 
8.19.2  Bromophenol blue (6 X) sample loading buffer 
Per 10 mL 
Bromophenol blue        0.025 g 
Glycerol        3.0 g 
A 1 X dilution of the buffer was added to the sample before loading it onto a gel. 
 
8.19.3  Size standards for agarose gel electrophoresis 
The Bioline hyperladder I or NEB 1 kb ladder was used as a size standard after 
diluting to a concentration of 1 µg/12 µL. Bioline hyperladder I size standard was 
added at a concentration of 1 µg/5 µL before loading it on to the gel and stored at 
4°C for up to 12 months. Refer to Appendix D for details. 
 
8.20 Kits, reagents and enzymes for DNA extraction and purification 
Quiagen miniprep kit was used for the extraction of genomic DNA. 
 
8.21 Polymerase chain reaction 
1 µL of the forward primer was mixed with 1 µL of the reverse primer and made up to 
5 µL with sterile 18.2 MΩ/cm water. 
The other reagents include KOD DNA polymerase enzyme, 1M MgSO4, deoxy 
nucleotide tri phosphate (dNTP), KOD DNA polymerase buffer and DNA to be 
amplified. 
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9.  Methodology used for the cloning, purification and structural studies of 
glycoside hydrolase enzymes from families 95 and 97 in B. fragilis 
 
9.1 Bioinformatics analysis 
The gene of interest was identified from GenPept in the NCBI sequence viewer v2.0 
and the FASTA format of the sequence was obtained. The conserved and semi 
conserved residues of the sequence was determined using the ClustalW software 
(www.ebi.ac.uk/Tools/clustalw). 
The expert protein analysis system (EXPASY) identification and characterisation tool 
was initially used for the determination of the molecular weight and pI of the proteins 
of interest. The presence of signal peptides and transmembrane helices in BF3763 
and BF0855 was identified using the SignalP 3.0 server 
(http://www.cbs.dtu.dk/services/SignalP/), and the TMHMM server 
(http://www.cbs.dtu.dk/services/TMHMM/). The „Translate tool‟ in Expasy was used 
to translate the gene sequence into amino acid sequence thereby determining the 
amino acids that are present in the protein (http://www.expasy.org/tools/dna.html) 
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The coding sequence (CDS) for the BF0855 protein from GH95 is 
        
  1 ttaagggttc aactcgatcc attcaccggc ttgagtatct atgttcaaga tatccgtgcc 
       61 ggataaagta tagttcttat tcggcttcaa tgtaccggga cgggccattt tcaacatgcc 
      121 gcctttctcc gaatagatgc gtacccgatt gatttctcca ccttccatcc gggccgatac 
      181 caggaatgca cccatggcgc gtaagttttc gaaggataca tctttccatt ctttcggtat 
      241 tgccgggaag atgcgtatta cgcctgtgtg actttgcagc aacatttctt gtatgcctgc 
      301 tgcaaaagcg aagttacctt cgagcgtgaa ggggcggtaa gtgaagcggg atttgccgct 
      361 ttgggtctgg tcaccgttgg catggaaggt gttcttcagg cagaagcatt ccgcaaaggt 
      421 tttcagggct tgtgcggcac cttcaccatc gaatgcacgg gctttcatat tggcgagcca 
      481 actgtatgaa tatcctgtcc agtagtccgg ccctacttta tcgagtctct tcaaggtggc 
      541 gcggatgatg tgttgtgact tttctccgtc gctccagtct atcagtccca gcggatggat 
      601 agccatggca tgtgaaaaat gacggtgtga ttctttgtag ggatatcctt tggcgaaagt 
      661 gaggcaacct tcttcgtcta tgtcgtaatc cggtagttgg gcttccaggg atgcccagtg 
      721 tccggcttcg tcggccaggt tcagttcgtg tgccagttcg gaagtagcct taaagaggaa 
      781 gtgcatcatt gccaggtcat aattggtcat gtcgctgaac cacgcttgca gggagttgtc 
      841 gaatatttcg ggacttgaac tgaattccag tttacgtact ccttcggggg taacttctga 
      901 aatttgctcc agatagattg ccacatcctt gatgaatgga taagcacgct ctttgaggaa 
      961 agtgcggtct gccgaatatt tccattgcag atagaagtgt tgtgccagcc atgcagctac 
     1021 ggtttgcgac atggagtatt gtatccatcc tcccatgggt tctcctgtca gggtacaaac 
     1081 ccccggtata ttcatccctt cggtaccgaa atagcggcgg gtgtagcgtt tgtatgcatc 
     1141 ccgttggttc cacaacgtgt tcagatagcc cattccttcg gtcaggtgat tgcctgtata 
     1201 ggccggccag taacttagct gggtatttaa atcgtgatga tagtctccct tccagggcgg 
     1261 aagtttgccg ttatcggctg tccatacagc ctgcagggag atggggtatg agtgttcgcg 
     1321 ggtagtggaa ccgaatttat acatttcgtt ctgatactgt ttttgcagta cagaatcggg 
     1381 tagagtgatc gatgattgtg cccagtactt gtcccaatat tccaggtgtg cctgataatc 
     1441 atgctttaga ccgcgttgca gggcggcttc tgccttttcg gaagcttgct cgccggataa 
     1501 ggaagaggtg acgctccagg taccgtacaa ggtttcgcct tcttgcttcc aacagactgt 
     1561 tacgtcatac gaaaagtctc cgtatccctt ttgatggtag gttatttggt ttccttcacg 
     1621 aaccactttt ccttgttgat agcctaatcg gtgcagatct tgtcccgaaa ccggatcgag 
     1681 gctgccatcc ggcttcgttt tattgtatac aggagtgatg atggagggtt ctatcggggt 
     1741 tttcaggtta cggaatacaa accatccgat cggttcggta gcatgaacga aagtctgcat 
     1801 ttgtgttccg tctgcccagt ctgcttcaca taaggcattg ttcaggtaaa gtcttacctg 
     1861 agtcggagtg ccgatctgct ctaatggaaa ttcgatggca gctccgggaa tcttggacgg 
     1921 cgcgggattc atgtcataag gccagtccag ctttttctgt acgggcagat agttcttttg 
     1981 acgaatatgt tcttttaccc aggagaagcg gaagttatct cccgacagac tgtctaccgg 
     2041 acgtaaatcc cataaatcgg ttctgtccag tgacaggcgt agggtggagt cacgttgcca 
     2101 taccaaggca ccgacggtag catttcccaa gggcattgct tcgtcccacg accgggcaag 
     2161 tccggtgaat acaagatcac tctctgaagg agtgaccgga caatagtcat acgagttgca 
     2221 actgctccac agaccacaac agagtagtaa tagtagtttg attttcat 
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The CDS for the BF3763 protein from GH97 is 
        1 atgaaaagaa aaatgatgtc cttattactc gcattggcgg taataagcgg aagtagcgtg 
       61 tacgctaaag tgattgacgt aatgtctccc aacggagcca ttaaagtatc ggtagacatc 
      121 aaggaccgga tttattattc ggtgtcctat gataatgacc agttattaaa agattgctat 
      181 ctcaacctgc aactgcagaa tgagacgtta ggtacgaatc cccacttacg gagcaccaaa 
      241 cgtggaacca ttgacgaaag tgtaaaacgt gaaatacctt tcaagaatgc gatcgtaaga 
      301 aatcactgta ataccctgag aatgaatttc agcggaaatt atgccgttga attccgcgta 
      361 ttcgacaatg gtatcgctta ccgttttgtg acagataaaa aaggagataa catcgtaatg 
      421 ggggaagact tcgcaattaa ctttccaacc aattataaag ctcatctctc ccaaccggat 
      481 ggctttaaaa cctcatacga atgcccatat actcatgtag ataccgaaaa gtatgctgct 
      541 accgaccgca tgagttacct gcctgtattg atagaaacgg ataaagcata taaaatactg 
      601 atatctgaag ccgacttatc cgattatccc tgtatgttcc ttaaaagtac cggtaagaac 
      661 ggaatgcagt ctatttttcc caaagcacct ttagccttcg gagaagatgg tgaccgtagc 
      721 ctcaagatta ccgaagaagc cgattacatt gccaagacgg acggcaaacg ttcattcccc 
      781 tggcgcatga tggtgatttc gaaagaagac aaagaactga ttgaaaacga aatggtgtat 
      841 aacctgtctg ctccttgtgt tcttgaagac tacagttgga tcaaaccggg acaagtgagt 
      901 tgggaatggt ggcacgacgc acgcctctat ggggtagatt tccgttcggg tttcaatatg 
      961 gattcctata aatactacat tgacttcgca tccaagttcg gtattcctta tatcatcatg 
     1021 gacgaaggat gggcgaaaaa cacacgtgat ccgtttaccc ccaatcccac catcaatctt 
     1081 accgaactga taaaatacgg aaaggaccgc aacgtaaaaa tcgtactttg gctgccatgg 
     1141 ctgactgtcg agaatcattt cgacctcttt aaaacatttg ccgattgggg catcgcagga 
     1201 gtgaagatcg acttcatgga ccgcagtgac cagtggatgg taaactatta tgaacgtgta 
     1261 gccaaagaag ccgccaagca taaactgttt gtagattttc atggtgcttt taaaccagcc 
     1321 ggacttgaac gcaaatatcc gaatgtgctt tcctatgaag gcgtattggg catggaacaa 
     1381 ggtggtaatt gcaaacctga aaacagcatt tatctgccct ttatgcgtaa tgccgtggga 
     1441 ccgatggatt tcactccggg ttcaatgatc tctgcacagc cggaagacaa ccgttccacc 
     1501 cgggccaatg ccatgggctc aggaacacgt gctttccaaa tggctctttt catcatcttc 
     1561 gaaagtggtc tgcaaatgtt agccgacaat ccggtttact attacagaga acttccctgt 
     1621 accgaattta tcacaagtgt tcccgtcacc tgggatgaaa ccaaggtcct ctatgccaaa 
     1681 gtaggtgaag cagtcgtcgt agccaaacga aaaggagaac agtggttcat cggaggtatc 
     1741 accggcaatc aaccacaaaa catcgagatc gacctcggat tcattccggc aggacaatca 
     1801 ttcacattaa cctcatttga agatggcatt aacgctgacc gtcaagcaat ggattacaag 
     1861 aaaaaggagt ctaccgtgaa caatcaaacc cgcatgacat tgaaaatggt acgcaacggg 
     1921 ggatgggccg gaacaattaa aatgaaatag 
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9.2 BLAST analysis 
The similarity of the genes and proteins of interest with other sequences was 
determined using the BLASTP (for proteins) and BLASTN (for DNA) links in the 
National Centre for Biotechnology Information site (www.ncbi.nlm.nih.gov/BLAST). 
 
9.3 Primer Design 
The primers were designed using the Web Primer server (http://genome-
www2.stanford.edu/cgi-bin/SGD/web-primer) with a default value of 18 for the 
minimum length of the primer. 
PCR primers for the amplification of the glycoside hydrolase family GH97 BF3763 
gene in B. fragilis NCTC 9343. 
Forward primer sequence:  
5‟- CACCACCACCAC ATGAAAGTGATTGACGTAATGTCTCCCAACGG-3‟ (44 bp) 
 
Reverse primer sequence:  
5‟- GAGGAGAAGGCGCGTTATTTCATTTTAATTGTTCCGGCCCATCCCCC- 3‟ (47 
bp) 
Refer to Appendix I for tables showing the conditions used for the amplification of the 
BF3763 gene from B. fragilis 
            
 
PCR of the glycoside hydrolase gene GH95_BF0855 from B. fragilis NCTC 9343. 
Primer sequences used for amplification  
Forward primer  
5‟-CACCACCACCACATGTATGACTATTGTCCGGTCACTCCTTCAGAGAG-3‟ 
Reverse primer  
5‟-GAGGAGAAGGCGCGTTAAGGGTTCAACTCGATCCATTCACCGGCTTGAGT-3‟ 
 
The primer sequences were ordered from MWG Biotech, Germany and the Ligation 
independent cloning (LIC) specific ends were added to the respective ends of the 
primer sequences. 
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9.4 Genomic DNA extraction and purification in B. fragilis NCTC 9343 
The DNeasy tissue kit was used for the extraction of DNA as per a standard 
protocol. A volume of 10 mL of LB medium was inoculated with a single colony of B. 
fragilis from a pure culture CBA plate. The medium was incubated overnight at 37°C 
anaerobically. 
0.5 mL of the culture was centrifuged at 5000 x g for 10 min. The supernatant was 
discarded and the pellets were resuspended in 180 µL of Buffer ATL (Recipe 
patented). To this, 20 µL of proteinase K was added and vortexed well. The mixture 
was incubated overnight at 56°C in a water bath. The lysate was vortexed for 15 s 
and 200 µL of Buffer AL (Recipe patented) was added to it. The sample was mixed 
thoroughly and 200 µL of absolute ethanol (96-100%) was added to it. The sample 
was vortexed again vigorously and the mixture was pipette out into a DNeasy Mini 
spin column placed in a 2 mL collection tube. This was centrifuged at 14000 x g for 1 
min. The flow through was discarded and the collection tube was replaced. 500 µL of 
Buffer AW1 (Recipe patented) was added to the Spin column and centrifuged at 
14000 x g for 1 min. The flow through was discarded again and the 2 mL collection 
tube was replaced. 500 µL of Buffer AW2 (Recipe patented) was added to the spin 
column and centrifuged at 20000 x g for 3 min. The flow through and the collection 
tube were discarded. The DNeasy mini spin column was placed in a clean 2.0 mL 
microcentrifuge tube and 200 µL of Buffer AE (10 mM Tris-Cl, 0.5 mM EDTA pH 9.0) 
was pipetted out onto the column. The sample was incubated in room temperature 
for 1 min and the DNA was eluted out by centrifuging at 14000 x g for 1 min. The 
eluted DNA of interest can be stored at -20°C until use. 
 
Agarose gel electrophoresis was performed to confirm the presence of the purified B. 
fragilis genomic DNA. 
 
9.5 Agarose gel electrophoresis 
A 1% (w/v) agarose gel was prepared by adding 1 g of agarose in 100 mL of 1 X 
TAE buffer and bringing it to boil to dissolve the solid bits. This was allowed to cool 
to about 60°C and then poured into a mini gel casting tray. Care must be taken to 
avoid air bubbles. A 12 toothed comb was then inserted into the solution. The gel 
was then left to set on the bench for 20 to 30 min. 
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Following this, the gel tray was placed horizontally in the electrophoresis tank and 1 
x TAE buffer was poured to submerge the gel completely. 
The comb was removed without damaging the gel and the samples were loaded into 
the wells. The samples were prepared by adding 5 µL of amplified DNA to 1 µL of 
the loading dye (bromophenol blue 6 X) along with 5 µL of the Bioline hyperladder 
standard (Refer to Appendix D). The electrophoresis was carried out at 100 mA, 200 
V for 35 min. 
 
The gels were then visualised using the Bio-Rad Gel doc system (using Quantity 
One TM software) and hard copies of the gel were printed out using the Mitsubishi 
Video Copy Processor attached to it. 
 
9.6 PCR amplification of the genes of interest 
KOD Hot start DNA polymerase was used to amplify the genes of interest in the PCR 
protocol using the Eppendorf MasterCyclerTM machine. 
 
9.7 Reaction components 
PCR components added to each tube GH95 (BF0855)  GH97 (BF3763)  
Sterile 18.2 MΩ/cm water                             34 µL                 33.6 µL 
12.5 µM Forward primer                               1 µL                  1.2 µL 
12.5 µM Reverse primer                              1 µL                   1.2 µL 
KOD reaction buffer 10 X                              5 µL                    5 µL 
(Refer to Appendix for details of the KOD reaction buffer recipe) 
B. fragilis genomic DNA (50 ng/ml)                1 µL                    1 µL 
MgSO4 (25 mM)                                         2 µL                    2 µL 
dNTPs (5 mM)                                         5 µL                    5µL 
KOD DNA polymerase (1U/µL)                    1 µL                    1 µL 
 
The PCR conditions used to amplify the BF3763 and BF0855 genes in B. fragilis has 
been detailed in tables in the Appendix section I. 
 
The amplified PCR products of BF3763 and BF0855 were analysed using agarose 
gel electrophoresis and purified using the MinElute PCR Purification Kit, QIAGEN. 
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To 90 µL of the PCR product, 450 µL of Buffer PB (Recipe patented) was added and 
mixed so that they were in the ratio of 1:5 respectively. The mixture was applied onto 
a MinElute column that was placed in a 2 mL collection tube and centrifuged at 
14000 x g for 1 min. The flow through was discarded and the collection tube 
replaced. 750 µL of Buffer PE (Recipe patented) was used to wash the column and 
then centrifuged at 14000 x g for 1 min. The washing step was repeated again. The 
flow through was discarded and the column was placed in a clean 1.5 mL 
microcentrifuge tube. 10 µL of buffer BE (Recipe patented) was pipetted onto the 
centre of the membrane  in the column, left for 1 min at room temperature and 
centrifuged at 14000 x g for 1 min. This step eluted the purified PCR product which 
was stored at -20°C until use.  
 
9.8 Insertion of LIC T4 polymerase (T4 pol) reaction  
The purified PCR product (10 µL) was mixed with 2 µL of 10 X T4 pol buffer (Refer to 
Appendix A2 for recipe details), 2 µL of 25 mM dATP, 1 µL of 100 mM dithiothreitiol 
(DTT), 0.4 µL of 2.5U/µL of LIC T4 DNA pol (Novagen) and made up to 20 µL by 
adding 5.6 µL of sterile 18.2 MΩ/cm water. The mixture was incubated at 22°C for 30 
min. To stop the reaction of T4 DNA polymerase, the mixture was incubated at 75°C 
for 20 min and centrifuged at 14000 x g for 10 s.   
 
For effective annealing of the genes, BF3763 and BF0855 to the LIC vector pET-
YSBLIC, 2 µL of the reaction mixture resulting from the above was added to 1 µL of 
the prepared pET-YSBLIC vector (50 ng/µL) and incubated at 20-22°C for 10 min. 
This was then made up to 4 µL by adding 1 µL of 100 mM EDTA and incubated at 
room temperature for 10 min. 
 
9.9 Preparation of electrocompetent TOP10 E.coli cells 
The glycerol stock of the cells was used to inoculate a plate that was incubated 
overnight at 37°C. A single colony from this was used to inoculate 50 mL of low salt 
LB which was incubated at 37°C in a shaker at 200 rpm until it reached an OD of 0.5 
to 0.7 at 600 nm. The culture was incubated on ice for 30 min and centrifuged at 
4000 x g for 15 min at 4°C. A volume of 25 mL of cold filter sterilised 18.2 MΩ/cm 
water was used to resuspend the pellets which were then centrifuged again and the 
supernatant was discarded. The pellets were resuspended in 12 mL of cold 18.2 
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MΩ/cm water. The resuspension and centrifugation steps were repeated again 
reducing the volume of water to 5 mL and then to 2 mL. The steps were repeated 
once final time reducing the volume of water used to resuspend the pellets to 0.2 
mL. The cells were aliquoted out into 40 µL quantities and stored at -80°C.   
 
9.10 Transformation 
A volume of 2 µL of the pET-YSBLIC vector containing the gene of interest was 
added to 40 µL of TOP10 E. coli cells, gently mixed with a pipette tip and incubated 
on ice for 1 min. This was transferred to a 2 mm electroporation cuvette which was 
kept ice cold and sterile. The cuvette was tapped gently in order to make sure that 
the solution covered the bottom of it. The cuvette was placed in a Bio-Rad ShockPod 
after drying the outside thoroughly and the lid was closed. The cells were 
electroporated using the BioRad Gene Pulser Xcell at 2.5 V for 20 ms. 1 mL of the 
SOC medium was added to the electroporated cells immediately and transferred into 
a clean sterile micro centrifuge tube using a sterile glass pipette. This was incubated 
at 37 °C for 60 min at 200 rpm and then plated out onto an LB agar plate containing 
kanamycin at a concentration of 100 µg/mL. The transformed cells were allowed to 
grow by incubating the plates at 37°C overnight. 
 
9.11 Screening of colonies for successful inserts 
The number of colonies present in the LB agar plates containing kanamycin was 
counted the following day. The colonies of interest were transferred onto a fresh 24 
grid LB agar plate supplemented with an appropriate concentration of kanamycin. 
The first colony was streaked across the first grid on the agar plate. The cells 
remaining on the pipette were gently and thoroughly mixed into 50 µL of sterile 18.2 
MΩ/cm water contained in a 0.2 mL PCR tube. The PCR tubes containing the cell-
water suspensions were incubated in the PCR machine at 95°C for 5 min to disrupt 
the cells and centrifuged at 14000 x g for 2 min. The pellet was discarded and the 
supernatant was transferred into a clean sterile 0.2 mL PCR tube. This was stored at 
-20°C until use.  The same process was repeated for each and every colony of 
interest on the agar plate. 
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9.12 PCR screening to identify colonies containing gene inserts 
A volume of 10 µL of the supernatant from above was mixed with 1µL of the forward 
primer (0.4 µM), 1 µL of the reverse primer (0.4 µM), 5 µL of dNTPs (2 mM), 1 µL of 
(5 U/µL) Taq polymerase, 5 µL of Taq buffer (10 X) (Refer to Appendix A2 for recipe 
details) and made upto 50 µL with sterile 18.2 MΩ/cm water. 
PCR conditions for the amplification of the BF3763 gene from transformed E. coli to 
screen for colonies containing successful inserts has been included in the Appendix 
section I. 
            
The presence of successful inserts was confirmed by agarose gel electrophoresis. 
Refer to Methods section 9.5 for details on how to perform agarose gel 
electrophoresis. 
Colonies containing successful inserts were used to inoculate LB broth media 
supplemented with an appropriate quantity of kanamycin and incubated overnight at 
37°C in a 200 rpm shaking incubator. 
 
9.13 Purification of the plasmid DNA from the colonies containing inserts 
The Bio/Spin-PTM Plasmid Miniprep Purification protocol was used to purify the 
plasmid DNA from the E. coli TOP10 cell colonies containing the gene of interest. A 
volume of 1.5 mL of the cell culture from overnight incubation was centrifuged at 
14000 x g for 1 min and the supernatant was discarded. The same step was 
repeated twice and the supernatant was discarded with a sterile pipette tip. A volume 
of 200 µL of Buffer I (Recipe patented) was added and vortexed to resuspend the 
cells.  To this, Buffer II (Recipe patented) of a volume of 200 µL was added and 
mixed by inverting 5 to 6 times. To this, 200 µL of Buffer III (Recipe patented) was 
added and mixed by inverting 5 to 6 times and centrifuged at 14000 x g for 5 min. A 
spin column was placed in a collection tube. The mixture was pipetted into the 
column and centrifuged at 14000 x g for 30 s. The flow through was discarded and 
700 µL of the washing solution was added to the column and centrifuged at 14000 x 
g for 1min. The flow through was discarded and the column was centrifuged at 
14000 x g for 3 min to remove any residual ethanol from the washing step. The flow 
through was discarded and the column was placed in a clean sterile 1.5 mL 
microcentrifuge tube. A volume of 50 µL of TE solution was added to the column and 
109 
 
centrifuged at 14000 x g for 1 min to elute the plasmid DNA which was stored at -
20°C until use. 
 
 
9.14 Method used to prepare chemically competent cells 
The glycerol stock of the cells was used to inoculate a plate that was incubated 
overnight at 37°C. A single colony from this was used to inoculate 50 mL of low salt 
LB which was incubated at 37°C in a shaker at 200 rpm until it reached an OD of 
0.35 to 0.4 at 600 nm. The cells were incubated on ice for 30 min and then 
centrifuged at 4000 x g for 10 min at 4°C. After discarding the supernatant, the 
pellets were resuspended in 15 mL of cold 80 mM MgCl2, 20 mM CaCl2 solution and 
then centrifuged at 4000 x g for 10 min at 4°C. The pellets were then resuspended in 
1 mL of 100 mM CaCl2. The cells were incubated on ice for 1 h. The cells were 
added to 50 % (v/v) glycerol making it up to a final concentration of 15 %( v/v) before 
freezing it in liquid nitrogen and storing at -80°C until use. 
 
9.15 Restriction digests of the recombinant BF3763 and BF0855 genes from 
pET-YSBLIC 
The restriction enzymes used to carry out the digestion was Eco RI and Xba I 
according to the analysis of the sequence in Webcutter 2.0 server 
(http://www.firstmarket.com/cutter/cut2.html). The restriction enzyme digestion was 
carried out to remove the recombinant genes from the vector. The restriction 
enzymes were kept on ice and centrifuged for 3 s before use. To 5 µL of the plasmid 
DNA, 0.5 µL of Xba I, 0.5 µL of Eco RI, 1 µL of 10 X NE Buffer 2, (Refer to Appendix 
A2 for recipe details) 1 µL of BSA (50 µg/ml (w/v)) and 2 µL of sterile 18.2 MΩ/ cm 
water was added to make it up to 10 µL. The mixture was incubated at 37°C for 2 h 
and the presence of the recombinant genes was analysed using agarose gel 
electrophoresis (Refer to section 9.5 in the Methods section). 
 
9.16 Transformation of the recombinant genes into BL21 cells 
 Chemically competent BL21 cells were prepared and 50 µl of the cells were treated 
with 2.5 µL of the purified plasmids by gentle mixing on ice for 5 min with a sterile tip. 
The cells were subjected to heat shock at 42°C in a water bath for 90 s and then 
immediately transferred back onto ice. A volume of 200 µL of NZY+ medium was 
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added to the mixture aseptically. The cell wall recovery was induced by incubating 
the mixture in a water bath at 37°C for 45 min. The transformed cells were plated out 
onto LB agar plates containing an appropriate amount of kanamycin and incubated 
overnight at 37°C. The number of colonies showing successful inserts was 2 for 
GH95 and 3 for GH97. 
 
The genes for GH95 and 97 have been cloned by previous students. All the details 
are available in the dissertations („Isolation and transformation of GH95_BF0855 
gene from Bacteroides fragilis NCTC 9343 in competent cells to produce soluble 
protein‟ by Cheun Hong Yeap, 2006 and „Cloning and expression of glycoside 
hydrolase family 97 BF3763 (putative exported protein) gene from the Bacteroides 
fragilis NCTC 9343 ATCC 25285 in Escherichia coli‟ by Lee Ling, Bong in 2006). 
Only experiments pertaining to the purification and characterisation of these 
enzymes have been performed by me. 
 
9.17 Solubilisation buffer experiment 
 
9.17.1  Growth of bacteria in starter cultures 
E. coli cells were grown in 30 mL sterile plastic containers containing 10 mL of LB 
media or 10 mL of autoinduction media starter cultures supplemented with an 
appropriate amount of kanamycin. The cultures were inoculated from an agar plate 
or glycerol stock using a sterile inoculation loop and grown overnight in a shaking 
incubator at 37°C and 200 rpm. 
 
 
9.17.2  Growth of bacteria for expression and purification using IPTG 
induced media 
An initial study was done to compare the expression of protein in LB and auto-
induction media. In both cases, 0.5 mL of the starter culture of BL21 E. coli cells was 
used to inoculate 50 mL of the starter culture. Following the inoculation of the media, 
the cultures were grown at 37°C in a shaking incubator at 200 rpm. 
When the culture reached an OD of 0.6, the flask containing LB medium was 
induced for the expression of the proteins of interest by the addition of 100 mM IPTG 
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(Isopropyl β-D-1-thiogalactopyranoside) to make the final concentration 1 mM and 
then the temperature was reduced to 30°C and the shaking reduced to 100 rpm. 
However, for auto-induction media cultures, the temperature was reduced to 30°C 
and the shaking to 100 rpm when it reached an OD of 0.6 without the addition of 
IPTG. The cultures were then incubated overnight and processed the following 
morning. 
 
9.17.3  Small scale protein extraction for the solubilisation buffer 
experiment 
The overnight culture was taken the following day and 3.0 mL of it was transferred 
into two clean microcentrifuge tubes of 1.5 mL each. The tubes were centrifuges at 
14000 x g for 1 min. Following centrifugation, the supernatant was discarded and the 
pellets were dissolved in 300 µL of the start buffer. The mixture was ultra-sonicated 
for 5 s at amplitude of 15 and maintained on ice while doing so. The cells were 
centrifuged at 14000 x g for 10 min and 200 µL of the supernatant also known as the 
cell free extract was transferred into a clean microcentrifuge tube. The remaining 
supernatant was discarded and the pellets were resuspended in 300 µL of the 
solubilisation buffer. An SDS-PAGE gel was run with 20 µL of the sample and 5 µL 
of the loading buffer except the solubilisation mixture which was placed in a boiling 
water bath for 1 min to dissolve the pellets and 20 µL of it was loaded on to the SDS-
PAGE gel. Molecular weight size standards were prepared with 8 µL of the loading 
buffer and run along with the samples in order to determine the size of the expressed 
protein. 
 
9.17.4  SDS-PAGE electrophoresis 
The BioRad Mini Protean III kit was used to perform 2D SDS-PAGE. Two clean 
glass plates of dimensions 10.1 X 7.2 cm and 10.1 X 8.2 cm were aligned parallel to 
each other and clamped. The larger glass plate had a spacer ridge of 0.75 mm 
attached to it. The two glass plates along with their casting clamp stand were 
mounted on the surface of a rubber gasket by applying vertical downward pressure. 
The resolving gel solution was made up in a plastic container and pipetted into the 
space between the two plates. A 2 cm mark was made from the top of the smallest 
plate and the solution was filled up to it. For efficient polymerisation, the surface of 
the gel was layered with 18.2 MΩ/cm water and the gel was allowed to polymerise 
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for 20 to 30 min. The water was removed from the surface of the set gel and blotting 
paper was used to remove any residual unset gel or water. Care was taken to avoid 
touching the surface of the gel with the blotting paper. The stacking gel solution was 
then made up and pipetted on to the surface of the resolving gel. This was filled up 
to the top of the small glass plate and a 10 toothed comb was inserted into the gap 
between the plates immediately (Size of the comb was 1.1 X 0.75 cm). The gel was 
then allowed to polymerise for 20 min and the combs were slowly removed to reveal 
the wells. Care was taken to avoid the formation of air bubbles while doing so and 
the surface of the gel was rinsed with 18.2 MΩ/cm water. The gels were placed in 
the electrophoresis module in such a way that the smaller glass plates faced towards 
the centre. The module was then lowered into the electrophoresis tank and SDS-
PAGE (1 X) running buffer was poured into it to fill both the central and the outer 
compartments. Care was taken to ensure that the electrodes were completely 
immersed in the buffer and no air bubbles formed. The buffer in the central 
compartment was allowed to flow into the wells and formed a layer on the top of the 
gel.  
The prepared samples were placed in a boiling water bath for 3 min and then 
centrifuged at 14000 x g for 1 min before loading them onto the gel with the help of a 
Hamilton syringe. The electrophoresis was performed at 120 mA and 200 V for about 
50 min. The completion of the process was indicated by the migration of the 
bromophenol blue dye to the bottom of the gel.     
Upon completion of electrophoresis, the gels were removed from the set up and 
placed in a plastic container containing Coomassie blue staining solution and rocked 
gently on a shaker for 10 min at room temperature. Following this, the gels were 
immersed in the destaining solution for atleast 6 to 8 h. Once the bands were clearly 
visible, the gels were rinsed with 18.2 MΩ/cm water and then visualised using the 
BioRad gel documentation system. Photographs of the gel were obtained using the 
Mitsubishi Video Copy Processor containing the Mitsubishi thermal paper (Refer to 
Appendix B for details).   
 
9.18 Large scale growth of bacteria 
A large scale growth of bacteria was carried out using the auto-induction medium 
where 500 mL of the medium was inoculated with 5 mL of the starter culture. 
The growth procedure was followed exactly the same way as mentioned above. 
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9.18.1  Protein extraction 
The induced cells were centrifuged at 4000 x g for 15 min and were resuspended in 
5 mL of re-suspension buffer. The cells were ultra-sonicated on ice at amplitude of 
14 for 2 min in 10 s bursts with 10 s intervals. The lysate was then transferred into 
centrifuge tubes and then spun at 24000 x g for 30 min at 4°C. The liquid 
supernatant or the cell free extract was transferred into a sterile plastic universal and 
stored in ice until purification. 
 
9.18.2  Protein Purification 
The recombinant proteins were purified using immobilised metal affinity 
chromatography (IMAC). Proteins have the presence of hexa-histidine tags at the N 
terminal that could be used to separate it out from other E. coli proteins using the 
SepharoseTM chelating fast flow resin which acts as the metal affinity matrix. The 
column was first stripped and charged using 1M NiSO4 followed by equilibration with 
200 mL of start buffer. After equilibration, the cell free extract (10-20 mL) was loaded 
onto the column and then eluted out with 100 mL of the elution buffer at a flow rate of 
4 mL/min. The presence of the protein was monitored using a UV spectrophotometer 
and the eluted fractions were collected in 4 mL quantities in plastic tubes. A volume 
of 20 µL of each sample was run on an SDS-PAGE gel to confirm and detect the 
fractions containing the pure protein. The pure protein fractions were then 
concentrated using a Vivaspin protein concentrator and then resuspended in the gel 
filtration buffer. 
 
Further purification of the proteins was carried out using gel filtration 
chromatography. The column was first equilibrated using 120 mL of the gel filtration 
buffer at a rate of 1 mL/min. A volume of 0.5 mL of the protein sample was loaded 
onto the column by injection and then eluted out at a rate of 1 mL/min. The presence 
of the pure protein was detected using the UV spectrophotometer and the eluted 
fractions were collected in 5 mL quantities in plastic tubes. A 20 µL sample from 
every fraction was run on an SDS PAGE gel to confirm the presence of the pure 
protein. The fractions of interest were pooled and concentrated. 
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9.18.3  Concentration of proteins 
The pure proteins were concentrated using the 30 kDa Vivaspin 6 mL cut off 
concentrator units (Viva Science). The pooled fractions were concentrated by 
centrifuging at 4000 x g and were buffer exchanged with 5 mM HEPES (pH 7.4) 
within the concentrator units. 
 
9.19 Concentration of proteins determined by Bradford's assay 
Standard dilutions of BSA were prepared within a range of 1-10 µg/mL and the total 
volume was made up to 500 µL. The absorbance of the solutions was recorded at 
595 nm using a visible spectrophotometer and a standard curve was drawn based 
on the values obtained. A blank was set up containing 18.2 MΩ/cm instead of BSA 
and added to the Bradford reagent. The protein solution was then diluted 
appropriately and 500 µL volumes were transferred into cuvettes. The absorbance 
values were measured and plotted against the standard to determine the protein 
concentration. 
From the standard curve, the value of c was found to be 0.6 which was the point on 
the y axis where the line intercepted. Substituting the rest of the values in the 
equation below, the value of m was determined to be 0.52. 
Unknown concentrations of protein samples and their dilutions 1:10, 1:50 and 1:100 
were prepared and mixed with the Bradford reagent. The absorbance values at 545 
nm was measured and applied to the equation y = mx + c where y = Absorbance at 
545 nm, x = the concentration of the unknown sample, m = the gradient of the 
straight line and c = the point of intercept of the line with the y axis. 
Once the concentration of the unknown protein was determined, it was multiplied by 
the dilution factor in order to obtain the concentration in mg/ mL. 
Protein conc. mg/ mL= Conc. obtained from the curve X dilution of the sample/1000. 
 20 µL of known concentrations of BSA were prepared and mixed with 200 µL of the 
Bradford reagent and the absorbance was measured at 545 nm. The concentration 
range of BSA was 0.1 to 1.0 mg/mL to generate a standard curve and the standard 
curve has been included in the Appendix section J. 
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The concentration of the GH95 protein was determined to be 43 mg/mL from the 
equation with an absorbance of 0.823 and a dilution factor of 100. The concentration 
of the GH97 protein was determined to be 29.2 mg/mL from the equation with an 
absorbance of 0.752 and a dilution factor of 100. 
 
The proteins were diluted to obtain a final concentration of 15 mg/mL with 5 mM 
HEPES buffer pH 7.4 before crystallisation. 
 
9.20 Crystallisation 
The protein concentration was determined using Bradford assay and then 
crystallisation trays were set up. 
 
9.20.1  Crystallogenesis 
1 ml of liquid Aquasil was mixed with 999 mL of 18.2 MΩ/cm water in a 2000 mL 
beaker and the cover slips were added to the solution. 
The liquid solution was stirred every 15 min for about 2 h. The cover slips were taken 
out and allowed to dry on a tissue paper. The cover slips were wiped down with a 
clean cloth before use. The crystal tray wells were filled with the appropriate buffer 
solutions from various screen aliquots and the cover slips containing drops of protein 
and buffer in three different concentrations of 1:1, 1:2, 2:1 respectively were inverted 
onto the surface of the wells which were greased beforehand. Once the tray of 24 
wells was set up, they were incubated at 22.4°C in the crystallisation incubator and 
monitored for the presence of crystals every week. The various crystal screens and 
their compositions have been included in Appendix H. Crystals were harvested in 
rayon fiber loops, bathed in cryo-protectant solution prior to flash freezing in liquid 
nitrogen.  
 
9.20.2  Data collection 
Diffraction data were collected on the European Synchrotron Radiation Facility 
(ESRF) from single crystals at 100 K with an oscillation range of 0.5 °. Data were 
collected at a wavelength of 0.933 Å on beamline ID14-2 using an ADSC Q4R CCD 
detector.  All diffraction data were processed with MOSFLM and reduced and scaled 
with SCALA (Leslie, 1992). All other computing was undertaken using the CCP4 
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suite (Anon, 1994) unless otherwise specified. The structure of BfGH97 was solved 
by molecular replacement using the program PHASER using the Bacteroides 
thetaiotaomicron BtGH97b (UniProtKB/TrEMBL entry Q8A6L0) structure (Okuyama 
et al., 2009) (PDB code 3A24) as a search model.  5 % of the total reflections were 
set aside for cross validation (“Rfree”) purposes and for the weighting of geometrical 
and temperature factor restraints. The structure was manually built with cycles of 
REFMAC (Murshudov et al., 1997). Solvent molecules were added using COOT 
(Emsley & Cowtan, 2004) and checked manually. The structure was validated using 
MOLPROBITY (Davis et al., 2007). 
 
9.21 Enzyme assay 
 
9.21.1  Preparation of substrates 
A volume of 1 mL of 6 mM substrates were prepared by dissolving the substrate in 
18.2 MΩ/ cm. Since the methylumbelliferone substrates were found to be difficult to 
dissolve, they were ultra-sonicated (15 amplitude) at 1 min intervals until the 
substrates dissolved completely. The appropriate volumes required for the assay 
were aliquoted out into clean microcentrifuge tubes. Care was taken to perform the 
assays with freshly prepared substrates. 
  
9.21.2  Enzyme assay protocol 
Two different assay methods were used to characterise and determine the specific 
activity of the enzymes expressed from GH95 and 97 namely fluorogenic and 
chromophoric assays. The putative enzymes expressed from GH95 and 97 were α- 
fucosidase and α- glucosidase respectively.  
 
9.21.3  Chromophoric assay 
p-Nitrophenyl α-D-Glucoside →α-D-Glucose + p-Nitrophenol 
 
CONDITIONS: T = 37°C, pH = 6.8, A 400nm, Light path = 1 cm 
The substrates used were p-nitrophenyl α-D-glucoside, p-nitrophenyl α-D- fucoside, 
p-nitrophenyl ß-D-maltoside and p-nitrophenyl α-D-galactoside. The activities of the 
enzymes were measured by their action against the substrates resulting in the 
release of 4- nitrophenol indicated by a change of colour to yellow. The assay 
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mixture contained 20 mM of the substrate, 5 mM HEPES pH 7.4, 10 mg/mL BSA and 
15 µL of the enzyme at a final concentration of 10 mg/mL. The volume of the assay 
mixture was made up to a total volume of 500 µL. The mixture was transferred to a 
clean plastic cuvette, mixed well with a sterile pipette tip and incubated at 37°C. The 
change in absorbance values at a wavelength of 420 nm was noted at 1 min 
intervals.  
 
9.21.4  Fluorimetric assay 
The substrates used to carry out the fluorimetric assays include 4-methylumbelliferyl 
α-D glucoside, 4-methylumbelliferyl α-D-fucoside and 4-methylumbelliferyl ß-D-
maltoside. These are synthetic substrates that react with enzymes to release a 
product called 4-methylumbelliferone (4-MU). 4-MU is a fluorescent dye whose 
fluorescence was measured using the Bio-Tek FL600 fluorescence microplate 
reader. The excitation wavelength used was 360 nm and the emission wavelength 
was 460 nm. Standard assays were performed at 37°C in a total volume of 500 µL of 
5 mM Hepes buffer, pH 7.4, containing 10 mg/mL BSA and 0.15 µg of the enzymes, 
α-D-glucosidase and α-D-fucosidase. The reaction mixture without the enzyme was 
transferred into a clean glass cuvette and placed into the cuvette holder in the 
fluorescence densitometer. Once the excitation and emission wavelengths were set, 
the enzyme was quickly added and mixed well with a sterile tip and the photometric 
values were measured at 10 min intervals for 60 min. The cell containing the reaction 
mixture was maintained at 37°C by a temperature controlled circulator. The 
photometric recordings were traced out onto chart paper using a chart recorder with 
a recorder pen attached to it. Positive activity was detected in the case of both 
enzymes. 
 
Two different types of substrates were used in the study to determine the activity of 
the recombinant enzyme, α-glucosidase purified from our experiment. Para 
nitrophenyl- α-D- glucopyranoside was used as a substrate where α-D-glucose and 
p-nitrophenol were expected to be produced as end products as a result of the 
hydrolysis of the α 1→6/ α 1→4 linkages in the substrate. The release of para 
nitrophenol into the reaction mixture would result in the development of a yellow 
colour. The intensity of the yellow colour indicated the amount of product released 
and was measured spectrophotometrically at 420 nm in the colorimetric assay 
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(Anon, 1996). The other substrate that was used in the study was 4- 
methylumbelliferly α-D-glucoside. The  α-glucosidase carried out an enzymatic 
hydrolysis of the fluorescent sugar resulting in the release of 4-methylumbelliferone 
as a byproduct of the reaction. The presence of the product in the reaction mixture 
was analysed using a fluorescent spectrophotomer where the excitation and 
emission wavelengths were used to measure the amount of product released in the 
fluorimetric assay (Sheldon et al., 2006). 
The BF0855 gene from B. fragilis NCTC 9343 was cloned and expressed in E. coli 
and the putative activity of the enzyme was predicted to be α-L-fucosidase or 1, 2 α-
L- fucosidase. α-L- fucosidase catalyses the reaction between α-L- fucoside and 
water resulting in the formation of L- fucose as an end product. They belong to the 
family of glycoside hydrolases that hydrolyse O and S glycosyl compounds. They are 
also known as α-L- fucoside fucohydrolase. It is involved in n-glycan and glycan 
structure degradation. In the presence of 4- methylumbelliferyl α-L- fucoside, 1, 2-α-
L- fucosidase catalyses the release of 4-methylumbelliferone as a byproduct of the 
reaction and this can be used in its fluorimetric assay. The substrate used in the 
colorimetric assay of α- L- fucosidase was para- nitrophenyl- α- D- fucoside. 
 
 
 
 
 
 
 
 
 
 
 
119 
 
10. Results and discussion of the proteomic analysis of Bacteroides fragilis 
NCTC 9343 and Enterobacter cancerogenus ATCC 35316 
Enterobacter cancerogenus and Bacteroides fragilis are some of the predominant 
flora of the gut and are capable of acting as opportunistic pathogens by causing gut 
associated infections. B. fragilis originate in the endogenous flora of the mucous 
membranes and are capable of causing a number of infections including intra 
abdominal abscesses, soft skin and tissue infections, bacteraemia, gangrene, 
necrotizing cellulitis and so on. They are also capable of causing severe secondary 
infections that include central nervous system infections, pleuropulmonary infections 
and septic arthritis (Pumbwe et al., 2006). Since Bacteroides spp. are strictly 
anaerobic in nature, it hard to detect them during specimen culture and analysis. E. 
cancerogenus has been known to occur as a secondary wound infection causing 
bacteria. They have been isolated from human faeces, found to be associated with 
the human gut and form a part of the normal human gut microbiota. 
A number of studies have been performed on the differential expression of proteins 
in B. fragilis and Enterobacter sp. in response to oxidative stress, antibiotic and so 
on. In order to determine the proteins that may be differentially expressed in 
metronidazole-resistant strains of B. fragilis, mutants lacking the flavodoxin and 
pyruvate-ferredoxin oxidoreductase genes were generated and studied (Diniz et al., 
2004). Other proteomic studies in B. fragilis were performed to determine the 
oxidative stress response (Rocha et al., 2003). A top down proteomics approach has 
been used to study the differential expression of heat resistant strains (Williams et 
al., 2005) and osmotic stress response (Riedel & Lehner, 2007) in E. sakazakii and 
selenite resistance in E. cloacae (Barasa, 2008). Since E. cancerogenus infections 
are not as commonly occurring as B. fragilis infections, no proteomics experiments 
have been performed to determine its virulence factors. 
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10.1 Growth analysis of E. cancerogenus and B. fragilis 
The two strains, Bacteroides fragilis NCTC 9343 and Enterobacter cancerogenus 
ATCC 35316, were grown anaerobically at 37°C in an anaerobic chamber. The 
presence of Gram-negative bacteria was confirmed by Gram staining (Refer to the 
Figs.12 and 13). 
 
 
Figure 12: Gram staining results for E. cancerogenus showing the presence of small 
rod shaped bacilli that stained pink. 
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Figure 13: Gram staining results for B. fragilis showing the presence of small rod 
shaped bacilli that stained pink. 
Minimal medium was prepared as described in the methodology section and the 
bacteria were grown in the media. The growth rate of both B. fragilis and E. 
cancerogenus was found to be very slow taking about 160 to 170 h to reach an OD 
of 1.0 at 600 nm. Hence modifications were made in the minimal media where yeast 
extract was used as a source of vitamin B and the concentration of casitone was 
increased from 0.2 g to 0.5 g per 100 mL of medium. The growth in this medium 
(semi- defined media) was found to be much quicker with the culture attaining an 
overnight stationary phase in case of E. cancerogenus (12-16 h) and 40 h for B. 
fragilis.  Table 3 showing the growth of E. cancerogenus and B. fragilis in minimal 
growth media have been included below. Table 4 included below details the growth 
of bacteria (E. cancerogenus and B. fragilis) in semi-defined media containing 
various sources of carbon. 
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Time in h  Average absorbance at  600 nm 
E. cancerogenus      B. fragilis  
0  0.000                           0.000  
12  0.008                           0.015  
24  0.023                           0.044  
48  0.158                           0.102  
72  0.278                            0.304  
96  0.488                            0.417  
120  0.821                            0.632  
144  1.025                            0.954  
168  1.238                            1.189  
192  1.143                            1.178  
Table 3: Growth of E. cancerogenus and B. fragilis in minimal media 
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Type of carbon source used in 
the semi-defined media 
Average OD at 4 h after 
inoculation 
Average OD at 8 h after 
inoculation 
Average OD at 16 h after 
inoculation (overnight 
incubation) 
 E. cancerogenus B. fragilis E. cancerogenus B. fragilis E. cancerogenus B. fragilis 
Glucose 0.839±0.0008         0.223±0.0009 1.036± 0.002 0.539±0.0012                 1.304± 0.0025 0.728±0.0008 
Mucin Type II 0.378±0.001 0.035±0.0008 0.367± 0.156 0.156±0.0008 0.358± 0.002 0.462±0.0017 
Mucin Type III 0.355 ±0.0005 0.038±0.0012 0.353± 0.093 0.201±0.0008 0.325± 0.0008 0.512±0.0008 
Glucose and Type II mucin (0.5 
g/100 mL of glucose and mucin 
Type II) 
0.993±0.0012 0.324±0.0012 1.148 ±0.001 0.498±0.0012 1.316±0.0016 0.819±0.0017 
Glucose and Type III media (0.5 
g/100 mL of glucose and mucin 
Type III) 
1.090±0.0124 0.287±0.0009 1.220±0.025 0.562±0.0016 1.414 ±0.0017 0.753±0.0016 
Type II and III mucin (0.5 g/100 
mL of mucin Type II and Type III) 
0.956±0.0008 0.045±0.001 1.134±0.002 0.198±0.0008 0.614±0.0012 0.485±0.0012 
Glucose and Type II and III mucin 
(0.5 g/100 mL of glucose, mucin 
Type II and Type III) 
0.068±0.0017 0.015±0.0017 0.881±0.0017 0.367±0.0008 0.821± 0.0012 0.328±0.0008 
Table 4: Growth of bacteria in the semi-defined media with different carbon sources 
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All experiments were performed in duplicate and the values represented in the tables 
indicate average values of absorbance (600 nm) at the respective time points. All the 
carbon sources were added at a concentration of 0.5 g per 100 mL of the media. A 
quantity of 0.5 g of mucin was weighed out from the bottle and added to the medium 
rather than measuring the concentration of sugar in it. 
 
10.1.1 Growth analysis of E. cancerogenus 
Media (450 mL) inoculated with a 1 mL volume from 10 mL overnight starter cultures 
showed the following growth results over a period of 8 h (Fig. 14). The optical density 
values were measured at 600 nm at various time periods. An average of three 
results is represented in the graph below for both OD values against time and three 
different media have been used. 
All the growth curve experiments were performed in triplicate and vertical error bars 
representing the standard deviation from the mean can be observed in the graph. 
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Figure 14: Graph representing the average absorbance vs time- growth rate of E. 
cancerogenus in three types of media 
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10.1.2 Growth analysis of B. fragilis 
Media (450 mL) inoculated with a 1 mL volume from 10 mL overnight starter cultures 
showed the following growth results over a period of 48 h (Fig. 15). The optical 
density values were measured at 600 nm at various time periods. An average of 
three results is represented in the graph below for both OD values and colonies 
forming units against time and three different media have been used. 
All the growth curve experiments were performed in triplicate and vertical error bars 
representing the standard deviation from the mean can be observed in the graph. 
The average absorbances for the growth of E. cancerogenus and B. fragilis in semi-
defined media have been included in the Appendix section E in the following tables. 
Tables 5, 6 and 7 included in the Appendix E show the growth of E. cancerogenus in 
non mucin, mucin Type II and Type III enriched media, respectively. Tables 8, 9 and 
10 included in the Appendix E show the data for the growth of B. fragilis in non 
mucin, mucin Type II and Type III enriched media, respectively. 
 
 
 
 
 
 
 
 
127 
 
 
Figure 15: Graph representing the average absorbance vs time- growth rate of B. 
fragilis in three types of media 
 
The harvesting time point for the cultures of E. cancerogenus and B. fragilis were 
determined based on halving the maximum OD value achieved during its growth in 
the semi-defined media as 0.6 and 0.7, respectively. This would also ensure that the 
cells were in their mid log phase. 
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10.2 Growth of E. cancerogenus ATCC 35316 and B. fragilis NCTC 9343 in 
semi-defined media 
Both bacteria were grown in three types of semi-defined media which included media 
without mucin, media enriched with porcine intestinal mucin Type II and media 
enriched with porcine intestinal mucin Type III. Even though initial attempts were 
aimed at growing the bacteria in minimal media with and without mucin, it was found 
that the extremely slow rate of growth of bacteria hindered the progress of 
experiments and hence the medium was slightly modified by the addition of yeast 
extract, replacing the vitamin solution and increasing the concentration of casitone 
from 0.2 to 0.5 g to enable quicker growth of the bacteria.  
Growth of the bacteria was studied in the logarithmic phase rather than the 
stationary phase because most of the virulence factors and other important proteins 
are normally expressed in the logarithmic phase of growth (Ernst et al., 1990).  
Several carbon sources were used to study the growth of E. cancerogenus and B. 
fragilis and it was found that the semi-defined medium containing glucose on its own 
(or in combination with mucin) supported efficient growth. In a semi-defined medium 
containing only mucin as a source of carbon, the growth rate was found to be low, 
with the optical density not increasing beyond 1.0, when compared to a semi-defined 
medium containing glucose and mucin. This may be due to the general tendency of 
bacteria to use glucose as the first source of carbon and other carbohydrate sources 
are utilised only when glucose is completely depleted in the media (Studier, 2005).  
 
10.3  Mucin used in the study 
The two types of mucin used were porcine gastric/intestinal mucin Type II and III. 
The main difference between the Type II and Type III medium is that mucin Type III 
is a partially purified powder that has the presence of 0.5 to 1.5% bound sialic acid. 
The sugar and amino acid composition of mucin has not been determined by the 
Sigma-Aldrich company from where it was purchased. The Type II mucin is a crude 
extract of mucin glycoproteins from the hog stomach using the enzyme pepsin and it 
has about 1% of bound sialic acid. Since the study aimed at analysing the differential 
protein expression in opportunistic pathogens when they come in contact with the 
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first line of cell defence, mucin, the closest possible system to the human body was 
necessary. Previous studies show that the core structures found in porcine gastric 
mucins are the same as that in human gastric mucins (Karlsson et al., 1997). One of 
the most easily accessible types of mucin was the porcine gastric mucin without the 
involvement of any ethical issues thereby encouraging the incorporation of mucin as 
a potential source of carbohydrates in the semi-defined medium.  
Out of several mucin types used in a study, ovomucoid, porcine gastric mucin and 
beef submaxillary mucin were found exhibit high similarity to human colonic mucin 
(Salyers et al., 1977). The variations mainly occur in a relatively small number of 
basic structures. Some of these variations include the presence of acidic structures 
derived from neutral oligosaccharides in human colonic mucin, variations in the 
degree of sialylation, the biantennary structures of mucin oligosaccharides and also 
the branched chain olicosaccharides which appear to be linear chain derivatives of 
the same core structure (Podolsky, 1985). High levels of sialylation have been 
observed in both human and porcine colonic mucin. The hydroxyl groups present at 
the end of the sialic acids that contain acetyl esters inhibit bacterial degradation of 
mucin (Corfield et al., 1992). Disulphide rich domains have been idenitified in both 
human intestinal and porcine submaxillary mucins but there may be a low degree of 
sequence identity (PerezVilar et al., 1996). 
It is possible that the activity of B. fragilis on colonic mucin may be different to that of 
gastric mucin since gastric mucin has been used in our studies due to the 
unavailability of colonic mucin.  
My results show the expression of a number of proteins related to oxidative stress 
and heat shock which indicate the presence of stress during growth. Previous 
proteomics studies in E. faecalis have revealed the expression of a number of stress 
associated proteins in exponentially grown cells, viable but non culturable cells and 
proteins expressed during starvation conditions (Heim et al., 2002). These stress 
proteins are generally expressed in response to bacterial growth and adaptability to 
various environmental conditions.    
Proteome profiles obtained from the growth of bacteria in mucin enriched media 
suggest that the differentially expressed proteins may be associated with 
colonisation where bacteria adapt themselves to bind to the mucous layers of the 
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gut. Bacterial proteins associated with the ability to induce an immune response 
within the host could act as potential virulence factors and eventually result in 
infection. In the proteomics studies, first dimension separation of proteins was limited 
to a pH range of 4-7 rather than a variety of different pH gradients. Performing 
experiments with different second dimension separations may also provide a better 
insight into understanding differential protein expression. There are a large number 
of bacteria that occur commonly on mucous membranes forming a part of the normal 
gut flora by adhering and colonising mucin. But certain environmental adaptations 
within them can result in their ability to produce enzymes and compounds that lead 
to virulence.  
 
10.4 Optimisation of two dimensional polyacrylamide gel electrophoresis (2DE-
PAGE) gels 
10.4.1 Comparison of staining methods 
An attempt was used to compare the Coomassie blue staining with fluorescent 
staining, but due to the inconvenience of the requirement to irradiate with UV light 
when excising protein spots and poorer resolution, the Coomassie blue staining 
technique was chosen to analyse the spots of interest. On comparison of the gels 
represented in Figs 16.1 and 16.2 it is evident that the spots have been expressed 
with better clarity and resolution when colloidal Coomassie blue stain was used. 
From the figure, it was evident that fluorescent staining failed to achieve the required 
sensitivity levels and seemed inconsistent when compared to Coomassie blue 
staining. The process of cutting out spots of interest would be a more tedious 
process if fluorescent staining was used since this would involve working in the 
presence of UV light. The gel looks smudgy and the presence of a dark background 
may obscure the number of low abundance proteins observed. The improper 
background staining may be attributed to the trapping of the fluorescent dye in 
detergent micelles and this has been observed in previous studies (Malone et al., 
2001). 
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Figure 16: Figure showing the difference between fluorescent staining and 
Coomassie blue staining. 
 
                                     
Figure 16.1: Proteome map of E. cancerogenus grown in semi-defined media 
without mucin. Separation was achieved using pH range 3-10 IEF strips. Gel was 
stained using fluorescent staining. 
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Figure 16.2: Proteome map of E. cancerogenus grown in semi-defined media 
without mucin. Separation was achieved using pH range 3-10 IEF strips Gel was 
stained using colloidal Coomassie blue staining. 
10.4.2 Comparison of pH ranges of IEF strips 
The proteins from the culture supernatant were initially analysed using pH range 3-
10 IEF strips. However the location of proteins seemed to be predominantly within 
the 4-7 pH range (Figures 17.1, 17.2 and 17.3) and hence the IPG strip pH range 
was changed to 4-7.  
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Figure 17: Isolation of E. cancerogenus proteins from 450 mL mid log phase 
cultures at an OD of 0.6 separated using pH range of 3-10 IEF strips  
 
                                     
Figure 17.1: Proteome map of E. cancerogenus grown in semi-defined media 
without mucin. Separation was achived using pH range 3-10 IEF strips. 
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Figure 17.2:  Proteome map of E. cancerogenus grown in semi-defined media 
enriched with mucin Type II. Separation was achieved using pH 3-10 IEF strips. 
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Figure 17.3: Proteome map of E. cancerogenus grown in semi-defined media 
enriched with mucin Type III. Separation was achieved using pH 3-10 IEF strips. 
 
10.4.3 Comparison of protein loadings 
The expression of proteins was studied in the mid logarithmic phase of growth of the 
culture and several optimisation experiments were performed to determine the 
appropriate volume of the culture that could provide a good separation and 
resolution of spots. Initial experiments were performed using 450 mL of the log 
phase cultures and were later reduced to a volume of 100 mL in order to obtain the 
best possible resolution (Figs. 18.1 and 18.2). 
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Figure 18. Proteins isolated from 100 and 450 mL of B.fragilis and E. cancerogenus 
grown in semi-defined media separated by pH 4-7 IEF strips 
 
                         
Figure 18.1: Proteins isolated from 450 mL of E. cancerogenus grown in semi-
defined media without mucin separated by pH 4-7 IEF strips. 
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Figure 18.2: Proteins isolated from 100 mL of E.cancerogenus grown in semi-
defined media without mucin separated by pH 4-7 IEF strips. 
 
10.4.4 Comparison of polyacylamide gel concentrations 
The protein expression patterns were found to be more distinct and better resolved 
in 12 % (w/v) rather than 14% (w/v) gels and hence 12 % (w/v) gels were used 
during the study (Figures 19.1 and 19.2). 
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Figure 19: Isolation of E. cancerogenus proteins from 100 mL log phase cultures at 
an OD of 0.6 separated using pH range of 4-7 IEF strips 
 
                      
Figure 19.1: Proteome map of E. cancerogenus grown in semi-defined media 
without mucin.  Separation was achieved using a 12% (w/v) gel  
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Figure 19.2: Proteome map of E. cancerogenus grown in semi-defined media 
without mucin.  Separation was achieved using a 14% (w/v) gel  
 
10.5 Two dimensional gel electrophoresis 
One of the initial problems was the culture volume required to obtain a protein 
expression profile with good resolution and minimising horizontal streaks. Hence 
different volumes of cultures were used to obtain expression patterns in the log 
phase and a 100 mL culture volume at an OD600nm of 0.6 or 0.7 in E. cancerogenus 
or B. fragilis, respectively, was found to be the most appropriate. Based on the 
results obtained, 100 mL culture volumes were used in the study (Refer to Figs. 
18.1, 18.2 with different volumes in results section).  
Sample preparation is one of the most important parts of the two dimensional gel 
electrophoresis (2DE) technique since even small variations in methodology could 
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result in massive changes in protein expression profiles. Reproducibility of gels was 
another major issue faced in the 2DE method. Care was taken to ensure that 
proteins studied from different conditions were extracted and analysed in a similar 
fashion aiming at minimising variation as much as possible (Choe & Lee, 2003). At 
least six gels were generated from each condition in order to confirm that they were 
reproducible.  During Mann-Whitney U analysis using the PDQuest and Redfin 
softwares, spots that were not up- or down-regulated in all the replicate gels 
compared to all the replicated control gels were excluded. During Student t-test 
analysis using the PDQuest, Redfin and SameSpots software, an average 
expression in each condition was considered rather than the expression levels in 
each replicate gel.  
Initial experiments resulted in a high amount of horizontal and vertical streaks on the 
gels with poor resolution. One of the main reasons for this was the incomplete 
resolubilisation of pellets following their treatment with the 2D Clean up kit. The 
protein pellets were resolubilised in the rehydration buffer by ultra-sonication on ice 
for a few seconds and the insoluble pellets were removed by centrifugation for 1 min. 
This helped to reduce protein overload on to the IPG strips and also resulted in 
efficient separation of proteins.       
The composition of the solutions used in the 2D Clean up kit are not freely available. 
Previous studies have shown that they help to remove contaminating 
polysaccharides from the protein samples (Zhang, 2006) (Zhang et al., 2007).The 2D 
Clean up kit consists of the precipitant, co-precipitant, wash buffer and wash additive 
solutions whose recipe has been patented. Alternatively, the acetone precipitation 
method could be used to prepare protein samples from B. fragilis cultures where 
acetone is the main compound precipitating out the proteins present in the cell free 
extract. 
Similar studies were performed to determine the pH range for the IPG strips used in 
the first dimension electrophoresis. The pH range of 3-10 was used initially but since 
most of the proteome expression was concentrated around the acidic pH range of 4-
7, further experiments were performed using IPG strips of pH 4-7 (refer to Figs. 17).  
An attempt was used to compare the Coomassie blue staining with fluorescent 
staining but due to the inconvenience of cutting out spots and improper resolution, 
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the Coomassie blue staining technique was chosen to analyse the spots of interest. 
The inconvenience of cutting out spots was that UV light was required to locate the 
exact spot boundaries and this would make the cutting process a tedious task and 
visualisation in visible light impossible. From Figs. 16.1 and 16.2, it is evident that the 
spots have been expressed with better clarity and resolution when colloidal 
Coomassie blue stain was used. The increased convenience of using colloidal 
Coomassie blue staining method when compared to fluorescent staining supported 
its use in the study. 
Since reproducibility and uniform dimensions of scan area on gels were some of the 
most important factors to be considered, the scanning of all the gels were performed 
together at the same time ensuring that the scan area was exactly the same for all of 
them. Further adjustments were possible using the PDQuest, Redfin and Samespots 
software tools where flipping of gels, cropping and background subtractions were 
carried out to optimise and compensate for differences in intensities of staining and 
other experimental variations. The spots on the gels were reviewed using the spot 
review tool and the consensus tool was used to edit any errors that may have 
occurred during spot analysis.  
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10.6 Separation of proteins from E. cancerogenus and B. fragilis grown in 
semi-defined media with and without mucin using 2DE gels. 
10.6.1 Sets of replicate 2DE gels of proteins from E. cancerogenus 
Multiple sets of gels of biological replicates of proteins from E. cancerogenus grown 
in media without mucin, media with mucin Type II and media with mucin Type III (IEF 
strip pH range 4-7, processing volume: 100 mL, harvesting OD at 600 nm: 0.6) (Figs. 
20-22). 
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Figure 20: Proteome maps of E. cancerogenus grown in semi-defined media without 
mucin (control media; using pH 4-7 IEF strips). 
 
                     
Figure 20.1: Proteome map no.1 of E. cancerogenus grown in semi-defined media 
without mucin  
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Figure 20.2: Proteome map no.2 of E. cancerogenus grown in semi-defined media 
without mucin. 
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Figure 20.3: Proteome map no.3 of E. cancerogenus grown in semi-defined media 
without mucin. 
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Figure 20.4: Proteome map no.4 of E. cancerogenus grown in semi-defined media 
without mucin. 
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Figure 20.5: Proteome map no.5 of E. cancerogenus grown in semi-defined media 
without mucin. 
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Figure 20.6: Proteome map no.6 of E. cancerogenus grown in semi-defined media 
without mucin. 
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Figure 20.7: Proteome map no.7 of E. cancerogenus grown in semi-defined media 
without mucin. 
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Figure 21: Proteome maps of E. cancerogenus grown in semi-defined media 
enriched with mucin Type II (using pH 4-7 IEF strips) 
 
 
                       
Figure 21.1: Proteome map no.1 of E. cancerogenus grown in mucin Type II 
enriched media                    
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Figure 21.2: Proteome map no.2 of E. cancerogenus grown in mucin Type II 
enriched media                    
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Figure 21.3: Proteome map no.3 of E. cancerogenus grown in mucin Type II 
enriched media                    
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Figure 21.4: Proteome map no.4 of E. cancerogenus grown in mucin Type II 
enriched media                    
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Figure 21.5: Proteome map no.5 of E. cancerogenus grown in mucin Type II 
enriched media                    
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Figure 21.6: Proteome map no.6 of E. cancerogenus grown in mucin Type II 
enriched media                    
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Figure 22: Proteome maps of E. cancerogenus grown in semi-defined media 
enriched with mucin Type III (using pH 4-7 IEF strips) 
 
 
             
Figure 22.1: Proteome map no.1 of E. cancerogenus grown in mucin Type III 
enriched media  
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Figure 22.2: Proteome map no.2 of E. cancerogenus grown in mucin Type III 
enriched media 
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Figure 22.3: Proteome map no.3 of E. cancerogenus grown in mucin Type III 
enriched media 
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Figure 22.4: Proteome map no.4 of E. cancerogenus grown in mucin Type III 
enriched media 
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Figure 22.5: Proteome map no.5 of E. cancerogenus grown in mucin Type III 
enriched media 
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Figure 22.6: Proteome map no.6 of E. cancerogenus grown in mucin Type III 
enriched media 
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Figure 22.7: Proteome map no.7 of E. cancerogenus grown in mucin Type III 
enriched media 
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Figure 22.8: Proteome map no.8 of E. cancerogenus grown in mucin Type III 
enriched media 
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10.6.2 Sets of replicate 2DE gels of proteins from B. fragilis 
Multiple sets of gels of proteins from B. fragilis grown in media without mucin, media 
with mucin Type II and media with mucin Type III (IEF strip pH range 4-7, processing 
volume: 100 mL, harvesting OD at 600 nm: 0.7) (Figs. 23-25). 
 
Figure 23: Proteome maps of B. fragilis grown in semi-defined media without mucin 
(control media; using pH 4-7 IEF strips) 
. 
                       
Figure 23.1 Proteome map no.1 of B. fragilis grown in semi-defined media without 
mucin  
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Figure 23.2: Proteome map no.2 of B. fragilis grown in semi-defined media without 
mucin  
 
 
 
66 kDa→ 
 
 
45 kDa→ 
 
36 kDa→ 
 
29 kDa→ 
 
 
24 kDa→ 
 
20 kDa→ 
 
 
14.2 kDa→ 
 
6.5 kDa→ 
 
 
pH 4→                                                                                     7 
166 
 
                      
Figure 23.3: Proteome map no.3 of B. fragilis grown in semi-defined media without 
mucin  
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Figure 23.4: Proteome map no.4 of B. fragilis grown in semi-defined media without 
mucin  
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Figure 23.5: Proteome map no.5 of B. fragilis grown on semi-defined media without 
mucin  
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Figure 23.6: Proteome map no.6 of B. fragilis grown in semi-defined media without 
mucin  
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Figure 24: Proteome maps of B. fragilis grown in media containing mucin Type II 
(using pH 4-7 IEF strips).   
                    
 
                  
Figure 24.1: Proteome map no.1 of B. fragilis grown in mucin Type II enriched media 
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Figure 24.2: Proteome map no.2 of B. fragilis grown in mucin Type II enriched media 
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Figure 24.3: Proteome map no.3 of B. fragilis grown in mucin Type II enriched media 
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Figure 24.4: Proteome map no.4 of B. fragilis grown in mucin Type II enriched media 
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Figure 24.5: Proteome map no.5 of B. fragilis grown in mucin Type II enriched media 
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Figure 24.6: Proteome map no.6 of B. fragilis grown in mucin Type II enriched media 
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Figure 25: Proteome maps of B. fragilis grown in semi-defined media enriched with 
mucin Type III (pH 4-7 IEF strips) 
 
                       
 
Figure 25.1: Proteome map no.1 of B. fragilis grown in mucin Type III enriched 
media  
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Figure 25.2: Proteome map no.2 of B. fragilis grown in mucin Type III enriched 
media 
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Figure 25.3: Proteome map no.3 of B. fragilis grown in mucin Type III enriched 
media 
 
 
66 kDa→ 
 
 
45 kDa→ 
 
36 kDa→ 
 
29 kDa→ 
24 kDa→ 
 
 
20 kDa→ 
 
 
 
14.2 kDa→ 
6.5 kDa→ 
 
 
pH 4→                                                                                       7 
179 
 
                       
Figure 25.4: Proteome map no.4 of B. fragilis grown in mucin Type III enriched 
media 
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Figure 25.5: Proteome map no.5 of B. fragilis grown in mucin Type III enriched 
media                        
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Figure 25.6: Proteome map no.6 of B. fragilis grown in mucin Type III enriched 
media 
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10.7 Analysis of 2DE gels 
10.7.1 Analysis of 2DE gels using Bio-Rad PDQuest software 
PDQuest software was used to analyse the spots present in the three different 
conditions. A reference master image was created which contained all the spots from 
all the three different conditions. Further landmarking and matching of gels was 
performed using the reference master gel as the template (Fig. 26.1, 26.3). The 
filename „PROTBF  1‟ refers to the 2D gel analysis in E. cancerogenus and the 
filename „PROTEOMICS 3‟ refers to the 2D gel analysis in B. fragilis. Refer to 
Appendix F for details. 
 
The spot review tool was used to generate bar charts showing the expression of all 
the spots included in the reference master gel (Appendix F1). The spots are 
assigned SSP numbers and the graphs show the level of expression of a spot in all 
the individual gels or can be adjusted to show average values within replicate 
groups. Differentially expressed proteins were identified based on these expression 
patterns and cut out from the gel for further analysis. The analysis manager was 
used to perform statistical analysis on the spot data and the two main statistical tests 
performed were the Student t-test and the Mann-Whitney U test (Table 11). 
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Replicate groups used in 
analysis 
Student t-
test 
Mann-Whitney U 
test  
Organism 
Non mucin v. mucin Type II 
enriched media 
85/127 42/127 E. cancerogenus 
Non mucin v. mucin Type III 
enriched media 
32/65 33/65 E. cancerogenus 
Non mucin v. mucin Type II 
enriched media 
45/84 39/84 B. fragilis 
Non mucin v. mucin Type III 
enriched media 
66/94 28/94 B. fragilis 
Table 11: Table represents the statistical test results for spot data in replicate groups 
using the Bio-Rad PDQuest software. The values represented in the table as x/y 
indicate that „x‟ refers to the differentially expressed proteins and „y‟ refers to the total 
proteins detected in each statistical test.
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Figure 26: Reference reference master gels used in the PDQuest analysis of spot 
data  
 
 
Figure 26.1: Reference master gel obtained from PDQuest analysis of E. 
cancerogenus spot data.  
 
10.7.2 Differential expression of proteins in E. cancerogenus 
Out of a total of 132 spots that were analysed, 98 proteins were identified using ESI 
LC MS/MS in E. cancerogenus. From the 98 proteins that were identified, 23 protein 
spots were differentially expressed in mucin enriched media. Seven proteins were 
shown to be up-regulated in both types of mucin enriched media (SSP numbers- 
4008, 5306, 5601, 5607, 5701, 5702, 6203, 6605), three proteins were up-regulated 
in mucin Type II enriched media (SSP numbers- 5102, 7602, 8205) and 5 proteins in 
mucin Type III enriched media (SSP numbers- 6306, 6401, 6408, 8707). Four 
pH 4→                                                                                              7                                                     
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proteins were found to be down-regulated in both types of mucin media (SSP 
numbers 3002, 5003, 7001, 8206), six proteins were found to be down-regulated in 
mucin Type II enriched media (SSP numbers 3601, 5302, 6303, 6408, 8707, 9601) 
and five proteins were down-regulated in mucin Type III enriched media (SSP 
numbers 2302, 5003, 5601, 6711, 8205) See Fig. 26.2 for graphical summary of 
differentially expressed proteins. 
 
Proteins involved in translation namely the elongation factors Tu and greA were 
found to be down-regulated in both mucin enriched media but elongation factor Ts 
was found to be up-regulated in mucin Type II enriched media (refer to Fig. 26.2, 
Table 20) Proteins involved in carbohydrate metabolism namely phosphoglycerate 
kinase and enolase were found to be up-regulated in both mucin enriched media. 
Immune response proteins and toxins, ecotin was found to be down-regulated in 
both mucin enriched media except the surface antigen outer membrane protein X 
and outer membrane protein A which was shown to be up-regulated in both mucin 
enriched media. The amino acid biosynthesis protein domains for carbamate kinase, 
DHAP synthetase I and cytidylate kinase were also found to be up-regulated in Type 
III mucin enriched media. A DNA synthesis associated glutaredoxin related protein 
region was also identified as up-regulated in mucin Type II enriched media. The 
oxidative stress associated protein regions namely universal stress protein, 
ribonucleotide reductase region; pyruvate formate lyase region and autonomous 
glycyl radical cofactor were down-regulated  in mucin Type III enriched media except 
the universal stress protein which was up-regulated in both mucin enriched media. 
The other up-regulated proteins include the protein transport associated periplasmic, 
translocation associated tolB proteins. These were found to be up-regulated in mucin 
Type III enriched media. The protein folding associated thiodisulphide 
oxidoreductase and protein metabolism associated acetoin reductase were also up-
regulated in mucin Type II enriched media. Four hypothetical proteins were detected 
(similar to Yba B and Yfa Z protein, Hypothetical protein 20877, 17757) of which the 
first two (similar to Yba B and Yfa Z protein) were found to be up-regulated in mucin 
Type II enriched media and the hypothetical protein 20877 was up-regulated in 
mucin Type III enriched media. The hypothetical protein 17757 was found to be 
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down-regulated in mucin Type III enriched media. Refer to Appendix G for details on 
the putative identifications obtained using BLAST analysis. 
Analyses performed using the Redfin and Samespots softwares confirmed the up-
regulation of the cell wall, membrane and envelope biogenesis associated protein 
outer membrane surface antigen X and carbohydrate metabolism associated 
phosphoglycerate kinase in both mucin enriched media in E. cancerogenus. 
Transcription associated elongation factor Ts was found to be up-regulated in mucin 
Type III enriched media in all the software analyses in E. cancerogenus. Refer to 
Tables 16 and 17 for further details. 
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Figure 26.2: Percentage regulation of spots in mucin enriched media with respect to 
the control non-mucin media in E. cancerogenus 
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Figure 26.3: Reference master gel obtained from PDQuest analysis of B. fragilis 
spot data. 
 
10.7.3 Differential expression of proteins in B. fragilis 
Out of a total of 106 proteins that were analysed, 73 were identified using LC MS/MS 
in B. fragilis and 45 were found to be differentially expressed. A total of 31 spots 
(SSP numbers- 1104, 2101, 2102, 2401, 2701, 2704, 2804, 2806, 3303, 3404, 4502, 
4601, 4607, 4608, 4702, 4804, 5106, 5201, 5205, 5402, 6102, 6103, 6202, 6206, 
6301, 6304, 6802, 6807, 6901, 7301, 7401) were differentially expressed in mucin 
enriched media but only 5 proteins (SSP numbers- 1104, 2701, 2704, 2806 and 
4804) were found to be up-regulated in mucin enriched media. SSP number 1104 
was up-regulated in both types of mucin media but SSP 2701and 2704 were up-
regulated in mucin Type III enriched media, absent in mucin Type II enriched media. 
SSP 2806 was found to be up-regulated in both mucin enriched media.  Twenty-five 
proteins were found to be down-regulated in mucin enriched media. Eight proteins 
pH 4→                                                                                                               7 
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were found to be down-regulated in both mucin enriched media (SSP numbers 1803, 
2102, 3001, 3303, 4601, 5106, 5205, 6103) whereas 12 proteins were down-
regulated in mucin Type II enriched media and 5 proteins were down-regulated in 
mucin Type III enriched media.  The presence of a host immune response may 
trigger the up-regulation of more proteins in the bacteria (Tran et al., 2003). The 
predominant proteins showing regulation in mucin enriched media have been 
indicated in Fig. 26.4 and Table 20.  
The 4 protein spots that were found to be up-regulated were the hypothetical protein 
BF2494 (SSP 1104), proton transport and ATP synthesis associated ATP synthase 
subunit E (SSP 2701, 2704) and translation associated 50S ribosomal protein 
L7/L12 (SSP 2806).  
The presence of protein isoforms may have been indicated by the identification of 
the same protein in more than one spot that occured adjacent to each other on the 
gels but not much information is available regarding the existence of isoforms in 
prokaryotic bacteria. Proteins that showed this phenomenon were the citric acid 
cycle associated malate dehydrogenase in B. fragilis, oxidative stress associated 
thiol peroxidase in B. fragilis and the immune response associated outer membrane 
proteins in E. cancerogenus and B. fragilis (refer to Figs. 30, 31, 33 and 34 for 
zoomed in images in the Discussion section). 
The proteins that showed down-regulation included the carbohydrate metabolism 
associated phosphoenol pyruvate carboxylase, triose phosphate isomerase, 
oxidative stress associated thiol peroxidase, immune response associated putative 
outer membrane protein, glutathione detoxification system associated 
lactoylglutathione lyase, RNA protection associated putative RNA binding protein, 
translation associated ribosomal protein L7/L12 and elongation factor Ts, citric acid 
cycle associated malate dehydrogenase and chaperone associated GrpE protein. 
Refer to Table 21 for details. Two down-regulated hypothetical proteins were 
identified namely BF1203 and BF0301 and one hypothetical protein BF2494 was up-
regulated. Refer to Appendix G4 for details on the putative identifications obtained 
using BLAST analysis. Hypothetical proteins BF2494 were found to be up-regulated 
in mucin Type II enriched media when analysed using both PDQuest and 
SameSpots softwares but not in Redfin. Similarly, BF1203 hypothetical proteins were 
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found to be down-regulated in both mucin Type II and III enriched media when 
analysed using both PDQuest and SameSpots softwares (tests were based on the 
Student t-test). 
Analyses performed using the Redfin and Samespots softwares in B. fragilis 
confirmed the down-regulation of the carbohydrate metabolism associated triose 
phosphate isomerase in mucin Type II enriched media. Energy production and 
conversion associated malate dehydrogenase proteins were found to be down-
regulated in mucin Type II enriched media but up-regulated in mucin Type III 
enriched media in B. fragilis. All analyses also showed the up-regulation of the 
transcription protein elongation factor Ts in mucin Type II enriched media. Student t-
test was used to perform the analyses using all the three softwares where 
expression levels were considered based on average values in each condition.  
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Figure 26.4: Percentage regulation of spots in mucin enriched media with respect to 
the control non-mucin media in B. fragilis 
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The general growth rate of both B. fragilis and E. cancerogenus were not profoundly 
influenced by the presence of mucin in the media especially with reference to culture 
density. 
 
10.7.4 Analysis of 2DE gels using Ludesi Redfin software  
Reports have been generated for the 2DE gel analysis using the Ludesi Redfin 
software for studying the differential expression of proteins in control vs mucin 
enriched media in E. cancerogenus and B. fragilis. Refer to Appendix F2 for results, 
including p values and expression levels of E. cancerogenus and B. fragilis proteins 
in non-mucin, mucin Type II and Type III enriched media. Spots selected for analysis 
were based on significant p values of <0.05 and a fold change of 1.5 or more. 
Expression profile filters were also used to detect up or down regulation of proteins.  
 
 
10.7.5 Analysis of 2DE gels using Nonlinear Dynamics SameSpots software  
The SameSpots analysis software from Nonlinear Dynamics was also used to study 
the differential expression of proteins in both bacteria. The spots of interest were 
selected based on the analysis of variance where significant p values of <0.05 and 
fold changes of 1.0 or more were considered. Refer to Appendix F3 for the analysis 
report of E. cancerogenus and B. fragilis spot data, respectively.  
 
10.7.6 Comparative analysis of spot data 
The spots with relevant p values from each analysis were manually compared in all 
the three softwares (Fig 27; Tables 12-19). The proteins highlighted in „bold‟ font in 
the tables indicate differential expression in all software analyses under those 
specific growth conditions and statistical tests.  SSP number refers to the Standard 
spot number which has been used to identify the protein spots using the default Bio-
Rad PDQuest software. Each circle of the Venn diagram indicates the differentially 
expressed proteins in one particular software package and the overlap regions 
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indicate the proteins identified commonly in two of the software packages. The 
central region where all the three circles overlap shows the proteins that have been 
differentially expressed in all the three software packages (Fig. 27). SSP numbers 
have been indicated for spots that remained unidentified using LC-MS analysis.   
 
Since SameSpots works only on the basis of average expression in each growth 
condition, the Mann-Whitney U test, where expression of a protein in each individual 
gel can be considered, could not be performed using data from SameSpots. 
Therefore the Student t-test was used to compare SameSpots, PDQuest and Redfin 
data, and the Mann-Whitney U test was used to compare PDQuest and Redfin data.  
 
The Student t-test was used to identify proteins with a significant p value (<0.05) 
from all three softwares and the average values were used to compare expression.   
The Mann-Whitney U test was used to identify proteins with a significant p value 
(<0.05) from all three softwares but the expression in individual gels was considered 
unlike the Student t-test where the average values were compared.  
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Figure 27: Comparative analyses of spot data using PDQuest, Redfin and 
SameSpots softwares 
 
Figure 27.1: Comparative analysis of proteins differentially expressed by E. 
cancerogenus in semi-defined media without mucin vs mucin Type II enriched media 
by PDQuest and Redfin softwares using Mann-Whitney U test. Refer to Table 12 for 
details on the differentially expressed proteins in media without mucin vs mucin Type 
II enriched media by PDQuest and Redfin softwares using the Mann-Whitney U test. 
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Protein identity- E. cancerogenus  PDQuest 
analysis  
Redfin analysis  
SSP 7001 (Not identified)  ↑   ↑ (4.57, 0.0144) 
SSP 6102 (Not identified)   ↑ (2.55, 0.0247) 
Peptidoglycan binding domain (5305)  ↑ (2.51, 0.0089) 
Ecotin (8206) ↓   
Glutaredoxin related protein (3002) ↓   
SSP 2802 (Not identified)  ↑  
Autonomous glycyl radical cofactor (4008) ↑    
Outer membrane protein surface antigen X 
(6203) 
↑   
Thiol disulphide oxidoreductase protein (6408) ↓   
Acetoin reductase (7602) ↑   
Tol B protein (8707) ↓   
Outer membrane protein A (4606) ↑    
Phosphoglycerate kinase (5701) ↑   
SSP 1602 (Not identified)  ↑   
SSP 5302 (Not identified)  ↓   
SSP 6303 (Not identified)  ↓   
Table 12: Differentially expressed E. cancerogenus proteins in non mucin vs mucin Type II 
enriched media by PDQuest and Redfin softwares using the Mann-Whitney U test. ↑ 
indicates up-regulation of the protein, ↓ indicates down-regulation of the protein. (Fold 
change, p value) for differentially expressed spots has been indicated in brackets for Redfin 
and SameSpots softwares. SSP numbers of protein spots are indicated in the first column. 
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Figure 27.2: Comparative analysis of proteins differentially expressed by E. 
cancerogenus in semi-defined media without mucin vs mucin Type III enriched 
media by PDQuest and Redfin softwares using the Mann-Whitney U test. Refer to 
Table 13 for details on the differentially expressed E. cancerogenus proteins in 
media without mucin vs. mucin Type III enriched media by PDQuest and Redfin 
softwares using the Mann-Whitney U test. 
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Protein identity- E. cancerogenus  PDQuest 
analysis  
Redfin analysis  
Elongation factor Ts (5601) ↓  ↓ (2.17, 0.0026) 
Carbamate kinase (5607) ↑ ↑ (2.58, 0.0296) 
Periplasmic protein (5306) ↑  ↑ (2.93, 0.0262) 
Ecotin (8206) ↓   
Autonomous glycyl radical cofactor (4008) ↓   
Phosphoglycerate kinase (5701) ↑   
Outer membrane protein surface antigen 
X (6203) 
↑  ↑ (2.85, 0.0143) 
Elongation factor greA (2302) ↓  
Glutaredoxin related protein (3002) ↓  
Hypothetical protein 17757(5003) ↓  
Universal stress protein A (5102) ↑   
Enolase (5705) ↑   
Hypothetical protein 20877 (6306) ↑   
Cytidylate kinase (6401) ↑   
2-dehydro-3-deoxy phosphooctonate 
aldolase (6605) 
↑   
Elongation factor Tu (6711) ↓  
SSP 2402 (Not identified)  ↑  
SSP 3602 (Not identified)  ↑  
Tol B (8707) ↑  
Table 13: Differentially expressed E. cancerogenus proteins in non mucin vs mucin 
Type III enriched media by PDQuest and Redfin softwares using the Mann-Whitney 
U test   
↑ indicates up-regulation of the protein 
↓ indicates down-regulation of the protein. (Fold change, p value) for differentially 
expressed spots has been indicated in brackets for Redfin and SameSpots 
softwares. SSP numbers of protein spots are indicated in the first column. 
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Figure 27.3: Comparative analysis of proteins differentially expressed by B. fragilis 
in semi-defined media without mucin v mucin Type II enriched media by PDQuest 
and Redfin software using Mann-Whitney U test. Refer to Table 14 for details on the 
differentially expressed B. fragilis proteins in media without mucin vs. mucin Type II 
enriched media by PDQuest and Redfin softwares using the Mann-Whitney U test 
based. 
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Protein identity- B. fragilis  PDQuest analysis Redfin analysis 
Putative thiol peroxidase (6304)  ↓ (2.22, 0.0264) 
Outer membrane protein H (6202)  ↓   
Putative RNA binding protein (6102) ↓  ↓ (3.66, 0.0139) 
SSP 3206 (Not identified)  ↓ ↓ (3.11, 7.293e-4) 
Putative thiol peroxidase (4601)  ↓  ↓ (3.07, 0.0163) 
Malate dehydrogenase (4607)  ↓  ↓ (3.07, 3.5558e-4) 
Hypothetical protein BF2494 (1104)  ↑   
50S Ribosomal protein L7/L12 (2102)  ↓   
Hypothetical protein BF2494 (2804)  ↓   
50S Ribosomal protein L7/L12 (3001)  ↓   
Triose phosphate isomerase (4502) ↓  ↓ (2.69, 0.0136) 
Elongation factor Ts (4702) ↓   
50S Ribosomal protein L7/L12 (5106)  ↓   
Hypothetical protein BF1203 (5205) ↓   
Phosphoenol pyruvate carboxykinase (6901) ↓   
Lactoylglutathione lyase (6103) ↓   
Putative outer membrane protein H (5402)  ↓   
Hypothetical protein BF 0301 (6206) ↓   
Fructose bisphosphate aldolase (6802) ↓   
Superoxide dismutase (7301) ↓   
SSP 1103 (Not identified)  ↑   
SSP 1211 (Not identified)  ↑   
SSP 5401(Not identified)  ↓   
SSP 1107(Not identified)  ↑   
SSP 1803 (Not identified)  ↓   
Putative thiol peroxidase (6301) ↑   
Table 14: Differentially expressed B. fragilis proteins in non mucin vs mucin Type II enriched media by 
PDQuest and Redfin softwares using the Mann-Whitney U test. ↑ indicates up-regulation of the 
protein; ↓ indicates down-regulation of the protein. (Fold change, p value) for differentially expressed 
spots has been indicated in brackets for Redfin and SameSpots softwares. SSP numbers of protein 
spots are indicated in the first column. 
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Figure 27.4: Comparative analysis of proteins differentially expressed by B. fragilis 
in semi-defined media without mucin vs mucin Type III enriched media by PDQuest 
and Redfin software using the Mann-Whitney U test. Refer to Table 15 for details on 
the differentially expressed B. fragilis proteins in media without mucin vs. mucin Type 
III enriched media by PDQuest and Redfin softwares using the Mann-Whitney U test. 
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Protein identity- B. fragilis  PDQuest analysis  Redfin analysis  
Putative thiol peroxidase (6304)  ↓ (2.22, 0.0264) 
Outer membrane protein H (6202) ↓  ↓ (4.69, 0.0176) 
SSP 3206 (Not identified)   ↑ (3.11, 7.293e-4) 
Putative thiol peroxidase (4601)  ↓  ↓ (3.07, 0.0163) 
SSP 1207 (Not identified)   ↓ (2.65, 0.0101) 
SSP 3305 (Not identified)   ↓ (2.47, 0.0479) 
Malate dehydrogenase  (4607) ↓ ↓ (2.62, 0.0211) 
Malate dehydrogenase (4608) ↑  ↑ (3.07, 3.5558e-4) 
SSP 5002 (Not identified)   ↓ (2.89, 0.0037) 
50S Ribosomal protein L7/L12 (2102) ↓   
50S Ribosomal protein L7/L12 (5106) ↓   
Lactoylglutathione lyase (6103) ↓   
Triose phosphate isomerase (6302) ↓  ↓ (2.69, 0.0136) 
Hypothetical protein BF2494 (2804)  ↓   
SSP 1103 (Not identified)  ↑   
Hypothetical protein BF2494 (1104)  ↑   
GrpE protein (2401) ↓   
ATP synthase subunit E (2701) ↑   
SSP 4101 (Not identified)  ↑   
Malate dehydrogenase (4804)  ↑   
Hypothetical protein BF1203 (5201)  ↓   
Superoxide dismutase (3404) ↑   
Thioredoxin (6301)  ↑   
Hypothetical protein BF1203 (5205) ↓   
Hypothetical protein BF 0301(6807) ↓   
SSP 1211 (Not identified)  ↑   
SSP  1402 (Not identified)  ↓   
SSP 1803 (Not identified)  ↓   
SSP 2403 (Not identified)  ↑   
SSP 2504 (Not identified)  ↑   
ATP synthase subunit E (2704)  ↑   
50S Ribosomal protein L7/L12 (2806) ↑   
Table 15: Differentially expressed B. fragilis proteins in non mucin vs mucin Type III enriched media by PDQuest and Redfin 
softwares using the Mann-Whitney U test. ↑ indicates up-regulation of the protein; ↓ indicates down-regulation of the protein. 
(Fold change, p value) for differentially expressed spots has been indicated in brackets for Redfin and SameSpots softwares. 
SSP numbers of protein spots are indicated in the first column. 
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Figure 27.5: Comparative analysis of proteins differentially expressed by E. 
cancerogenus in semi-defined media without mucin vs mucin Type II enriched media 
by PDQuest, Redfin and Same spots software using the Student t-test. Refer to 
Table 16 for details on the differentially expressed E.cancerogenus proteins in media 
without mucin vs. mucin Type II enriched media by PDQuest, SameSpots and Redfin 
softwares using the Student t-test. 
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Protein identity- E. cancerogenus  PDQuest 
analysis  
Redfin analysis  Samespots 
analysis  
SSP 7001 (Not identified by mass 
spectrometry) 
↑   ↑ (4.57, 0.0144)  
SSP 6102 (Not identified)   ↑ (2.55, 0.0247)  
SSP 1602 (Not identified) ↓   ↓ (3.4, 0.024) 
Peptidoglycan binding domain (5305)  ↑ (2.51, 0.0089)  
Ecotin (8206) ↓    
Glutaredoxin related protein (3002) ↓    
Autonomous glycyl radical  cofactor  
(4008) 
↓    
Outer membrane protein X (6203) ↑  ↑ (2.85, 0143) ↑ (2.3, 0.006) 
Acetoin reductase (7602) ↑    
Tol B protein (8707) ↓    
Outer membrane protein II (4505) ↓    
Enolase (5705)   ↑ (6.5, 0.029) 
Phosphoglycerate kinase (5701) ↑  ↑(2.51, 0.0089)  ↑ (2.3, 0.032) 
SSP 7003 (Not identified)  ↑ (2.55, 0.0116) ↑ (2.3, 0.006) 
Inorganic pyrophosphatase (5405) ↑ ↑ (1.73, 0.0033)  
Thiol disulphide oxidoreductase protein 
(6408) 
↓   ↓ (2.2, 0.003) 
SSP 2509 (Not identified)  ↑   
SSP 3602 (Not identified)  ↓    
SSP 5302 (Not identified)  ↓    
Putative glutathione peroxidase (4701)   ↑ (1.81, 0.0459)  
ABC type sugar transport system (6001)   ↑ (4.41, 0.045)  
Table 16: Differentially expressed E. cancerogenus proteins in non mucin vs mucin Type II enriched 
media by PDQuest and Redfin and Samespots softwares using the Student t-test (i.e. based on 
averages) ↑ indicates up-regulation of the protein. ↓ indicates down-regulation of the protein. (Fold 
change, p value) for differentially expressed spots has been indicated in brackets for Redfin and 
SameSpots softwares. SSP numbers of protein spots are indicated in the first column. 
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Figure 27.6: Comaparative analysis of proteins differentially expressed by E. 
cancerogenus in semi-defined media without mucin v mucin Type III enriched media 
by PDQuest, Redfin and SameSpots softwares using the Student t-test (i.e. based 
on averages). Refer to Table 17 for details on the differentially expressed 
E.cancerogenus proteins in media without mucin vs. mucin Type III enriched media 
by PDQuest, SameSpots and Redfin softwares using the Student t-test. 
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Protein identity- E. 
cancerogenus  
PDQuest 
analysis  
Redfin 
analysis  
Samespots 
software  
Elongation factor Ts (5601) ↓  ↓ (2.17, 0.0026) ↓ (2.5, 0.041) 
Carbamate kinase (5607) ↓  ↓ (2.58, 0.0296)  
Periplasmic protein (5306) ↑  ↑ (2.93, 0.0262)  
Ecotin (8206) ↓   ↓ (6.0, 3.043e-004) 
Autonomous glycyl radical 
cofactor  (4008) 
↓    
Phosphoglycerate kinase (5701) ↑    
Outer membrane protein 
surface antigen X (6203) 
↑  ↑ (2.85, 0.0143) ↑ (2.3, 0.006) 
Elongation factor greA (2302) ↓   
Glutaredoxin related protein 
(3002)  
↓   
Hypothetical protein 17757 (5003)  ↓  ↓ (2.1, 0.054) 
Universal stress protein (5102) ↑    
Enolase (5705) ↑    
Outer membrane protein A (4606) ↑    
Cytidylate kinase (6401) ↑   ↑ (2.5, 0.045) 
 
DAHP synthetase (6605) ↑    
Elongation factor Tu (6711) ↑ ↑ (2.55, 0.0247)  
SSP 7003 (Not identified)   ↑ (2.55, 0.0116) ↑ (2.3, 0.006)  
ABC type sugar transport system 
(6001) 
 ↑ (4.41, 0.045)  
Table 17: Differentially expressed E. cancerogenus proteins in non mucin vs mucin Type III 
enriched media by PDQuest and Redfin and SameSpots softwares using the Student t-test 
(i.e. based on averages). ↑ indicates up-regulation of the protein 
↓ indicates down-regulation of the protein. (Fold change, p value) for differentially expressed 
spots has been indicated in brackets for Redfin and SameSpots softwares. SSP numbers of 
protein spots are indicated in the first column. 
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Figure 27.7: Comparative analysis of proteins differentially expressed by B. fragilis 
in semi-defined media without mucin vs mucin Type II enriched media by PDQuest, 
Redfin and Same Spots softwares using the Student t-test (i.e. based on averages). 
Refer to Table 18 for details on the differentially expressed B. fragilis proteins in 
media without mucin vs. mucin Type II enriched media by PDQuest, SameSpots and 
Redfin softwares using the Student t-test. 
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Protein identity- B. fragilis  PDQuest 
analysis  
Redfin analysis  Samespots 
software  
Putative thiol peroxidase (6304)  ↓ (2.22, 0.0264) ↑(4.2, 0.024) 
Outer membrane protein H (6202)  ↓  ↓ (4.69, 0.0176)  
Putative RNA binding domain (6102) ↓  ↓ (3.66, 0.0139)  
SSP 3206 (Not identified)  ↓ (3.11, 7.293e-4) ↓ (1.9, 0.003) 
Putative thiol peroxidase (4601)  ↓  ↓ (3.07, 0.0163)  
Malate dehydrogenase (4607)  ↓  ↓ (3.07, 3.5558e-4) ↓ (3.2, 0.002) 
Hypothetical protein BF2494 (1104)  ↑   ↑ (5.1, 6.672e-004) 
50S Ribosomal protein L7/L12 (2102)  ↓    
Hypothetical protein BF2494 (2804)  ↓    
50S Ribosomal protein L7/L12 (3001)  ↓   ↓ (2.4, 0.043) 
Triose phosphate isomerase (4502) ↓  ↓ (2.69, 0.0136) ↓ 4.5, 0.052) 
Elongation factor Ts (4702) ↑  ↑ (2.34, 0.0250) ↑ (2.4, 0.043) 
50S Ribosomal protein L7/L12 (5106)  ↓    
Hypothetical protein BF1203 (5205) ↓   ↓ (1.5, 0.033) 
Lactoylglutathione lyase (6103) ↓  ↓ (2.68, 0.0211)  
Hypothetical protein 1203 (5402)  ↓    
Hypothetical protein 0301 (6206) ↓    
Phosphoenol pyruvate carboxykinase (6901) ↓    
Fructose bisphosphate aldolase (6802) ↓   ↓ (3.0, 0.002) 
SSP 3904 (Not identified)    ↓ (3.7, 0.003) 
50S Ribosomal protein L7/L12 (3106)    ↓ (1.7, 0.009) 
Superoxide dismutase (6206) ↓   ↓ (6.9, 0.004) 
SSP 5806 (Not identified)    ↓ (4.3, 0.028) 
SSP 1101 (Not identified)   ↓ (6.1, 5.017e-004) 
Triose phosphate isomerase (6302) ↓  ↓ (6.78, 0.0156)  
SSP 1302 (Not identified)    ↓(2.0, 6.287e-004) 
Adenylate kinase (4302)   ↓(2.6, 0.046) 
Table 18: Differentially expressed B. fragilis proteins in non mucin vs mucin Type II enriched media by PDQuest 
and Redfin and SameSpots softwares using the Student t-test (i.e. based on averages)  ↑ indicates up-regulation 
of the protein ↓ indicates down-regulation of the protein. (Fold change, p value) for differentially expressed spots 
has been indicated in brackets for Redfin and SameSpots softwares. SSP numbers of protein spots are indicated 
in the first column. 
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Figure 27.8: Comparative analysis of proteins differentially expressed by B. fragilis 
in semi-defined media without mucin vs mucin Type III enriched media by PDQuest, 
Redfin and SameSpots softwares using the Student t-test (i.e. based on averages). 
Refer to the Table 19 for details on the differentially expressed B. fragilis proteins in 
media without mucin vs. mucin Type III enriched media by PDQuest, SameSpots 
and Redfin softwares using the Student t-test. 
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Protein identity- B. fragilis  PDQuest 
analysis  
Redfin analysis  Samespots 
software  
Putative thiol peroxidase (6304) ↓  ↓ (2.22, 0.0264)  
Outer membrane protein H (6202) ↓  ↓ (4.69, 0.0176)  
SSP 3206 (Not identified)   ↑ (3.11, 7.293e-4) ↑ (1.9, 0.003) 
SSP 1207 (Not identified)   ↓ (2.65, 0.0101)  
SSP 3305 (Not identified)   ↓ (2.47, 0.0479)  
Malate dehydrogenase (4607)   ↓ (3.07, 3.5558e-4)  
Malate dehydrogenase (4608)  ↑  ↑ (3.24, 0.0431) ↑ (1.3, 0.053) 
SSP 5002 (Not identified)   ↓ (2.89, 0.0037)  
50S Ribosomal protein L7/L12 (2102) ↓   ↓ (2.4, 0.043) 
50S Ribosomal protein L7/L12 (5106) ↓    
Lactoylglutathione lyase (6103) ↓  ↓ (2.68, 0.0211)  
SSP 3904 (Not identified)    ↓ (3.7, 0.003) 
Adenylate kinase (4302)   ↓ (2.6, 0.046) 
SSP 7001 (Not identified)    ↓ (3.8, 0.001) 
Hypothetical protein BF2494 (1104) ↑   
Hypothetical protein BF1203 (5205) ↓   ↓ (1.5, 0.033) 
Hypothetical protein BF1203 (5201)  ↓   ↓ (2.8, 0.024) 
Malate dehydrogenase (4705)    ↓ (2.1, 0.047) 
Putative thiol peroxidase (4701)    ↑(4.2, 0.024) 
SSP 3702 (Not identified)    ↑ (3.6, 0.012) 
SSP 1803 (Not identified)  ↓   ↓ (1.5, 0.049) 
SSP 5103 (Not identified)   ↓ (2.46, 0.0271) ↓ (1.8, 0.043) 
Outer membrane protein  precursor (3303)  ↓  ↓ (5.07, 2.848e-6)  
SSP 2403 (Not identified)  ↑  ↑ (2.70, 0.0381)  
GrpE protein (2401) ↓  ↓ (2.66, 0.0034)  
Table 19: Differentially expressed B. fragilis  proteins in non mucin vs mucin Type III enriched media by PDQuest 
and Redfin and SameSpots softwares using the Student t-test (i.e. based on averages) ↑ indicates up-regulation 
of the protein; ↓ indicates down-regulation of the protein. (Fold change, p value) for differentially expressed spots 
has been indicated in brackets for Redfin and SameSpots softwares. SSP numbers of protein spots are indicated 
in the first column. 
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10.7.7 Analysis using Redfin and SameSpots softwares 
 
 Initial analysis of results was performed using the PDQuest software using the 
Student t-test and hence this has been used as the default method for discussing the 
results. Following further analysis using the Redfin and SameSpots softwares, the 
differential expression data from all the three softwares were compared. PDQuest 
and Redfin software analyses were based on the Mann Whitney U test performed to 
determine the proteins showing a regulation based on the levels of expression in 
each individual gel in every growth condition. Analyses using PDQuest, SameSpots 
and Redfin softwares were based on the Student t-test performed based on the 
average level of expression of proteins in every growth condition. 
The Mann Whitney U test based analysis of proteins showed a down-regulation of 
elongation factor Ts in mucin Type III enriched media and an up-regulation of the 
outer membrane surface antigen protein in mucin Type III enriched media in E. 
cancerogenus. Apart from these two proteins, the periplasmic proteins and 
carbamate kinase proteins were up-regulated in mucin Type III enriched media 
whereas SSP number 7001 protein which was unidentifiable from mass 
spectrometry was up-regulated in mucin Type II enriched media in E. cancerogenus. 
The Student t-test based analyses of proteins from all the 3 softwares showed an up-
regulation of outer membrane surface antigen protein in both mucin Type II and III 
enriched media and an up-regulation of phoshoglycerate kinase in mucin Type II 
enriched media in E. cancerogenus. In mucin Type III enriched media in E. 
cancerogenus, the elongation factor Ts protein was found to be down-regulated. 
From both the tests, it could be identified that the outer membrane surface antigen 
was up-regulated in mucin Type III enriched media in E. cancerogenus indicating 
that this protein may be a potential virulence factor whose expression may be 
associated with the presence of mucin in the growth media. 
 
The Mann Whitney U test based analysis of proteins in B. fragilis showed a down-
regulation of the RNA binding protein, thiol peroxidase, malate dehydrogenase and 
triose phosphate isomerase proteins in mucin Type II enriched media. In mucin Type 
III enriched media, down-regulation of the outer membrane protein H, thiol 
peroxidase and triose phosphate isomerase proteins was observed in B. fragilis.  
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The Student t-test based analyses of proteins from all the 3 softwares showed a 
down-regulation of malate dehydrogenase, triose phosphate isomerase and an up-
regulation of elongation factor EFTs in mucin Type II enriched media in B. fragilis. In 
mucin Type III enriched media only malate dehydrogenase was found to be up-
regulated in all the 3 softwares.  
From both the tests, it could be identified that malate dehydrogenase was found to 
be up-regulated in mucin Type III enriched media and down-regulated in mucin Type 
II enriched media suggesting that they may be existing as isoforms. Triose 
phosphate isomerase was also found to be down-regulated in mucin Type II 
enriched media suggesting that these proteins may be associated with the 
pathogenicity of B. fragilis when grown in the presence of mucin. 
 
10.8 Liquid chromatography - Mass spectrometric analysis of protein spots  
A total of 132 E. cancerogenus protein spots were analysed using LC-MS of which 
98 spots were identified and 34 spots were found to be differentially expressed, 
according to PDQuest software analysis using Student t-test. Of the 34 spots that 
showed a regulation of expression, 23 spots were identifiable and the remaining 11 
were unidentifiable. For B. fragilis, a total of 106 protein spots were analysed of 
which 73 spots were identified and 45 were found to be differentially expressed. Of 
the 45 spots that showed differential expression, 31 spots were identifiable and the 
remaining 14 were unidentifiable. Figure 28 shows the differentially expressed 
proteins in the reference master gel for E. cancerogenus and Figure 29 shows the 
differentially expressed proteins in the reference master gel for B. fragilis. Refer to 
Appendix sections G2 and G3 for details on the peptide match scores and identities 
of proteins using the Mascot search for both E. cancerogenus and B. fragilis.  
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Figure 28: The SSP numbers of differentially expressed protein spots on the 
reference master gel of E. cancerogenus based on the PDQuest software analysis. 
    Indicates up-regulation and       indicates down-regulation in mucin enriched media 
 
 
7707 
211 
 
 
Figure 29: The SSP numbers of differentially expressed protein spots on the 
reference master gel of B. fragilis based on the PDQuest software analysis. 
    Indicates up-regulation and       indicates down-regulation in mucin enriched media 
 
 
 
212 
 
Tables 20 and 22 represent the list of proteins identified, including the spots that 
were found to be differentially expressed in E. cancerogenus and B. fragilis 
respectively. Tables 21 and 23 represent the list of proteins identified, excluding the 
spots that were found to be differentially expressed in E. cancerogenus and B. 
fragilis. 
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S.No SSP 
number 
Identity of the 
protein 
Function Regulation 
 
Peptide 
match score/ 
number of 
peptides  
Fold 
change 
(PDQuest) 
Accession 
number 
1 2302 Elongation factor 
gre A 
Unknown function ↓ mucin Type III 
media 
125/3 5.9 gi│261342624 
2 3002 Hypothetical 
protein 03947 
Post translational 
modifications, protein 
turnover and 
chaperones 
↓ mucin media 101/2 6.9 gi│261339586 
3 4008 Autonomous glycyl 
radical cofactor 
GrcA 
General function 
prediction only 
↓ mucin Type III 
media 
150/4 1.7 gi│261340878 
4 4606 Omp A Cell wall, membrane, 
envelope biogenesis 
↑ mucin media 84/2 2.4 gi│261339284 
5 5003 Hypothetical 
protein 17757 
Protein function 
unknown 
↓ mucin Type III 
media 
126/2 2.2 gi│261342318 
6 5102 Universal stress 
protein A 
Signal transduction 
mechanisms 
 ↑ mucin Type III 
media 
195/7 7.2 gi│261341988 
7 5306 Periplasmic protein Function unknown ↑ mucin Type III 
media  
130/4 5.5 gi│261339031 
8 5601 Elongation factor 
Ts 
Translation, 
ribosomal structure 
and biogenesis 
↓ mucin Type III 
media 
376/8 6.5 gi│261338832 
9 5607 Carbamate kinase Amino acid transport ↑  mucin Type III 355/6 4.9 gi│261339130 
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and metabolism media 
10 5701 Phosphoglycerate 
kinase 
Carbohydrate 
transport and  
metabolism 
↑ mucin Type II 
media 
684/13 4.7 gi│261342323 
11 5702 Phosphopyruvate 
hydratase 
Carbohydrate 
transport and 
metabolism 
↑ mucin Type III 
media 
238/4 3.8 gi│261342208 
12 6203 Outer membrane 
protein surface 
antigen X 
Cell wall, membrane, 
envelope biogenesis  
↑ mucin media 129/2 2.3 gi│261341400 
13 6306 Hypothetical 
protein 20877 
General function 
prediction only 
↑ mucin Type III 
media 
91/3 7.5 gi│261342932 
14 6401 Cytidylate kinase Nucleotide transport 
and metabolism 
↑ mucin Type III 
media 
115/3 2.4 gi│261339244 
15 6408 Periplasmic protein 
disulphide 
isomerise I  
Energy production 
and conversion 
↓ mucin Type II 
media 
189/5 6.6 gi│261342934 
16 6605 2-dehydro-3-
deoxyphosphoocto
nate aldolase 
Amino acid transport 
and metabolism 
↑ mucin Type III 
media 
144/3 6.5 gi│261340146 
17 6711 Elongation factor 
Tu 
Translation, 
ribosomal structure 
and biogenesis 
↓ mucin Type III 
media 
246/7 3.3 gi│261341842 
18 7602 Acetoin reductase Secondary 
metabolites 
↑ mucin Type II 
media 
298/5 1.5 gi│261341164 
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biosynthesis, 
transport and 
catabolism, signal 
transduction 
mechanisms 
19 7707 Gamma glutamyl 
phosphate 
reductase 
Energy production 
and conversion  
↓ mucin Type II 
media 
97/2 4.7 gi│261340945 
20 8205 yfaZ family protein Unknown function  ↓ mucin Type III 
media 
195/3 1.8 gi│261339072 
21 8206  Ecotin  Cell wall, membrane, 
envelope biogenesis 
↓ mucin media 147/5 8.9 gi│261340622 
22 8707 tolB translocation 
protein 
Intracellular 
trafficking, secretion 
and vesicular 
transport 
↓ mucin Type II 
media 
271/7 2.6 gi│261341330 
23 9601 Omp A Cell wall, membrane, 
envelope biogenesis 
 ↓ mucin Type II 
media 
152/3 5.7 gi│261339284 
Table 20: Table represents E. cancerogenus proteins that have been identified to be expressed in all three conditions with any up 
or down-regulation using PDQuest software. Regulation in mucin media in the table refers to both mucin Type II and Type III 
enriched media.
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S.No SSP 
number 
Identity of the 
protein 
Function Regulation 
 
Peptide 
match score/ 
number of 
peptides  
1 1108 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
None 155/5 
2 1703 Porin 02457 Cell wall, 
membrane and 
envelope 
biogenesis 
None 55/2 
3 2001 Hypothetical 
protein 03856 
Unknown 
function 
None 116/8 
4 2104 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
None 134/6 
5 2305 PTS system II A 
subunit 
Carbohydrate 
transport and 
metabolism 
None 237/7 
6 2403 Heat shock 
protein grpE 
Post 
translational 
modifications, 
protein 
turnover and 
chaperones 
None 77/2 
7 2506 Heat shock 
protein grpE 
Post 
translational 
modifications, 
protein 
turnover and 
chaperones 
None 60/2 
8 3808 Trigger factor 
protein 
Post 
translational 
modifications, 
protein 
turnover and 
chaperones 
None 573/12 
9 3809 Trigger factor 
protein 
Post 
translational 
modifications, 
protein 
None 71/2 
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turnover and 
chaperones 
10 3901 Hypothetical 
protein 00599, 
Dnak chaperone 
protein 
Heat shock 
proteins 
None 560/9 
11 3902 Hypothetical 
protein 00599, 
Dnak chaperone 
protein 
Heat shock 
proteins 
None 561/12 
12 4101 Hypothetical 
protein 03459, 
Autonomous 
glycyl radical 
cofactor 
General 
function 
prediction only 
None 185/3 
13 4202 Hypothetical 
protein 03416, 5-
methylaminometh
yl-2-thiouridylate 
methyltransferase 
Translation, 
ribosomal 
structure and 
biogenesis 
None 126/3 
14 4401 Peroxiredoxin 
01092 
Post 
translational 
modifications, 
protein 
turnover and 
chaperones 
None 191/4 
15 4402 00804 inorganic 
pyrophosphatase 
Energy 
production and 
conversion 
None 71/2 
16 4505 Omp II,  01735 Cell wall, 
membrane, 
envelope 
biogenesis 
None 278/5 
17 4602 Omp A Cell wall, 
membrane, 
envelope 
biogenesis 
None 468/16 
18 4701 Putative 
glutathione 
peroxidase 
Post 
translational 
modification, 
protein 
turnover, 
None 137/4 
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chaperones 
19 4812 Porin 02457 Cell envelope 
biogenesis 
None 84/2 
20 4814 Tol C protein Intracellular 
trafficking, 
secretion and 
vesicular 
transport  
None 175/4 
21 4901 Molecular 
chaperone DnaK 
Post 
translational 
modification, 
protein 
turnover, 
chaperones 
None 60/2 
22 5002 01181, YbaB 
family, 
hypothetical 
protein 
Protein 
function 
unknown 
None 166/3 
23 5107 Riboflavin 
synthase subunit  
β, 01103 
hypothetical 
protein,  6,7, 
dimethylribityllum
azine synthase 
Biosynthesis of 
riboflavin 
None 265/4 
24 5207 DNA binding 
protein, 02636 
General 
function 
prediction only 
None 218/8 
25 5305 Peptidoglycan 
binding domain, 
01554 
Cell wall 
degradation 
None 111/3 
26 5401 Inorganic 
pyrophosphatase, 
00804 
Energy 
production and 
conversion 
None 160/5 
27 5403 Inorganic 
pyrophosphatase, 
00804 
Energy 
production and 
conversion 
None 185/4 
28 5405 Inorganic 
pyrophosphatase 
Energy 
production and 
conversion 
None  235/6 
29 5406 Inorganic Energy 
production and 
None  163/5 
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pyrophosphatase conversion 
30 5604 Elongation factor 
Ts, 00441 
Translation, 
ribosomal 
structure and 
biogenesis  
None 259/5 
31 5704 Phosphoglycerate 
kinase 
Carbohydrate 
transport and 
metabolism 
None 638/15 
32 5705 Enolase, 04083 Carbohydrate 
transport and 
metabolism 
None 483/14 
33 6001 ABC type sugar 
transport system  
Carbohydrate 
transport and 
metabolism 
None 85/2 
34 6202 OmpX, 01529 Cell wall, 
membrane, 
envelope 
biogenesis 
None 247/3 
35 6307 F0F1 ATP 
synthase subunit 
B 
Energy 
production and 
conversion 
None 186/4 
36 6603 01449, 
hypothetical 
protein (DNA 
uptake, outer 
membrane 
assembly) 
Function 
unknown 
None 328/6 
37 6702 Phosphopyruvate 
hydratase, 04083 
Carbohydrate 
transport and 
metabolism 
None 479/9 
38 7301 Single stranded 
DNA binding 
protein 
General 
function 
prediction only 
None  219/4 
39 7401 03228, 
hypothetical 
protein, TRX like 
ferredoxin family, 
NADH: 
ubiquinone 
oxidoreductase 
subunit E 
Energy 
production and 
conversion 
None 74/1 
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40 7403 02508, 
hypothetical 
protein, phage 
shock protein psp 
A 
Lipid transport 
and 
metabolism 
None 76/2 
41 7501 Hypothetical 
protein, 2,5 diketo 
D gluconate 
reductase A 
Biosynthesis of 
vitamin C, 
carbohydrate 
metabolism 
None 152/4 
42 7704 01034, Aldehyde 
dehydrogenase 
Energy 
production and 
conversion 
None 87/2 
43 7710 03735, 
Flavodoxin 
Energy 
production and 
conversion 
None 247/7 
44 8602 04209, protein of 
unknown function 
Unknown 
function 
None 126/3 
45 8604 Phosphopyruvate 
hydratase 
Carbohydrate 
transport and 
metabolism 
None 635/16 
46 8610 01936, Aldose-1-
epimerase 
Carbohydrate 
transport and 
metabolism 
None 115/2 
47 8611 03358, 
Dihydrodipicolinat
e synthase 
Amino acid 
transport and 
metabolism 
None 78/2 
48 8704 00565, Peptidyl-
prolyl cis trans 
isomerase SurA 
Post 
translational 
modification, 
protein 
turnover and 
chaperones 
None 223/4 
Table 21: Table represents E. cancerogenus proteins that have been identified to be 
expressed in all three conditions without regulation using PDQuest software 
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S. No SSP 
number 
Identity of the 
protein 
Function Regulation Peptide match 
score/ number of 
peptides 
Fold change 
(PDQuest) 
Accession 
number 
1 1104 BF2494, 
Hypothetical 
protein 
Mediates 
protein-protein 
interactions 
↑ mucin media 366/8 3.1 gi│60681974 
2 2101 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
↓ mucin Type 
II media 
265/4 1.5 gi│60683451 
3 2102 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
↓ mucin media 347/30 9.9 gi│60683451 
4 2401 GrpE protein Post translational 
modification, 
protein turnover 
and chaperones 
↓  mucin Type 
III media 
83/2 8.9 gi│60681311 
5 2701 ATP synthase 
subunit E 
Energy 
production and 
conversion 
↑ mucin Type 
III media 
197/4 5.3 gi│60682222 
6 2704 ATP synthase 
subunit E 
Energy 
production and 
↑mucin Type 
III media 
175/5 2.9 gi│60682222 
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conversion  
7 2804 TRP repeat 
containing 
protein, 2494 
Mediates 
protein-protein 
interactions 
↓ mucin Type 
II media 
393/7,366/8 8.8 gi│60681974 
8 2806 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
↑mucin Type 
III media 
165/6 2.6 gi│60683451 
9 3303 Omp precursor Cell wall, 
membrane, 
envelope 
biogenesis 
↓ mucin media 184/8 8.3 gi│60680025 
10 4202 Omp precursor Cell wall, 
membrane, 
envelope 
biogenesis 
↓ mucin media 473/13 4.4 gi│60680025 
11 4502 Triose phosphate 
isomerase 
Carbohydrate 
transport and 
metabolism 
↓ mucin Type 
II media 
183/4 9.3 gi│60683174 
12 4601 Putative thiol 
peroxidase 
Post translational 
modification, 
protein turnover 
and chaperones  
↓mucin media 112/2 9.3 gi│60682249 
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13 4605 Thioredoxin Post translational 
modification, 
protein turnover 
and chaperones  
↓mucin Type II 
media 
140/5 4.2 gi│60680203 
14 4607 Malate 
dehydrogenase 
Amino acid 
transport and 
metabolism 
↓ mucin Type 
II media 
159/4 7 gi│60683199 
15 4608 Malate 
dehydrogenase 
Amino acid 
transport and 
metabolism 
↑mucin Type 
III media 
85/2 3.7 gi│60683199 
16 4702 Elongation factor 
Ts 
Translation, 
ribosomal 
structure and 
biogenesis  
↓ mucin Type 
II media 
331/7 7.3 gi│60683229 
17 4705 Malate 
dehydrogenase 
Amino acid 
transport and 
metabolism  
↓mucin media 159/4 3.7 gi│60683199 
18 4804 Malate 
dehydrogenase 
Amino acid 
transport and 
metabolism  
↑mucin Type 
III media 
171/5 3.5 gi│60683199 
19 5106 50S ribosomal 
protein L7/L12, 
Hypothetical 
Translation, 
ribosomal 
structure and 
↓ mucin media 93/1, 60/3 1.4 gi│60683451 
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protein 2161 biogenesis  
20 5205 Hypothetical 
protein 1203, 
putative anti-
sigma factor 
Signal 
transduction 
mechanisms 
↓mucin media 403/7 9.1 gi│60680695 
21 5402 Hypothetical 
protein 1203 
Signal 
transduction 
mechanisms  
↓ mucin Type 
II media 
361/9 8.7 gi│60680695 
22 6102 Putative RNA 
binding protein 
General function 
prediction only 
↓ mucin Type 
II media 
159/4 7.3 gi│60682207 
23 6103 Lactoylglutathione 
lyase 
Amino acid 
transport and 
metabolism 
↓mucin media 195/3 8.7 gi│60682596 
24 6206 Superoxide 
dismutase (Fe), 
hypothetical 
protein 0301 
General function 
prediction only 
↓mucin Type II 
media 
100/3, 136/2 8.1 gi│60679842 
25 6301 Thioredoxin Post translational 
modification, 
protein turnover, 
chaperones 
↑ in mucin 
Type III media 
87/2 5.6 gi│60680203 
26 6302 Triose phosphate 
isomerase 
Carbohydrate 
transport and 
↓ mucin media 87/2 9.8 gi│60683174, 
gi│60682249 
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metabolism 
27 6802 Fructose-
bisphosphate 
aldolase 
Carbohydrate 
transport and 
metabolism 
↓mucin media 196/6 8.3 gi│60682607 
28 6807 Conserved 
hypothetical 
protein 
Unknown 
function 
↓ mucin media 610/14 4.1 gi│60491969 
29 6901 Phosphoenol 
pyruvate 
carboxykinase 
Carbohydrate 
transport and 
metabolism. 
↓ mucin Type 
II media 
663/14 9.1 gi│53715725 
30 7301 FeS Superoxide 
dismutase 
Inorganic ion 
transport and 
metabolism 
↓ mucin media 466/37 9.6 gi│60682036 
31 7401 Ribosome 
recycling factor 
Translation, 
ribosomal 
structure and 
biogenesis 
↓mucin media 235/5 9.2 gi│60680182 
Table 22: B. fragilis (Table represents proteins that have been identified to be expressed in all three conditions with any up or down 
regulation using PDQuest software). Regulation in mucin media in the table refers to both mucin Type II and Type III enriched 
media. 
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S. No SSP 
number 
Identity of the 
protein 
Function Regulation Peptide 
match score/ 
number of 
peptides 
1 0605 BF2494, TRP 
repeat containing 
protein similar to 
tetratricopeptide 
repeat family 
Mediates protein-
protein 
interactions 
None 45/2 
2 1208 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
None          141/4 
3 2106 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
None 121/2 
4 3001 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
None 93/1 
5 3105 50S ribosomal 
protein L7/L12 
Translation, 
ribosomal 
structure and 
biogenesis 
None 160/2 
6 3302 Co-chaperonin 
GroES 
Post translational 
modification, 
protein turnover 
and chaperones  
None 48/1 
7 3401 FeS superoxide 
dismutase 
Inorganic ion 
transport and 
metabolism 
None 211/5 
8 3403 FeS superoxide 
dismutase 
Inorganic ion 
transport and 
metabolism 
None 466/38 
9 3902 Chaperone dnaK Post translational 
modification, 
None 345/10 
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protein turnover 
and chaperones 
10 4302 Adenylate kinase Nucleotide 
transport and 
metabolism 
None 105/2 
11 4408 GrpE protein Post translational 
modification, 
protein turnover 
and chaperones  
None 98/3 
12 4701 Putative thiol 
peroxidase 
Post translational 
modification, 
protein turnover 
and chaperones  
None 172/5 
13 5201 Hypothetical 
protein 1203, 
putative anti-
sigma factor 
Signal 
transduction 
mechanisms 
           
None 
133/3 
14 5204 Hypothetical 
protein 1203 
Signal 
transduction 
mechanisms 
None 361/9 
15 5808 Enolase Carbohydrate 
transport and 
metabolism 
None 469/8 
16 5810 Phosphopyruvate 
hydratase 
Carbohydrate 
transport and 
metabolism 
None 354/6 
17 6202 Putative OmpH Cell wall, 
membrane, 
envelope 
biogenesis  
None 60/1 
18 6304 Thiol peroxidase Carbohydrate 
transport and  
metabolism 
None 484/18 
19 6709 Hypothetical 
protein 1004 
Protein function 
unknown 
None 358/9 
20 6801 Chaperonin groEL Post translational None 703/12 
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modification, 
protein turnover, 
chaperones  
21 6803 Enolase Carbohydrate 
transport and 
metabolism 
None 179/4 
Table 23: B. fragilis (Table represents proteins that have been identified to be 
expressed in all three conditions without any up or down regulation using PDQuest 
software) 
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MASCOT search results with the peptide scores and identity of the protein spots can 
be seen in Appendix G.  
This study was able to identify 62% of the differentially expressed proteins using LC-
MS analysis in E. cancerogenus and 67% of the differentially expressed proteins 
were identified in B. fragilis. 
10.9 Mass spectrometric analysis of proteins 
Formic acid (FA) was used in the preparation of buffers for LC-MS analysis instead 
of trifluoroacetic acid (TFA). This is because TFA has known negative effects which 
include suppression of sensitivity and ionisation of protein samples by binding and 
pairing to the basic groups of peptides when ionised in the gaseous phase. At a 
concentration of 0.1% (w/v) or more, TFA is capable of preventing spray formation or 
nebulisation due to the generation of a high surface tension during the ionisation 
process (Anon, 2002). Also, better resolution of peaks has been observed during the 
separation of proteins using liquid chromatography (Anon, 2002). Hence this buffer 
was used in our study. 
Sample carry over was another potential problem that was found to influence the 
results obtained from the MS data. This was overcome by performing water runs in 
between the sample runs to remove any of the remaining peptides present in the 
monolith column.  
Concentration of protein present in a spot was another important issue for 
determining its identity. Determining the concentration of the protein to be loaded to 
identify it from the LC-MS analysis was essential since the differential protein 
expression profile contained several different proteins of varying intensities. Since at 
least six replicates of each gel condition was generated, each of the spot was 
processed separately and pooled together for analysis. Initial trial experiments were 
performed by cutting out six sets of faint, medium and dark spots. It was observed 
that three or four faint spots pooled together gave a positive identification for the 
majority protein on MS analysis. On average, 4 spots were pooled together to detect 
fainter spots whereas 2 or 3 replicate spot samples were pooled together to detect 
dark and medium spots respectively. 
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Some of the spots remained undetectable because of the very low concentrations or 
due to sample loss during processing. Pressure variations in LC set up and needle 
blockages in the MS set up resulted in loss of some of the samples too. The 
autosampler that transferred the sample on to the column used an injection needle to 
pick up the sample from the multi-well microtitre plate and care had to be taken to 
avoid the pipetting of air bubbles along with the sample into the wells since this 
sometimes resulted in the blockage of the system. Frequent ultra-sonication and 
cleaning of the needles and the shield in the MS system helped to prevent 
blockages. 
The possibility of adjacent spots overlapping each other on the gel suggests that the 
cutting out of spots need to be very accurate. It was also a possibility that some of 
the adjacent overlapping spots were isoforms resolving poorly. Some of the adjacent 
overlapping spots were identified to be the same protein. The inability to obtain a 
positive identity for some protein spots may be attributed to the fact that proteins 
were lost during processing, freeze drying or experimental errors. Several steps 
involved the solubilisation, freeze drying and resuspension of proteins which added 
to the loss of proteins. 
In order to avoid random matching of measured masses to peptides in the MASCOT 
sequence database, the searches were restricted to the grouping of „Eubacteria.‟ 
Random matching results could also provide false positive results and hence certain 
criteria were set up to segregate false positives from correct identifications. This 
included selection of results where the protein score was more than 40 and at least 2 
peptides matched to the query sequence.  
A total of 23 differentially expressed proteins were identified out of 34 in E. 
cancerogenus and 31 proteins were identified out of 45 in B. fragilis. The default 
statistical analysis used in PDQuest was the Student t-test. More than 60% of the 
differentially expressed proteins were identified in both cases but a substantial 
amount of the protein samples were lost due to processing or experimental errors. 
The LC-MS spectra generated from the protein spots were searched through the 
MASCOT server in the NCBI and SWISS PROT databases. It was found that the 
NCBI prioritised the B. fragilis strain YCH76 over the NCTC 9343 strain. The exact 
reason for this is unknown. The significant hits in the YCH76 strain prompted us to 
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perform NCBI blast searches with its NCTC 9343 counterparts and it was observed 
that the matched peptide sequences were identical in both cases. There is a 
possibility that the unique classification, categorisation and annotation of sequences 
in the NCBI database is responsible for the results obtained. Similar searches in the 
SWISS PROT database produced matching peptide sequences in the NCTC 9343 
strain but the ion scores were found to be lower. This may be because SWISS 
PROT database has a manually annotated protein sequence record (Mizrachi, 
2002). Previous work by other scientists have suggested the presence of similar 
problems in data analysis (Ingrell, 2009). Refer to the second section of the 
discussion for further details.  
Differential expression of virulence associated proteins like neuraminidases, 
sialidases, mucinases and glycoside hydrolases were expected to be evident from 
the proteomic experiments but surprisingly, none of these proteins were identified. B. 
fragilis, known to exhibit a well established catabolic pathway in its activity against 
sialic acids by producing silaidases did not express the protein in the presence of 
mucin, unless it was expressed in undetectable amounts. The reason behind 
repression of these enzymes may be due to the presence of glucose in the semi-
defined growth media in addition to mucin which may be inducing a catabolite 
repression.  
 It may be interesting to perform specific assays to determine the presence of these 
enzymes in the cell free extracts since they have not been detected from the 
proteomics experiments. 
 
 
 
 
 
 
 
232 
 
10.10 Expression of proteins involved in translation, ribosomal structure and 
biogenesis  
The ribosome recycling factor (RRF) protein was found to be down-regulated in 
mucin enriched media in B. fragilis but no regulation was observed in E. 
cancerogenus. The protein plays a vital role in the recycling of ribosomes after 
completion of protein synthesis. The two main signal transduction associated 
proteins required for the release of ribosomes from the mRNA are elongation factor 
(EF-G) and the ribosome recycling factor (originally known as the ribosome recycling 
factor (RRF); (Wilson et al., 2005). RRF dissociates ribosomes from mRNA after 
termination of translation and is essential for bacterial growth (Janosi et al., 1994). 
The activity of this protein is important for the availability of free ribosomes for further 
continuation of protein synthesis. These proteins play an important role in inducing 
immune responses within the host during infection by activating the production of 
IgG antibodies (Cassataro et al., 2007). This suggests that these proteins may be 
up-regulated during adverse growth conditions but has been found to be down-
regulated in mucin enriched media in B. fragilis. Previous studies have shown that 
the growth of Streptococcus oralis in acidic conditions resulted in an up-regulation of 
these surface-associated proteins (Wilkins et al., 2003). 
 
The 50S ribosomal protein L7/12 was found to be down-regulated in mucin enriched 
media in B. fragilis even though no regulation was observed in E. cancerogenus. The 
main functions of the 50S ribosomal subunit L7/L12 is mRNA directed protein 
synthesis, increase in polypeptide synthesis and reduction of missense error rate.  
Variable expression levels of 50S ribosomal subunit L7/L12 were observed in mucin 
media in B. fragilis which could be related to the possible existence of isoforms even 
though this phenomenon has not been observed in bacteria. But a general down-
regulation of the protein was observed in mucin enriched media except SSP number 
2806 which shows an up-regulation in expression. 
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10.11 Expression of proteins involved in transcription 
Elongation factor Ts was found to be down-regulated in mucin enriched media in B. 
fragilis and E. cancerogenus. Interestingly, it has been known from previous studies 
in S. pneumoniae that opaque invasive variants of the bacteria were found to exhibit 
a down regulation of elongation factor Ts when compared to the less invasive 
variants that expressed higher amounts of the elongation factor (Overweg et al., 
2000).  The elongation factor Ts plays an important role in protein synthesis by 
acting as a nucleotide exchange factor that is required for the regeneration of 
elongation factor Tu (EF-Tu) from its inactive EF-Tu-GDP form to the active form EF-
Tu-GTP.  This enables EF-Tu to interact with the next incoming amino acid (Hwang 
& Miller, 1985).  
 
Elongation factor EF-Tu was found to be down-regulated in mucin enriched media in 
E. cancerogenus even though the protein showed no differential expression in B. 
fragilis. EF-Tu is an intracellular protein that contains a number of other proteins 
associated with it and is involved in translation elongation factor activity and GTP 
binding. It plays an important role in the translation process by initiating the selection 
and binding of the cognate amino-acyl t-RNA to the acceptor A site (Pape et al., 
1998). They may be associated with the translation and biogenesis of ribosomal 
structures apart from being involved in transcription. Differential expression studies 
in mycobacteria showed the down-regulation of these proteins until they came in 
contact with the host macrophages which indicates that the expression of these 
proteins may be triggered by the presence of a host immune response (Monahan et 
al., 2001). 
 
Putative RNA binding protein domains were down-regulated in mucin enriched 
media in B. fragilis. These proteins play an important role in regulating transcription 
termination; protect the mRNA from degradation during unfavourable growth 
conditions like cold shock and nucleic acid recognition (Stulke, 2002). They are 
capable of stopping translation by preventing the binding of mRNA to ribosomes and 
can control the secondary structure formation of mRNA by promoting or preventing 
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translation initiation thereby modulating metabolic processes. They induce 
antitermination of carbon and nitrogen catabolic genes to suit the survival of bacteria 
in the growth media and the CRM domain forms the conserved region of RNA 
binding protein with 100 amino acids involved in nucleic acid recognition (Barkan et 
al., 2007). RNA binding attenuation protein trp, was found to be associated with the 
production of a putative efflux protein in B. subtilis suggesting that it may be a 
potential virulence factor (Yakhnin et al., 2006).  Down-regulation of these proteins in 
mucin enriched media suggests that the adaptability of B. fragilis in this media is 
much better when compared to the control semi-defined media. 
 
10.12 Expression of proteins involved in secondary metabolite biosynthesis, 
transport and catabolism 
Acetoin reductase, a very essential enzyme involved in acetoin catabolism and 
acetoin dehydrogenation activity has been found to be up-regulated in media 
enriched with mucin Type II but down-regulated in media enriched with mucin Type 
III in E. cancerogenus. This protein was not identified in B. fragilis. The enzyme 
catalyses the conversion of acetoin and NADH to 2, 3 butanediol and NAD (+) which 
is a characteristic of anaerobic fermentation processes. This is also used in the 
commercial production of 2,3 butanediol (Xiao & Xu, 2007). A study in B. subtilis has 
revealed that this cytoplasmic protein is expressed under anaerobic conditions when 
the cells enter the late log phase where the production of butanediol can be 
observed whereas the early log phase shows accumulation of acetoin (Nicholson, 
2008). The production of acetoin is essential for maintaining the pH of the media 
where it compensates for the acidic end products that are produced when glucose is 
present as a source of carbon in the media and this has been observed in V. 
cholerae (Kovacikova et al., 2005). This suggests that the growth stage of the 
bacteria during media harvest play a very important role in their protein expression.  
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10.13 Inorganic ion transport and metabolism associated protein expression 
The enzyme superoxide dismutase has been identified to be down-regulated in 
mucin enriched media in B. fragilis. This protein has not been identified in E. 
cancerogenus. They are housekeeping enzymes that respond or confer resistance to 
oxidative stress in bacteria. Their location is periplasmic and catalyses the 
dismutation of superoxide into oxygen and hydrogen peroxide thus functioning as an 
antioxidant in cells exposed to oxygen. They are produced to allow the host to 
outcompete any aerobic flora or reduce reactive oxygen species. They destroy 
radicals that are commonly produced within cells and are toxic to biological systems. 
They occur as homodimers or homotetramers (Messerschmidt et al., 2001). Previous 
studies have shown that the expressions of these enzymes are encoded by the sodA 
and sodB genes. The sodA gene was activated when the growth conditions shifted 
from anaerobic to aerobic conditions and the sodB gene was switched off under 
aerobic conditions (Matsumura et al., 1993). Growth of bacteria in media containing 
glucose and phosphate has been known to induce autoxidation (Carlsson et al., 
1978) but a down-regulation of the enzyme results in a reduction in control of 
autoxidation and formation of superoxide radicals indicating  that B. fragilis has a 
poorer survival rate in the presence of mucin. 
 
10.14 Expression of proteins involved in cell wall, membrane and envelope 
biogenesis 
Several outer membrane proteins have been differentially expressed in mucin 
enriched media with both B. fragilis and E. cancerogenus. Outer membrane protein 
A was up-regulated while outer membrane protein II was found to be down-regulated 
in E. cancerogenus. The outer membrane surface antigen X was found to be up-
regulated in both mucin Type II and III enriched media in E. cancerogenus. In B. 
fragilis, two different spots were found to contain the same outer membrane protein 
precursors which were down-regulated in both cases in mucin enriched media. This 
could possibly indicate that the protein is present as isoforms in B. fragilis but no 
information is available in literature regarding the existence of isoforms in outer 
membrane proteins of bacteria. Refer to Figs. 30, 31 and 32 which indicate spots 
that expressed the same protein in B. fragilis and E. cancerogenus. 
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Figure 30: Figure showing the differentially expressed spots of outer membrane 
proteins in B. fragilis. SSP numbers 3302 and 5402 were identified to be outer 
membrane protein H and SSP numbers 3303 and 4202 were identified to be outer 
membrane protein precursors.  
 
 
Figure 31: Figure showing the differentially expressed spots of outer membrane 
protein H in B. Fragilis 
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Figure 32: Figure showing the differentially expressed spots of outer membrane 
proteins in E. cancerogenus. SSP numbers 4606, 4505 and 9601 were identified to 
be outer membrane protein II and SSP numbers 4602 and 4603 were identified to be 
outer membrane protein A.  
Outer membrane proteins are porins involved in transport of solutes, are 
immunogenic in nature and occur as epitopes on the bacterial surface exhibiting 
antigenic properties (Luo et al., 1997). Outer membrane protein H have been known 
to be up-regulated during periods of iron starvation where lack of iron activates the 
fur gene which then activates the ompH gene leading to the increased production of 
the protein (Bosch et al., 2001). These proteins may also be associated with 
intracellular trafficking, transport and secretion of vesicles apart from cell envelope 
biogenesis. They enable the adaptation of bacteria to various niches by obtaining 
iron from host-iron complexes. Increased amounts of glucose could also result in the 
suppression of the outer membrane protein H expression (Wheeler, 2009). Previous 
studies have shown that depletion of carbon sources in the growth media can result 
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in the activation of the gene encoding the synthesis of the protein since general 
expression in the presence of sugars is prevented by catabolite repression as 
studied in Photobacterium sp. (Bartlett & Welch, 1995). Outer membrane proteins A 
and II have been known to play an important role in conjugation, invasion of host 
tissues and detection of viruses apart from inducing immunogenic responses in the 
host (Singamsetty et al., 2008).  Deletion of the gene encoding the synthesis of the 
outer membrane proteins caused a reduction in the biomass, reduced survival rate at 
high temperatures, loss of viability in stationary phase (Beher et al., 1980) and 
accumulation of low molecular weight solutes (Barrios et al., 2006). Previous studies 
in B. fragilis (Ko et al., 2009) and Chlamydia pneumonia (Hogan et al., 2003) have 
shown the outer membrane potein encoding genes to be associated with virulence 
and seem to be up-regulated in severe cases of infection.  
 
10.15 Intracellular trafficking, secretion and vesicular transport associated 
protein expression  
Translocation associated TolB proteins were found to be differentially expressed in 
mucin enriched media in E. cancerogenus where up-regulation was observed in 
mucin Type III enriched media and down-regulation was observed in the mucin Type 
II enriched media. This protein was not identified in B. fragilis.  TolB proteins are 
known to be involved in a number of functions that include translocation of colicins of 
group E and A including the delivery of the toxins to their respective target sites, 
assembly of porins in the outer membrane, recycling of peptidoglycan and linking the 
peptidoglycan layer to the outer membrane of the cell (Abergel et al., 1999). They 
have been known to interact with trimeric outer membrane complexes including 
ompF and ompC but do not interact with monomeric forms like ompA (Rigal et al., 
1997). They are a part of the Tol dependent translocation system where they form 
complexes with porins and can initiate the import or export of colicin but increased 
expression of TolA proteins in the form of TolA II His-porin complexes can result in 
the down-regulation of the TolB proteins (Lazzaroni et al., 2002). They may also be 
essential for maintenance of the outer membrane stability (Lazzaroni et al., 1999). 
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10.16 Expression of proteins involved in post translational modifications, 
protein turnover and chaperones  
Putative thiol peroxidase was found to be differentially expressed in B. fragilis in 
mucin Type II and III enriched media but was not identified in E. cancerogenus. The 
protein was found to be up-regulated in SSP number 6301 and down-regulated in 
SSP numbers 4601 and 4605 in mucin enriched media in B. fragilis (Figure 33). . 
They play an important role as antioxidants and may be activated under conditions of 
oxidative stress and protect cells against the damaging effects of reactive oxygen 
species produced during metabolism (Missall et al., 2004). In the presence of 
hydrogen peroxide, they convert the reduced form of thioredoxin to the oxidised form 
and are also known as peroxiredoxins. The presence of varying concentrations of 
oxidants in the growth media produced as a result of the accumulation of toxic 
metabolic end products may be responsible for the differential expression of these 
enzymes in mucin enriched media. Under anaerobic growth conditions, the 
expression of these proteins is controlled by the binding of designated proteins that 
prevent the activation of the tpx promoter (Kim et al., 1999). The regulation of these 
proteins may be attributed to the adaptation capabilities of bacteria to various 
ecological niches even under conditions of stress.  
These proteins protect DNA and detoxify peroxides. The activation of the genes 
controlling the expression of these proteins is controlled by the tpx promoter (Kim et 
al., 1999). Considering the lack of oxygen in anaerobic growth conditions, the down-
regulation of these proteins suggests the possible lowering of oxidative stress in 
mucin enriched media (Kim et al., 1999).  
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Figure 33: Figure showing the differentially expressed spots of putative thiol 
peroxidase in B. fragilis  
E. cancerogenus showed a down-regulation of a protein from the glutaredoxin family 
in mucin Type III enriched media but was not identified in B. fragilis. Glutaredoxin 
related proteins are disulphide reductases that contain glutaredoxin and NADPH as 
cofactors. They have the presence of an intramolecular disulphide bond, act as 
electron carriers in the synthesis of deoxyribonucleotides and contribute to cellular 
functions like cell proliferation, viability and stabilisation during stress conditions 
(Holmgren et al., 2005). Thiol disulphide oxidoreductases play an important role in 
disulphide bond formation in cytochrome biogenesis (Holmgren et al., 2005). 
Previous studies in E. coli reveal the ability of these proteins to adhere to tissue 
culture cells and may contribute to the formation of pili (Donnenberg et al., 1997). 
They have been known to contribute to bacterial virulence by acting as a folding 
catalyst suggesting that the down-regulation of these proteins in mucin media may 
be associated with the absence of a host immune response that induced expression 
(Yu & Kroll, 1999). This explains the reason behind the observation of a down-
regulation of the glutaredoxin family related protein like thiol disulphide 
oxidoreductase in mucin Type III enriched media in E. cancerogenus. Other factors 
such as general metabolic requirements or toxic by product build up could also be 
responsible. 
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The co-chaperonin protein GroES was found to be up-regulated in mucin Type III 
enriched media in B. fragilis. This protein was not identified in E. cancerogenus. This 
is an oligomeric molecular chaperone which functions in protein folding and 
intracellular signals. It is a surface protein which is released from cells when 
required. It captures the substrate with the help of co-chaperone GroES and ATP 
which help with the binding. The substrate is then discharged into the 
microenvironment inside the chaperone promoting productive folding. The 
polypeptide is later released into the solution. GroES works as a co-chaperone with 
GroEL during protein folding. They have metal binding enzyme sites and can play an 
important role in host immunogenicity (Ranford et al., 2004). These chaperonins are 
known to act as intercellular signals interacting with a variety of cell types, including 
leukocytes, vascular endothelial cells and epithelial cells and may be responsible for 
key cellular activities such as synthesis of cytokines and adhesion proteins (Landry 
et al., 1996) . Co-chaperonin GroES is a known virulence factor and has been known 
to be associated with inducing inflammation and promoting cell proliferation (Lin et 
al., 2006). Up-regulation of these virulence associated proteins in mucin Type III 
enriched media indicate that they may be expressed during infection of the host by 
bacteria.  
A heat shock protein, GrpE was found to be differentially down-regulated in mucin 
enriched media in B. fragilis but no regulation was observed in E. cancerogenus. 
This is a stress related protein that works in conjunction with two other proteins 
namely DnaK and DnaJ forming complexes and is activated to repair damaged 
proteins or to initiate folding of proteins (Packschies et al., 1997). Apart from being 
involved in protein folding and disaggregation of heat shock proteins, these proteins 
also carry out the degradation of misfolded proteins. Unfolded proteins bind to DnaJ 
protein to form an unstable complex which is then stabilised by the hydrolysis action 
of DnaK. The movement of the folded protein is initiated by the removal of an ADP 
molecule which is converted to ATP coupled to the DnaK protein caused by the 
GrpE protein (Straus et al., 1990). Inactivation of the gene encoding the GrpE protein 
in E. coli has known to enhance the production of heat shock proteins and the 
continual production of the heat shock protein could not be stopped even though the 
growth conditions were returned to normal (Lipinska et al., 1988). Down-regulation of 
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the protein indicates the lowering of heat shock or oxidative stress when grown in 
mucin enriched media when compared to the control media. 
 
ATP synthase subunit E was up-regulated in mucin Type II and III enriched media in 
B. fragilis but no regulation was observed in E. cancerogenus. ATP synthases form 
proton channels that cause an influx of ions across the membrane thereby 
generating a proton gradient formed by the hydrolysis of ATP or oxidative 
phosphorylation of ADP and resulting in the generation of energy for metabolic 
processes (Feniouk & Junge, 2005).   Differential expression studies in 
Mycobacterium avium showed the up-regulation of the the ATP synthase subunit C 
called the AtpC component of the ATP synthase complex (Radosevich et al., 2007). 
The exact function of the subunit E is not known but the up-regulation of the protein 
may be associated with energy generation for efficient growth of the bacteria. Up-
regulation of the ATPase subunit E may be associated with the availability of a large 
amount of sugar substrates for growth thereby supporting an increased generation of 
energy in B. fragilis. It is quite interesting that only the subunit E of the ATP synthase 
complex appeared to be up-regulated in mucin enriched media instead of the entire 
protein complex. ATP synthase subunit B, another component of the ATP synthase 
complex was identified during MS analysis of protein spots but did not show any 
differential expression in mucin enriched media. The exact reasons for the 
differential expression of the ATP synthase subunit E in mucin enriched media 
remain unknown.  
 
10.17 Expression of proteins involved in energy production and conversion  
Phosphoenol pyruvate carboxykinase (PEPCK), an important enzyme in the 
gluconeogenetic pathway catalysing the decarboxylation of oxaloacetate into 
phosphoenol pyruvate and carbon-di-oxide was shown to be down-regulated in 
mucin Type II and III enriched media in B. fragilis. This protein was not identified in 
E. cancerogenus. They utilise ATP or GTP as a source of phosphates and exhibit 
catalytic activity by binding to metal containing sites. The activation of these 
enzymes occurs when non fermentable sources of carbon are present in the media 
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and have been known to occur in ruminal and other anaerobic bacteria (Schocke & 
Weimer, 1997). Over expression of these proteins could affect the growth balance 
since they are known to have an influence over the oxygen concentrations in the 
media and this alteration in expression has been studied in E. coli (Chao & Liao, 
1993). Since mucin acts as a rich source of carbon substrates, the fermentation of 
these substrates probably depend on the energy conservation and nutritional 
specialisation of B. fragilis. Studies have shown the up-regulation of the acuF gene 
which encodes the synthesis of PEPCK when non fermentable sources of carbon 
are present in the growth media (Hynes et al., 2002). Hence the down-regulation of 
the protein in mucin enriched media can be attributed to the lack of requirement of 
more sugars for growth as mucin itself acts as a major source of carbon. 
 
One of the interesting results from my study showed the differential regulation of 
malate dehydrogenase enzymes in B. fragilis but was not identified in E. 
cancerogenus. These enzymes were found to be down-regulated in mucin Type II 
and III enriched media in SSP number 4607 but the same enzyme was found to be 
up-regulated in mucin Type II and III enriched media in SSP number 4804 (Fig. 34). 
This could indicate that the enzyme exists in isoforms that may be differentially 
expressed based on their function but has been observed only in eukaryotes and is 
not known to exist in B. fragilis. Malate dehydrogenases catalyse the conversion of 
malate to oxaloacetate in the citric acid cycle and their expression has been known 
to vary with the carbon substrates and growth conditions used for culturing bacteria 
(Minarik et al., 2002). Apart from being involved in carbohydrate metabolism, they 
may also be associated with amino acid transport and metabolism. Previous studies 
in malate dehydrogenase enzymes have shown that they exist as isoenzymes and 
also exhibit allelic polymorphisms in eukaryotes (Gietl, 1992) and in phototropic 
bacteria Rhodobacter sphaeroides and Rhodopseudomonas palustris (Eprintsev et 
al., 2008) . There were considerable amounts of distinctive amino acids associated 
with the allelic polymorphisms of the mdh gene indicating that this could have been 
caused by the horizontal transfer of genes in E. coli and S. enterica (Boyd et al., 
1994). The mdh gene in E. coli encodes for the ArcA protein whose expression is 
down-regulated under anaerobic conditions and regulation of expression was studied 
in response to varying oxygen, carbon and haeme availability in the growth media 
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(Park et al., 1995). The differential expression of these proteins may be associated 
with the presence of mucin in the semi-defined growth media which acts as a rich 
source of carbon providing a better survival rate for the bacteria. 
 
Figure 34: Figure showing the differentially expressed malate dehydrogenase spots 
in B. fragilis 
 
NAD dependent aldehyde dehydrogenase enzyme was found to be down-regulated 
in media containing mucin Type II in E. cancerogenus. These proteins were not 
identified in B. fragilis. The aldehyde dehydrogenase enzymes are very closely 
associated with the gamma glutamyl phosphate reductase enzymes. They catalyse 
the dehydrogenation or oxidation of aldehydes to produce acidic end products in the 
presence of NADP as a co-factor. One of the important features of this enzyme is 
that it can act as an allergen that induces IgE responses in humans and mammals. 
The enzyme may be acting as a potential virulence factor by triggering immune 
responses within the host by activating the IgG antibodies. Under anaerobic 
conditions, aldehyde dehydrogenases metabolise endogenous acetaldehyde and 
ferment nutrients to produce energy (Mikulskis et al., 1997). Previous studies 
showed that the expression of these proteins in germ free mice were modulated 
when challenged by bacteria and were found to be down-regulated (Fukushima et 
al., 2003). Down-regulation of aldehyde dehydrogenase in mucin Type II enriched 
media indicates that the presence of mucin may be modulating the expression of this 
enzyme.  
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10.18 Expression of carbohydrate transport and metabolism associated 
proteins 
Triose phosphate isomerase (TPI) which is involved in the interconversion of the TPI 
isomers dihydroxy acetone phosphate (DHAP) and glyceraldehyde-3-phosphate was 
found to be down-regulated in mucin Type II and III enriched media in B. fragilis. The 
enzyme plays an important role in carbohydrate metabolism through glycolysis and 
energy production. Regulation of the tpi gene which encodes the enzyme that can 
result in the accumulation of sugar moieties which becomes impossible to 
metabolise (Solem et al., 2008). They are also known to be immunogenic in nature 
where these enzymes were up-regulated in convalescent phase serum obtained 
from patients suffering from pneumococcal infections caused by S. pneumoniae 
(Zysk et al., 2000). Growth of B. fragilis in cell culture could trigger an up-regulation 
of these proteins since they are associated with the host immune system. Differential 
expression studies in planktonic and biofilm cultures showed the up-regulation of 
these enzymes in biofilm conditions (Becker et al., 2001). Previous studies have 
shown that these enzymes can be over expressed during stress conditions like 
deprivation of oxygen and this suggests that the down-regulation of these proteins 
may be due to the ability of bacteria to grow well in the presence of mucin (Yamaji et 
al., 2004). Regulation of expression of these proteins indicates that they play a vital 
role in carbohydrate metabolism and immune response suggesting that they could 
act as potential virulence factors when grown in host cells. 
Up-regulation of the conserved domains of enolase or phosphopyruvate hydratase 
was observed in E. cancerogenus media enriched with mucin Type II and III. The 
enzyme forms an integral part of the glycolytic pathway catalysing the conversion of 
2-phosphoglycerate to phosphoenol pyruvate. The expression of these enzymes has 
been found to be enhanced under anaerobic conditions and mutants lacking the 
presence of the enolase gene have been unable to utilise gluconeogenetic and 
glycolytic carbon sources (Lemaire & Wesolowski-Louvel, 2004). Enolase has also 
been known to play an important role in tissue invasion and pathogenesis in Gram-
positive bacteria and may be over expressed in infection conditions (Liu & Shih, 
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2007). The up-regulation of these proteins in E. cancerogenus suggests the 
possibility that they may be indirectly involved in pathogenicity and may act as 
potential virulence factors and are therefore worthy of further study. 
Phosphoglycerate kinase; a key enzyme involved in the glycolytic pathway was up-
regulated in mucin Type II and III enriched media in E. cancerogenus. This protein 
was not identified in B. fragilis. These enzymes are involved in the anaerobic 
fermentation and generation of energy from carbon sources by catalysing the 
conversion of 1, 3-bisphosphoglycerate into 3-phosphoglycerate in the glycolytic 
cycle. Inactivation of the pgk gene encoding the synthesis of phosphoglycerate 
kinase resulted in the accumulation of 1, 3-bisphosphoglycerate thereby leading to 
the inability to generate energy for metabolism (Nakano et al., 1999). Up-regulation 
of these enzymes indicates the efficient metabolisation of sugars which is probably 
enhanced in the presence of mucin which acts as a rich source of carbon. 
Fructose 1,6-bisphosphate aldolase was found to be down-regulated in mucin Type 
II and III enriched media in B. fragilis following analysis using the PDQuest gel 
analysis software. This protein was not identified in E. cancerogenus. This enzyme 
catalyses the conversion of fructose 1,6 bisphosphate to dihydroxyacetone 
phosphate and glyceraldehyde-3-phosphate in the glycolytic pathway involving the 
binding of a divalent metal ion (Zinc) to the active site (Anon, 2009). This enzyme 
has been known to be expressed when B. fragilis cell suspensions were grown in 
media containing glucose and lactate as carbon sources (Macy et al., 1978). 
Previous studies in Trichomonas vaginalis revealed the up-regulation of malate 
dehydrogenases and fructose 1,6 bisphosphate aldolases and were found to be 
associated with virulence (Cuervo et al., 2008). Hence these enzymes may be 
potential virulence factors and play a vital role in the adherence of bacteria to host 
cells. They were found to be over expressed in the viable but non culturable state of 
bacteria suggesting that they play a vital role in the alternate metabolic pathways 
involved in the generation of energy (Heim et al., 2002) . In our experiments, fructose 
1,6 bisphosphate aldolase was found to be down-regulated in mucin enriched media 
indicating better energy generation and viability of cells in mucin enriched media.   
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10.19 Amino acid transport and metabolism associated protein expression 
Proteins from the carbamate kinase family involved in ATP and amino acid synthesis 
pathways was found to be up-regulated in mucin enriched media in E. 
cancerogenus. This protein was not identified in B. fragilis. Carbamate kinases 
catalyse the conversion of carbamoyl phosphate and ADP to carbamate and ATP. 
Hence this acts as a major source of ATP for energy metabolism. Previous studies 
have shown the over expression of this enzyme induced by growth of bacteria in 
anaerobic conditions, moderate expression induced by the presence of arginine and 
repression caused by the presence of ammonia (Abdelal et al., 1982). Expression of 
carbamate kinase was found to increase when S. aureus cultures were grown under 
biofilm conditions and seem to play an important role in the growth of bacteria 
(Resch et al., 2005). This indicates that the enzyme is involved in energy production 
reactions for the better growth of bacteria and its up-regulation may be attributed to 
the availability of rich sources of carbon under strict anaerobic conditions. Up-
regulation of these proteins in mucin enriched media indicates an increase in energy 
metabolism in the presence of mucin in E. cancerogenus. 
One of the other proteins that were differentially under expressed in mucin Type II 
and III enriched media was the lactoylglutathione lyase enzyme in B. fragilis. This 
protein was not identified in E. cancerogenus. This enzyme has been known to play 
an important role in the detoxification of the bacterial system and may be produced 
in response to oxidative stress (MacLean et al., 1998). Only a general prediction of 
the function of these proteins is available associating them with amino acid transport 
and metabolism. This enzyme is also known as glyoxalase I and it catalyses the 
isomerisation of hemithioacetal adducts which are produced as a result of the 
reaction between glutathione (containing a glutathionyl group) and methylglyoxal 
(containing an aldehyde group). The end product of the reaction was 
lactoylglutathione which protected the system from the toxic effects of methylglyoxal 
(Korithoski et al., 2007). The glutathione conjugates formed from the glyoxalase I-II 
pathway can activate KefB and KefC potassium channels that cause a lowering of 
the pH of the bacterial cell intracellularly thereby protecting them against the toxic 
effects of electrophiles (Ferguson et al., 1998). Studies have shown that the genes 
encoding the expression of these enzymes when over expressed, resulted in an 
increased tolerance of the organism to methylglyoxal and osmotic stress exhibiting a 
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protective function (Takatsume et al., 2005). They may be over expressed in cases 
of oxidative stress especially when acidic conditions prevail in the growth media 
(Wilkins et al., 2002). Similar results have been observed in S. mutans where the lgl 
gene was over expressed during growth in acidic media (Korithoski et al., 2007). But 
the down-regulation of the enzyme in mucin enriched media indicates a decrease in 
toxic metabolites or oxidative stress which suggests better viability and survival rates 
in mucin media rather than the control semi-defined media. 
Proteins from the 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase I 
(DAHP) family was found to be up-regulated in mucin enriched media in E. 
cancerogenus. This protein was identified to be 2-dehydro-3-deoxy phosphooctonate 
aldolase and was not expressed in B. fragilis. 2-dehydro-3-deoxy phosphooctonate 
aldolase belongs to the transferase enzyme family and has been known to be up-
regulated at transition stages from logarithmic to stationary phase in growth cultures 
(Sowell et al., 2008).The enzyme, 3-deoxy-D-arabino-heptulosonate 7-phosphate 
synthetase I plays an important role in the aromatic amino acid biosynthesis and 
shikimate pathway (Panina et al., 2001). Two of the main amino acids synthesised 
using the shikimate pathway are tyrosine and phenylalanine and the feedback 
inhibition caused by the end products of the shikimate pathway does not affect the 
activity of DAHP synthase enzyme in Bacillus sp. (Kim, 2001). It catalyses the 
condensation reaction that converts phosphoenol pyruvate and D-erythrose-4-
phosphate to 3-deoxy-D-arabino-heptulosonate 7-phosphate and this step plays an 
important role in the synthesis of amino acids like tyrosine and phenyl alanine 
(Herrmann, 1995).  Since the substrates used in the condensation reaction are 
mainly sugar phosphates and mucin acts as a rich source of carbohydrates and 
complex polysaccharides, the up-regulation of these enzymes in B. fragilis can be 
understood.  
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10.20 Expression of poorly characterized proteins with a general function 
prediction only  
The periplasmic protein, ecotin was found to be down-regulated in E. cancerogenus 
but not identified in B. fragilis. The protein acts as a broad range serine protease 
inhibitor that is capable of acting against enzymes like trypsin, chymotrypsin, blood 
peptidase factor Xa, thrombin and urokinase type plasminogen activator (Mcgrath et 
al., 1995). They exhibit a high degree of variation and develop adaptive interactions 
that suit the survival of the pathogen in host tissue and studies show that its location 
in the cell is periplasmic (Mcgrath et al., 1991). They have a protective function and 
may be responsible for the bacteriostatic activity of the bacteria against neutrophil 
elastases (Eggers et al., 2004). Since the presence of a host immune response 
triggers the expression of ecotin, its down-regulation suggests the lack of host 
digestive enzymes. This indicates that ecotin may be used as a protective system 
against proteolytic enzymes or other antibacterial agents and the lack of any 
components that challenge the growth of bacteria may have caused its down-
regulation in mucin enriched media. In fact, media containing mucin support better 
growth of bacteria. 
Differential expression of ribonucleotide reductase, pyruvate formate lyase (PFL) and 
autonomous glycyl radical cofactor were observed in E. cancerogenus. This protein 
was not identified in B. fragilis. Proteomic analysis of the spots revealed up-
regulation of the protein in mucin Type II enriched media whereas down-regulation 
was observed in mucin Type III media. The autonomous glycyl radical cofactor plays 
an important role in the in the regulation of transcription and may be induced under 
conditions of oxidative stress since it acts as an antioxidant (Wyborn et al., 2002). 
The enzyme ribonucleotide reductase is involved in the aerobic glycolysis reaction 
whereas pyruvate formate lyase takes part in the anaerobic glycolysis reaction 
(Leppanen et al., 1999). Under oxidative stress conditions, the fragmentation of 
pyruvate formate lyase takes place and this induces the activation of the 
autonomous glycyl radical cofactor gene which then acts as an independent glycyl 
radical carrier and replaces the C terminal glycyl radical in PFL (Wagner et al., 
2001). Previous studies have shown that the enzyme pyruvate formate lyase is over 
expressed in the presence of pyruvate or milk and can yield mixed acid end products 
following anaerobic fermentation (Derzelle et al., 2005). Since the exact composition 
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of mucin remains unknown, the end products of glycolysis may be inducing the 
expression of this protein in mucin Type II enriched media when compared to the 
mucin Type III enriched media as revealed in previous work (Sawers & Bock, 1988 ). 
A transcription elongation associated protein, elongation factor GreA was identified 
to be down-regulated in mucin Type II and III enriched media in E. cancerogenus. 
They are involved in the process of transcription regulation where the elongation 
factors cleave 2 or 3 nucleotides from the N terminal end of the nascent transcripts 
of RNA polymerases which are trapped by the arresting sites in the DNA forming 
locked DNA/RNA polymerase tertiary complexes as they pass through them. Once 
cleaved, resumption of the process of elongation takes place from the 3‟ end (Lu et 
al., 1997). Their functions include DNA dependent regulation of transcription, DNA 
binding and transcription elongation regulator activity (Stepanova et al., 2007). 
These are cell surface associated proteins that are over expressed during stress 
conditions. Induced stress conditions like growth in lower pH (5.0) in Streptococcus 
mutans (Len et al., 2004) and mutation of the pgi gene that encodes the synthesis of 
the phosphoglycerate kinase enzyme trigger the increased expression of these 
proteins (Kabir & Shimizu, 2003). The lack of any stress conditions and the ability to 
survive effectively in the media could be responsible for the down-regulation of this 
protein in mucin enriched media when compared to the control non mucin media in 
E. cancerogenus. 
 
10.21 Expression of signal transduction mechanism associated proteins 
The universal stress proteins were found to be up-regulated in mucin Type II and 
mucin Type III enriched media in E. cancerogenus. This protein has not been 
identified in B. fragilis. This result is similar to the autonomous glycyl radical cofactor 
differential expression suggesting reduced accumulation of toxic end products or 
oxidative stress in mucin Type III media when compared to mucin Type II media.   
These cytoplasmic proteins play a major role in protecting DNA against damaging 
agents and they have been known to be over expressed when cells enter a 
preparatory phase before transition from the log phase to the stationary phase 
(Nystrom & Neidhardt, 1994). Expression may also be induced by depletion of 
carbon sources in growth media (Persson et al., 2007) or in the presence of stress 
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inducing agents like salt or toxic by-products of metabolism (Weber & Jung, 2002). In 
some cases, these proteins have been known to be expressed even before complete 
depletion of carbon sources in the media  (Chang et al., 2002). Previous studies in 
the universal stress proteins expressed by E.coli showed that 6 different proteins 
which were encoded by 6 different genes uspA, B, C, D and E were produced under 
different conditions of stress. The genes usp C and E were found to produce proteins 
that were involved in cell adhesion and motility and this could be related to the up-
regulation of these proteins in mucin enriched media (Nachin et al., 2005).    
 
 
10.22 Nucleotide transport and metabolism associated protein expression  
Three other proteins found to be differentially expressed were cytidylate kinase in E. 
cancerogenus, phosphoglycerate kinase in E. cancerogenus and the 50S ribosomal 
protein L7/12 in B. fragilis. Cytidylate kinase proteins were found to be up-regulated 
in mucin Type III enriched media and down-regulated in mucin Type II enriched 
media in E. cancerogenus. These are cytoplasmic proteins that play a vital role in 
pyrimidine and nucleic acid metabolism by catalysing the transfer of a phosphate 
group from ATP thereby converting dCMP to dCDP and ADP. The two main 
functions of the protein include cytidylate kinase activity and ATP binding and they 
also require the binding of metal ions like magnesium (Mg2+). When mutants lacking 
the conserved serine residues were generated, there was a dramatic decrease in the 
phosphorylation of dCMP indicating that these residues were highly conserved 
(Bertrand et al., 2002). Not much information is available regarding the differential 
expression of these proteins but over expression in mucin Type III media suggests 
the possible availability of more energy in the form of ATP for nucleic acid synthesis 
unlike the mucin Type II or non mucin media.  
E. cancerogenus showed the up-regulation of a periplasmic protein with a 
phospholipid binding domain in mucin enriched media. SSP number 6408 also 
showed a differential expression of a periplasmic protein disulphide isomerase I. This 
protein showed a down-regulation in the mucin Type II enriched media in E. 
cancerogenus. This protein was not identified in B. fragilis. The periplasmic protein 
disulphide isomerase belongs to the thiol disulphide oxidoreductase protein family 
252 
 
and is known to play an important role in the oxidative protein folding pathway. 
Gram-negative cell walls have the presence of phospholipids associated with their 
peptidoglycan and periplasmic layers. Periplasmic proteins form a part of bacterial 
transport systems with a high affinity and solute binding extracellular site (Ito et al., 
1981). They may also be involved in the formation and aggregation of porins that 
transport nutrients across the membrane but the exact function of these proteins 
remain unknown (Lazar & Kolter, 1996). Previous studies have shown that increased 
concentrations of sucrose is capable of inducing the over expression of these genes 
and mucin being a rich source of carbohydrates like sucrose could be responsible for 
the up-regulation of these proteins (Costerto et al., 1974). 
 
10.23 Summary 
Some of the differentially expressed proteins identified in E. cancerogenus and B. 
fragilis were found to be hypothetical proteins that showed the presence of unknown 
domains of function. These include the SSP numbers 5003 (hypothetical protein 
03947), 6306 (hypothetical protein 20877) and 8205 (Yfaz family protein) in E. 
cancerogenus and SSP numbers 1104 (BF2494), 2804 (BF2494), 5205 (BF1203) 
and 6206 (BF0301) in B. fragilis. Two of the proteins that were found to be 
differentially expressed in both E. cancerogenus and B. fragilis were elongation 
factor Ts and outer membrane proteins.  
Apart from the differentially expressed proteins, several other proteins were found to 
be expressed in B. fragilis and E. cancerogenus. These can be classified as proteins 
required for the general metabolism and growth of bacteria in both control and mucin 
enriched media. A list of these proteins is available in the „Result section Table 
numbers 20 and 22 ‟.  
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10.24 Future work 
Cell culture coated multiwell plates can be used to study the interactions between 
the bacteria and eukaryotic cells. This may help in the better understanding of the 
virulence factors involved in the host infections caused by the bacteria since the 
presence of a host immune response may trigger the expression of virulence 
associated proteins.  
The database used for searching and identifying the proteins of interest from the 
mass spectra was predominantly NCBI. It may be better to use other protein 
identification databases like PRIDE for determining the identity of proteins since they 
provide an identity based on searches in several databases including NCBI and 
UniProt. 
A non gel based approach may also be used in studying differential expression in 
mucin media in both log and stationary phase. Even though the log phase is known 
to be associated more with virulence, it may be interesting to find out the differences 
in regulation that occurs in the stationary phase. One of the modern proteomics 
technologies includes Shotgun proteomics or Multidimensional protein identification 
technology (MUDPIT) where the proteins are subjected to a 2D-LC separation 
through strong cation exchange columns in the first dimension. The second 
dimension separation employs reverse phase chromatography. The cell lysates are 
tryptic digested before separation and pre-fractionation is carried out with iso-electric 
focussing. In order to obtain a better resolution of proteins, affinity chromatography 
using non-specific dyes could also be performed. The digestion and separation of 
proteins is followed by mass spectrometric analysis. The peptides are subjected to 
MS/MS by using electrospray ionisation (ESI) or matrix assisted laser desorption/ 
ionisation (MALDI). The spectrum generated from the mass spectrometric analysis is 
compared to a database to determine the identity of the protein of interest. This is 
considered an efficient method because it helps to identify proteins with high 
molecular masses, extreme pI, hydrophobic or when they occur in low abundance. 
This approach could also help in the identification of integral membrane proteins and 
overcome some of the drawbacks of two dimensional gel electrophoresis. Analysis of 
proteins using this technique could be used as a future method of studying 
differential expression of proteins.  
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In the proteomics technique, the sample processing step plays a very important role 
since slight variations can cause drastic changes in expression. In my methodology, 
the use of the clean up kit seems to help in obtaining a good resolution of proteins 
but the components of this kit remains unknown. It would be interesting to compare 
the expression of proteins when the acetone precipitation method is used instead of 
the 2D clean up kit. 
Further work could also be done in trying to generate mutants that lack the genes 
associated with the expression of proteins like the outer membrane surface antigens 
which are known for their virulence and appear to be differentially expressed in both 
B. fragilis and E. cancerogenus. This could be useful in providing more information 
regarding the pathogenicity of these bacteria. 
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11. Results and discussion of the expression and structural analysis of B. 
fragilis proteins from glycoside hydrolase families 97 and 95.  
11.1 Construction of plasmid vector expression constructs  
NB. Expression vector constructs carrying the genes encoding proteins CAH09443 
and CAH06598 from glycoside hydrolase families 97 and 95 respectively, were 
provided by Lee Ling Bong and Cheun Hong Yeap from Northumbria University. 
FASTA format of the putative α-fucosidase (CAH06598) of glycoside hydrolase 
family 95 from B. fragilis NCTC 9343: 
>gi|60491840|emb|CAH06598.1| conserved hypothetical protein [Bacteroides fragilis 
NCTC 9343] 
 
              1 mkiklllllc cglwsscnsy dycpvtpses dlvftglars wdeamplgna tvgalvwqrd 
       61 stlrlsldrt dlwdlrpvds lsgdnfrfsw vkehirqkny lpvqkkldwp ydmnpapski 
      121 pgaaiefple qigtptqvrl ylnnalcead wadgtqmqtf vhatepigwf vfrnlktpie 
      181 psiitpvynk tkpdgsldpv sgqdlhrlgy qqgkvvregn qityhqkgyg dfsydvtvcw 
      241 kqegetlygt wsvtsslsge qasekaeaal qrglkhdyqa hleywdkywa qssitlpdsv 
      301 lqkqyqnemy kfgsttrehs ypislqavwt adngklppwk gdyhhdlntq lsywpaytgn 
      361 hltegmgyln tlwnqrdayk rytrryfgte gmnipgvctl tgepmggwiq ysmsqtvaaw 
      421 laqhfylqwk ysadrtflke raypfikdva iyleqisevt pegvrklefs sspeifdnsl 
      481 qawfsdmtny dlammhflfk atselaheln ladeaghwas leaqlpdydi deegcltfak 
      541 gypykeshrh fshamaihpl glidwsdgek sqhiiratlk rldkvgpdyw tgysyswlan 
      601 mkarafdgeg aaqalktfae cfclkntfha ngdqtqsgks rftyrpftle gnfafaagiq 
      661 emllqshtgv irifpaipke wkdvsfenlr amgaflvsar meggeinrvr iysekggmlk 
      721 marpgtlkpn knytlsgtdi lnidtqagew ielnp 
 
 The protein was found to contain a signal peptide that was cleaved between the 19th 
and 20th position of the amino acid sequence (Appendix I). The protein parameters 
were determined from the Protparam tool (Refer to Appendix I for details).  
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FASTA format of the putative α-glucosidase (CAH09443) of the glycoside hydrolase 
family 97 from B. fragilis NCTC 9343: 
>gi|60494642|emb|CAH09443.1| putative exported protein [Bacteroides fragilis 
NCTC 9343] 
 
        1 mkrkmmslll alavisgssv yakvidvmsp ngaikvsvdi kdriyysvsy dndqllkdcy 
       61 lnlqlqnetl gtnphlrstk rgtidesvkr eipfknaivr nhcntlrmnf sgnyavefrv 
      121 fdngiayrfv tdkkgdnivm gedfainfpt nykahlsqpd gfktsyecpy thvdtekyaa 
      181 tdrmsylpvl ietdkaykil iseadlsdyp cmflkstgkn gmqsifpkap lafgedgdrs 
      241 lkiteeadyi aktdgkrsfp wrmmvisked kelienemvy nlsapcvled yswikpgqvs 
      301 wewwhdarly gvdfrsgfnm dsykyyidfa skfgipyiim degwakntrd pftpnptinl 
      361 telikygkdr nvkivlwlpw ltvenhfdlf ktfadwgiag vkidfmdrsd qwmvnyyerv 
      421 akeaakhklf vdfhgafkpa glerkypnvl syegvlgmeq ggnckpensi ylpfmrnavg 
      481 pmdftpgsmi saqpednrst ranamgsgtr afqmalfiif esglqmladn pvyyyrelpc 
      541 tefitsvpvt wdetkvlyak vgeavvvakr kgeqwfiggi tgnqpqniei dlgfipagqs 
      601 ftltsfedgi nadrqamdyk kkestvnnqt rmtlkmvrng gwagtikmk 
 
The SignalP server predicted the presence of a signal peptide with probable 
cleavage positions between the 22nd and the 23rd residues of the amino acid 
sequence (Appendix I). The protein parameters were determined from the Protparam 
tool (Appendix I).  
The genes were amplified using the following primers: 
Forward primer for BF3763 
5‟- ATGAAAGTGATTGACGTAATGTCTCCCAACGG-3‟ 
Reverse primer for BF3763 
5‟- ATTGTTCCGGCCCATCCCCC-3‟ and 
Forward primer for BF0855 
5‟- TATGACTATTGTCCGGTCACTCCTTCAGAGAG-3‟ 
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Reverse primer for BF0855 
5‟- AGGGTTCAACTCGATCCATTCACCGGCTTGAGT-3‟ 
The amplified genes which encoded the mature CAH09443 and CAH06598 proteins 
were cloned into the pETYSBLIC vector (see Appendix C) 
The BF3763 and BF0855 genes were cloned and expressed in E. coli using the pET-
YSBLIC vector system. E. coli was used as a host for the expression of recombinant 
proteins because of the ease of promoter control, high amount of product yields, high 
densities of growth in cultures, easy to grow with regards to metabolic carbon 
requirements (Brown, 1953). The pET-YSBLIC vector is a modification of the 
pET28a vector developed at York University where the gene of interest can be 
inserted into the vector through ligation independent cloning. The LIC vector is 
modified to encode a hexa-histidine tag that is incorporated at the N terminus of the 
protein of the encoded gene thereby making its purification easy. These factors 
make the LIC vector the most suitable candidate for cloning and expression 
experiments. 
 
The SignalP and TMHMM websites were used to determine the presence of signal 
peptides and transmembrane helices in the proteins of interest so that genes 
sequences encoding these protein elements could be excluded during cloning. This 
was done to prevent the accumulation of secreted and transmembrane proteins in 
the inner membrane of the host which would inhibit growth. 
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11.2 Protein expression comparison using IPTG induced media and auto-
induction media 
Figs. 35 and 36 show SDS gels of CAH06598 and CAH09443 proteins, respectively, 
isolated from recombinant E.coli cells grown in IPTG induced media and auto-
induction media. 
        
             1       2       3      4        5                                                                             
                      
Figure 35: Analysis of CAH06598 expression (86 kDa) using a 12% (w/v) SDS gel 
obtained from growing the recombinant E. coli in IPTG induced media. Lane 1- 
Solubilisation buffer sample, Lane 2- 1 in 10 dilution of CFE, Lane 3- Cell free extract 
(CFE), Lane 4- Low molecular weight marker, Lane 5- High molecular weight 
marker. 
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      1          2         3           4        5 
  
Figure 36: Analysis of CAH09443 expression (74 kDa) using a 12% (w/v) SDS gel 
obtained from growing recombinant E. coli in auto-induction media. Lane 1- 
Solubilisation buffer sample, 2- Low molecular weight marker, 3- High molecular 
weight marker, 4- 1in 10 dilution of CFE, 5- CFE         
Since the cell free extract in the auto-induction media showed better expression than 
the IPTG induced media, the former was used in the protein purification experiment. 
The analysis of protein production was performed by comparing the expression 
levels in auto-induction and IPTG induced media. The auto-induction media which 
had the presence of glucose and α-lactose in it supported the growth of the 
recombinant E. coli and glucose was initially used as the source of carbon. Once the 
glucose present in the media was completely depleted, the cells started metabolising 
the lactose present. According to previous studies, this stage was normally achieved 
when the cells entered their mid or late log phase (Studier, 2005). The cultures were 
incubated overnight at 30°C with constant aeration and harvested at their stationary 
phase of growth (OD >4.0). However, the differences in level of expression of the 
protein of interest was not studied in lower temperatures or at various time points 
post induction even though lower temperatures (20°C) have been known to support 
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←45 kDa 
←36 kDa 
←29 kDa 
←24 kDa 
 
←20 kDa 
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better growth due to increased solubility of oxygen (Donovan et al., 1996). But since 
the expression of proteins was found to be very significant in the culture conditions 
used in the experiment and no other contaminating proteins were detected, the same 
system was used to obtain stable protein expression. 
 
11.3 Protein expression and purification of B. fragilis proteins CAH06598 and 
CAH09443 
CAH06598 and CAH09443 were extracted, purified using immobilised nickel affinity 
chromatography (Figs 37 and 41, respectively) and run on 12% (w/v) SDS-gels 
(Figs. 38 and 42, respectively) to confirm the proteins of the right molecular weight. 
Further purification of the proteins was performed using gel filtration and fractions 
observed on SDS gels. 
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Figure 37: Nickel column purification of CAH06598 protein. The blue line represents 
the UV absorbance and the peak that appears between 20 and 40 min confirms the 
results from the SDS gels. 
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Figures 38: Nickel column purification results for CAH06598 protein 
  1   2     3    4    5    6     7   8     9 10 
                       
Figure 38.1: 12% (w/v) SDS gel showing purified fractions. Lanes 1, 2, 3, 4, 7, 8, 9 
and 10 shows the presence of a band at 86 kDa indicating the presence of the 
CAH06598 protein which corresponded to the eluted fraction numbers of 26, 27, 28, 
29, 30, 31, 32 and 33 respectively. Lanes 5 and 6 represent the high and low 
molecular weight standards respectively. 
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Figure 38.2: 12% (w/v) SDS gel showing purified fractions. Lanes 1 to 8 shows the 
decrease in intensity of the band at 86 kDa, indicating the presence of the 
CAH06598 protein, as elution continued and represent fraction numbers 34 to 41 
respectively. Lanes 9 and 10 show the high and low molecular weight standards.   
Fractions 34-41 were pooled and concentrated in a 30 kDa cut-off centrifugal 
concentrator and washed into 20 mM HEPES buffer pH 7.4. The concentrated 
protein was then purified using a HiLoad 16/60 Superdex 200 prep grade gel 
filtration column (Fig. 39) and the fractions containing CAH09443 analysed via SDS-
PAGE (Fig. 40).  
Figure 39: Gel filtration graph of CAH06598 protein showing the UV absorbance 
peak. Refer to Appendix section I for details. 
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Figure 40: 12% (w/v) SDS gel showing the gel filtration fractions containing 
CAH06598 protein. Lanes 3, 4, 5, 7, 8, 9 and 10 represent the fractions 14, 15, 16, 
17, 18, 19 and 20 respectively indicating the presence of protein bands at 86 kDa. 
Lane 6 shows the high molecular weight standard.   
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Figure 41:  Nickel column purification results for CAH09443 protein. The blue line 
represents the UV absorbance and the peak that appears between 30 and 40 min 
indicates the elution of the protein at these corresponding fractions.  
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Figure 42: Nickel column purification results for CAH09443 protein (12% (w/v) SDS-
gel). Lanes 2, 3, 4 and 6 represent fractions 34, 36, 38 and 40 respectively showing 
the presence of bands at 74 kDa. Lanes 1, 7, 8, 9 and 10 represent the fractions 31, 
41, 43, 45 and 47 and Lane 5 represents the high molecular weight standard. 
Fractions 34-40 were pooled and concentrated in a 30 kDa cut-off centrifugal 
concentrator and washed into 20 mM HEPES buffer pH 7.4. The concentrated 
protein was then purified using a HiLoad 16/60 Superdex 200 prep grade gel 
filtration column (Fig. 43) and the fractions containing CAH09443 analysed via SDS-
PAGE (Fig. 44). 
 
Figure 43: Gel filtration graph of CAH09443 protein showing the UV absorbance 
peak. Refer to Appendix section I for details. 
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Figure 44: 12% (w/v) SDS gel showing the gel filtration results for CAH09443 
protein. Lanes 1, 2, 3 and 8 show the fractions 10, 12, 13 and 15 respectively and 
Lane 9 and 10 represent the low and high molecular weight standards. Lanes 4 to 7 
represent fractions 17, 19, 21 and 23 which do not show the presence of bands. 
Fractions 10 to 15 were pooled for further concentration. 
 
The purified proteins were concentrated to a volume of 0.5 mL and the concentration 
of protein was estimated using Bradford‟s assay. They were diluted down to a 
concentration of 15 mg/mL from 43 mg/mL (CAH06598) and 29 mg/mL (CAH09443) 
respectively before crystallogenesis. 
The proteins expressed and purified from CAH09443 showed tendencies towards 
precipitation at pH 9 and above. Hence the proteins were maintained in 5 mM 
HEPES buffer at a pH of 7.4. The nickel column purification of recombinant proteins 
from E. coli did not yield good peaks of absorbance at 280 nm in the UV 
chromatograms but strong and well detectable bands were observed on performing 
the SDS-PAGE analysis. The UV chromatogram peaks for GH95 proteins were 
found to be better resolved when compared to CAH09443.  
.  
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11.4 Protein crystallogenesis and diffraction results for B. fragilis CAH06598 
and CAH09443. 
A number of different crystallisation screens were used in the attempt to crystallise 
B. fragilis CAH06598 and CAH09443 proteins. These include PEG/Ion, Hampton 
Screen (HS) I and II, Clear Strategy Screen (CSS) I and II, PEG/Anion, PEG/Cation, 
PEG/pH, SaltRx, Newcastle and Index screens.  
Crystals of CAH06598 proteins were observed in the Peg/Ion screen 3 containing 
0.2 M ammonium fluoride and 20% (w/v) polyethylene glycol (PEG) 3350, CSS II 
screen condition 35 containing 10% PEG 8000, 10% PEG 1000 and 0.2 M Calcium 
acetate, HS I screen condition 20 containing 0.2 M ammonium sulphate, 0.1 M 
sodium acetate pH 4.6 and 25% (w/v) PEG 4000, Newcastle screen condition 1 
containing 50% PEG 400, 0.2 M lithium sulphate and 0.1 M sodium acetate pH 5.1  
and PEG/Anion screen condition 8 containing 0.2 M sodium sulphate and 20% PEG 
3350. But no diffraction was obtained from the crystals of the above mentioned 
conditions. 
The PACT ANION screen number 12 for CAH09443 produced crystals that diffracted 
and the screen was composed of 20% (v/v) PEG 3350 (Polyethylene Glycol) and 
200 mM of sodium malonate. The proteins were buffered in 5 mM HEPES at a pH of 
7.4.  Other conditions that produced crystals include Peg/Ion condition 40 containing 
0.2 M potassium thiocyanate, 0.1 M Bis-tris propane pH 8.5 and 20% PEG 3350, 
PEG/Anion condition 34 containing 0.2 M sodium potassium phosphate, 0.1 M Bis-
tris propane pH 7.5 and 20% PEG 3350 and PEG/Anion condition 22 containing 0.2 
M sodium potassium phosphate, 0.1 M Bis-tris propane pH 6.5 and 20% PEG 3350. 
But unfortunately these crystals did not diffract.  
Crystallisation studies were performed on both the CAH06598 and CAH09443 
protein families but no crystals were detected in CAH06598 that gave a positive 
diffraction pattern. CAH09443, yielded crystals with a positive diffraction pattern in 
the PACT/ANION screen number 12 but when the selenomethionine proteins were 
produced in minimal media, crystals were obtained but did not show a diffraction 
pattern. Attempts were made at growing selenomethionine protein crystals by 
seeding existing crystals into new screen conditions but no detectable crystals were 
observed. 
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11.5 Production, purification and crystallogenesis of a selenomethionine 
derivative for B. fragilis CAH09443 
 A selenomethionine derivative of CAH09443 was expressed, purified (Fig. 45) and 
crystallised but no positive diffraction patterns were obtained from the crystals.  
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Figure 45: Purification results for selenomethionine incorporated CAH09443 
derivative. 
12% (w/v) SDS gels showing the nickel column purification and gel filtration 
purification results for the selenomethionine preparations of CAH09443 respectively.   
 
1     2   3     4    5   6     7    8    9   10                                                             
                                                             
Figure 45.1: 12% (w/v) SDS gel showing the nickel column purification results for 
selenomethionine preparation of CAH09443 protein. Lanes 5 and 6 shows the 
presence of bands at 74 kDa and these were from fractions 41 and 43 and Lanes 1, 
2, 3, 4, 7 and 8 represent fractions 31, 33, 36, 38, 46 respectively. Lanes 9 and 10 
represent low and high molecular weight standard. 
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Figure 45.2: Nickel column purification results for the selenomethionine derivative of 
CAH09443 protein. 
Figure 45.3: Gel filtration graph of CA09443 protein showing the UV absorbance 
peak for the selenomethionine derivative. Refer to Appendix section I for details. 
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Figure 45.4: 12% (w/v) SDS gel showing gel filtration purification results for 
selenomethionine preparation of CAH09443 protein. 
 Lanes 4 to 7 shows the presence of purified fractions and the fraction numbers were 
12, 13, 14 and 15. Lanes 9 and 10 were the low and high molecular weight 
standards and lanes 1 to 3 and 8 represent fractions 9, 10, 11 and 16 respectively.     
 
The gels indicate the presence of bands at the correct molecular weight of 74 kDa. 
 
Crystals were produced on screening using the Newcastle crystal screen condition 
17 containing 40% MPD, 5% PEG 8000 and 0.1 M sodium cacodylate pH 7.0 but did 
not show diffraction. 
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11.6 Structure solution of CAH09443 via molecular replacement  
NB. Structure solution of CAH09443 was performed by Dr Edward Taylor at York 
Structural Biology Laboratory. 
The crystals were found to belong to space group P 2 21 21 with two molecule in the 
asymmetric unit with the approximate cell dimensions of a = 60.33 Å b = 132.82 Å c 
= 163.65 Å (Table 24). The structure was determined via molecular replacement 
using Bacteroides thetaiotaomicron BtGH97b (UniProtKB/TrEMBL entry Q8A6L0) 
structure (PDB code 3A24) as a search model and refined to a resolution of 2.70 Å 
with an R-factor of 0.225 and R-free of 0.296 (Table 24).  
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Data Processing BfGH97 
Space Group (No.) P 2 21 21 (18) 
Unit Cell lengths (Å) a = 60.33 b = 132.82 c = 163.65 
Unit Cell angles (º) α = β =  γ= 90 
Molecules in asymmetric unit 2 
Resolution Range (outer shell)1 81.82- 2.70  (2.85-2.70) 
Rmerge* 0.11   (0.464) 
I >
* 6.3 (15.6 ) 
Completeness* 99.8 (99.7) 
Redundancy* 6.6  (5.7) 
Refinement Statistics  
Resolution Range (Å) 103.13- 2.70 
Rcryst 0.225 
Rfree
2 0.296 
No. protein atoms 9953 
Mean B value protein atoms (Å2) 28.0 
Mean B value solvant atoms (Å2) 29.4 
Ramachandran Statistics3 88.2% preferred regions, 7.5% 
allowed regions, 4.2% outliers 
Table 24: Data collection and refinement statistics for BfGH97 (B. fragilis CAH09443 
protein). Structure figures were drawn with PyMOL (DeLano Scientific 
www.pymol.org). 
1 Numbers in parenthesis correspond to the high resolution outer shell 
2 Estimated Standard Uncertainty, based upon Rfree, calculated using REFMAC 
3 Calculated using Validation options in COOT 
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11.7 Three dimensional structure of CAH09443. 
The tertiary structure of CAH09443 reveals two domains (Fig. 46); an N-terminal β-
super-sandwich domain (in yellow) and a canonical (β/α)8 barrel (in red). This is a 
similar architecture to other GH97 enzymes, specifically the Bacteroides 
thetaiotaomicron α-glucosidase, BtGH97a (Gloster et al., 2008; Kitamura et al., 
2008) and α-galactosidase, BtGH97b (Okuyama et al., 2009). Previous studies in the 
Bacteroides thetaiotomicron GH97 showed that one of the general characteristics of 
GH97 enzymes may be their ability to possess two catalytic residues that act as 
bases at the end of β strands 3 and 5 or a conserved nucleophilic residue at the end 
of the β strand 4 (Refer to Fig. 47 for calcium binding sites of the BtGH97 enzymes) 
(Okuyama et al., 2009). Our enzyme, BfGH97 seems to show the presence of a 
conserved nucleophilic aspartic acid residue at the position 405 which corresponds 
to the position 415 in BtGH97b (Refer to Fig. 48 for details of the ClustalW 
alignment).  
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Figure 46: Structure of CAH09443. Crystal structure of CAH09443 coloured 
according to domains. The N-terminal β-super-sandwich domain is in yellow and a 
canonical (β/α)8 barrel is in red. 
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Figure 47: Figure shows the calcium binding sites in BtGH97a and BtGH97b 
(Okuyama et al., 2009).  
 
11.8 Biochemical assay for CAH06598 and CAH09443. 
CAH06598 was predicted to be a putative uncharacterized protein and CAH09443 
was predicted to be α-glucosidase.  
 
Table 25 shows the presence or absence of activity in fluorescent and chromogenic 
assays for CAH06598 and CAH09443 proteins against methylumbelliferyl and p-
nitrophenyl glycoside substrates, respectively. 
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Substrates used in enzyme 
assay 
B. fragilis CAH06598 
(GH95) 
B. fragilis CAH09443 
(GH97) 
Para nitrophenyl α-D-
glucoside 
- + (18 h incubation) 
Para nitrophenyl α-D-
fucoside 
+ (18 h incubation) - 
Para nitrophenyl α-D-
galactoside 
- + (18 h incubation) 
Para nitrophenyl β-D-
maltoside 
- - 
4-methylumbelliferyl α-D-
glucoside 
- + (2 min incubation) 
4-methylumbelliferyl α-D-
fucoside 
+ (2 min incubation) + (2 min incubation) 
4-methylumbelliferyl β-D-
maltoside 
- - 
Table 25: Determination of the activity of CAH06598 and CAH09443 against a 
variety of para nitrophenyl and methylumbelliferyl substrates at 37°C.  
+ indicates presence of activity 
- indicates absence of activity 
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Two types of enzyme assays were performed to determine the putative activity of the 
enzymes from CAH06598 and CAH09443 which was α-fucosidase and α-
glucosidase respectively. The fluorimetric assays showed activity towards their 
respective substrates but the chromophoric assays did not show positive activity. As 
mentioned in the results section Table number 23, the pNP assay showed a change 
in colour of the reaction mixture when incubated overnight at 37°C but no instant 
reactions or change of colour to yellow was observed. This suggests that the 
reaction occurred at a slower rate in the pNP assay which could probably be 
optimised by changing the concentration of the substrates, enzymes or by modifying 
the reaction conditions. The enzymes were found to be very specific in their 
reactions towards the substrates even though a wide range of substrates were used. 
This also indicates that the fluorescent assays were more sensitive when compared 
to the chromophoric assays. The CAH06598 putative α-fucosidase enzyme exhibited 
activity towards 4-methylumbelliferyl α-D-fucoside and CAH09443 putative α-
glucosidase exhibited activity towards 4-methylumbelliferyl α-D-glucoside indicating 
the specificity of the enzyme in its activity against the substrates used. No assay 
experiments were performed to determine the optimum temperature and pH for the 
activity of the enzymes since positive activity was observed at 37°C and the pH was 
maintained at 7.4 since the CAH09443 enzyme precipitated at higher pH. 
 
α-Glucosidase enzymes are also known as acid maltases, glucoinvertases, 
glucosidosucrases, lysosomal α-glucosidases, maltases and maltase-
glucoamylases. They are capable of hydrolysing terminal, non reducing 1→4 linked 
D-glucose residues resulting in the release of α-D-glucose as an end product. They 
are also known as exo-enzymes because they carry out exohydrolysis of α1→4 
glucosidic linkages and hydrolyse oligosaccharides rapidly. The hydrolysis of 
polysaccharides is comparatively slower and industrial enzymes are capable of 
hydrolysing 1, 6 α-D-glucose linkages in polysaccharides (Hughes et al., 2003).  
These enzymes play an important role in the hydrolysis of complex polysaccharides 
into glucose and act as one of the major factors that contribute to type 2 diabetes. 
Attempts are being made to use acarbose, which is a competitive inhibitor of α-
glucosidase to lower the blood glucose levels in diabetic patients following the 
consumption of food containing carbohydrates (Van de Laar et al., 2005). The 
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enzymes also take part in glycogen metabolism and nutrient uptake of bacteria. They 
catalyse the transglycosylation of α-D-glucose moieties and are industrially useful in 
the biosynthesis of oligosaccharides or glycoconjugates (Shirai et al., 2008). 
 
 
11.9 Future work 
Further experiments could be performed to generate a catalytic mutant of CAH09443 
that lacks the putative acid catalyst, Asp404. This amino acid residue has been 
identified to be the acid catalyst as it aligns with the acid catalyst, Asp415 of the α-
galactosidase, BtGH97b, from Bacteroides thetaiotaomicron (Fig. 47). Once the 
mutant is generated, its structure can be solved in the presence of substrate, 
therefore providing additional structural data with respect to enzyme-substrate 
interactions. 
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gi|60494642|emb|CAH09443.1|      MKRKMMSLLLALAVISGSSVYAKVIDVMSPNGAIKVSVDIKDRIYYSVSY 50 
gi|29339180|gb|AAO76978.1|       MKKLTFLLLCVLCTLS--LQAQKQFTLASPDGNLKTTITIGDRLTYDITC 48 
                                 **:  : ** .*..:*      * : : **:* :*.:: * **: *.::  
 
gi|60494642|emb|CAH09443.1|      DNDQLLKDCYLNLQLQN-ETLGTNPHLRSTKRGTIDESVKREIPFKNAIV 99 
gi|29339180|gb|AAO76978.1|       NGRQILTPSPISMTLDNGTVWGENAKLSGTSRKSVDEMIPSPF-YRASEL 97 
                                 :. *:*. . :.: *:*  . * *.:* .*.* ::** :   : :: : : 
 
gi|60494642|emb|CAH09443.1|      RNHCNTLRMNFSGNYAVEFRVFDNGIAYRFVTDKKGDNIVMGEDFAINFP 149 
gi|29339180|gb|AAO76978.1|       RNHYNGLTLRFKKDWNVEFRAYNDGIAYRFVNQGKKPFRVVTEVSDYCFP 147 
                                 *** * * :.*. :: ****.:::*******.: *    *: *     ** 
 
gi|60494642|emb|CAH09443.1|      TNYKAHL----SQPDG-----FKTSYECPYTHVDTEKYAATDRMSYLPVL 190 
gi|29339180|gb|AAO76978.1|       SDMTASVPYVKSGKDGDYNSQFFNSFENTYTTDKLSKLNK-QRLMFLPLV 196 
                                 :: .* :    *  **     * .*:* .**  . .*    :*: :**:: 
 
gi|60494642|emb|CAH09443.1|      IETDKAYKILISEADLSDYPCMFLKSTG----KNGMQSIFPKAPLAFGED 236 
gi|29339180|gb|AAO76978.1|       VDAGDGVKVCITESDLENYPGLYLSASEGANRLSSMHAPYPKRTVQGGHN 246 
                                 :::... *: *:*:**.:** ::*.::      ..*:: :** .:  *.: 
 
gi|60494642|emb|CAH09443.1|      GDRSLKITEEADYIAKTDGKRSFPWRMMVISKEDKELIENEMVYNLSAPC 286 
gi|29339180|gb|AAO76978.1|       -QLQMLVKEHEDYIAKVDKPRNFPWRIAVVTTTDKDLAATNLSYLLGAPS 295 
                                  : .: :.*. *****.*  *.****: *::. **:*  .:: * *.**. 
 
gi|60494642|emb|CAH09443.1|      VLEDYSWIKPGQVSWEWWHDARLYGVDFRSGFNMDSYKYYIDFASKFGIP 336 
gi|29339180|gb|AAO76978.1|       RMSDLSWIKPGKVAWDWWNDWNLDGVDFVTGVNNPTYKAYIDFASANGIE 345 
                                  :.* ******:*:*:**:* .* **** :*.*  :** ******  **  
 
gi|60494642|emb|CAH09443.1|      YIIMDEGWAKNTR-DPFTPNPTINLTELIKYGKDRNVKIVLWLPWLTVEN 385 
gi|29339180|gb|AAO76978.1|       YVILDEGWAVNLQADLMQVVKEIDLKELVDYAASKNVGIILWAGYHAFER 395 
                                 *:*:***** * : * :     *:*.**:.*. .:** *:**  : :.*. 
 
gi|60494642|emb|CAH09443.1|      HFD-LFKTFADWGIAGVKIDFMDRSDQWMVNYYERVAKEAAKHKLFVDFH 434 
gi|29339180|gb|AAO76978.1|       DMENVCRHYAEMGVKGFKVDFMDRDDQEMTAFNYRAAEMCAKYKLILDLH 445 
                                 .:: : : :*: *: *.*:*****.** *. :  *.*: .**:**::*:* 
 
gi|60494642|emb|CAH09443.1|      GAFKPAGLERKYPNVLSYEGVLGMEQGGNCKP-----ENSIYLPFMRNAV 479 
gi|29339180|gb|AAO76978.1|       GTHKPAGLNRTYPNVLNFEGVNGLEQMKWSSPSVDQVKYDVMIPFIRQVS 495 
                                 *:.*****:*.*****.:*** *:**   ..*     : .: :**:*:.  
 
gi|60494642|emb|CAH09443.1|      GPMDFTPGSMISAQPEDNRSTRANAMGSGTRAFQMALFIIFESGLQMLAD 529 
gi|29339180|gb|AAO76978.1|       GPMDYTQGAMRNASKGNYYPCYSEPMSQGTRCRQLALYVVFESPFNMLCD 545 
                                 ****:* *:* .*.  :  .  ::.*..***. *:**:::*** ::**.* 
 
gi|60494642|emb|CAH09443.1|      NPVYYYRELPCTEFITSVPVTWDETKVLYAKVGEAVVVAKRKGEQWFIGG 579 
gi|29339180|gb|AAO76978.1|       TPSNYMREPESTAFIAEIPTVWDESIVLDGKMGEYIVTARRKGDVWYVGG 595 
                                 .*  * **  .* **:.:*..***: ** .*:** :*.*:***: *::** 
 
gi|60494642|emb|CAH09443.1|      ITGNQPQNIEIDLGFIPAGQSFTLTSFEDGINADRQAMDYKKKESTVNNQ 629 
gi|29339180|gb|AAO76978.1|       ITDWSARDIEVDCSFLGD-KSYHATLFKDGVNAHRAGRDYKCESFPIKKD 644 
                                 **. ..::**:* .*:   :*:  * *:**:**.* . *** :. .:::: 
 
gi|60494642|emb|CAH09443.1|      TRMTLKMVRNGGWAGTIKMK 649 
gi|29339180|gb|AAO76978.1|       GKLKVHLAPGGGFALKIK-- 662 
                                  ::.:::. .**:* .**   
 
                                    
 
Figure 48: Sequence alignment (of the CAH09443 amino acid residues and the 
AA076978 residues of BtGH97b showing the conserved aspartic acid residue 
(emboldened and underlined) positioned at 415 and 404 respectively using 
ClustalW). (http://www.ebi.ac.uk/Tools/clustalw2/index.html). 
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APPENDICES 
Appendix A- Chemicals, media and enzymes 
 
This section of the Appendix contains a list of the chemicals, enzymes and media 
used in the study. 
A1 Chemicals used in the study 
Acros 
Lactose 
p-aminobenzoic acid 
Cysteine 
Imidazole 
Iodoacetamide 
Monosodium phosphate 
Duchefa 
Ethylenediaminetetraacetic acid disodium salt 
Fisher BioReagents 
Acrylamide/Bisacrylamide 37.5:1 40% solution 
Brilliant blue G-250 
Coomassie Blue R-250 
Methanol 
Fisher chemicals 
Acetic acid, glacial 
Acetone 
Acetonitrile 
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Ammonium bicarbonate 
Ammonium sulphate 
Ethanol 
Glycerol 
D-(+)-Glucose 
Ammonium per sulphate 
N,N,N‟,N‟-tetra methylethylene diamine (TEMED) 
Phosphoric acid 
Potassium dihydrogen phosphate 
Propan-2-ol 
Dipotassium hydrogen phosphate 
Sodium carbonate 
Sodium hydroxide 
Sodium tetraborate 
Melford 
Agarose (High gel strength) 
Dithiothreitol 
Glycine 
N-[2-hydroxyethylpiperazine-N‟-[2-ethanesulphonic acid] (HEPES) 
Isopropyl-β-D-thiogalactopyranoside 
Kanamycin 
Sodium chloride 
Sodium dodecyl sulphate 
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Tris [Hydroxymethyl] aminomethane (Tris-HCl) 
Urea 
Promega 
Trypsin Gold 
Riedel-deHaen 
Hydrochloric acid 
Sulphuric acid 
Sigma 
L-Aspartic acid 
Ammonium sulphate 
Bovine serum albumin (BSA) 
Bromophenol blue 
CHAPS 
Citric acid 
Dipotassium phosphate 
Ethidium bromide 
Ferrous sulphate 
Magnesium sulphate 
Magnesium chloride 
β-mercaptoethanol 
Pantothenic acid 
Potassium chloride 
Xylene cyanol 
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Potassium monophosphate monobasic 
Phenol 
Resazurin 
Riboflavin 
Sodium acetate 
Sodium chloride 
Sodium hydroxide 
Sodium sulphite 
Calcium chloride 
Cobalt chloride 
Cupric chloride 
Manganese chloride 
Nickel (II) chloride 
Barium chloride 
Strontium chloride 
Zinc chloride 
Bradfords reagent 
Porcine gastric Mucin Type II 
Porcine gastric mucin Type III 
Media: 
Oxoid 
Agar (Bacteriological agar N° 1) 
NZ amine (casein hydrolysate) 
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Tryptone 
Yeast extract 
Columbia Agar base 
Anaerobic CO2 generation compact [CO2 Gen
TM (Atmosphere Generation System)] 
Difco 
Casitone (Bactopeptone) 
BactAlertTN Anaerobic Basal media 
Hampton Research 
Aquasil 
Amino acids and vitamins used in media: 
Acros Sigma  Fisher 
Scientific 
BDH Aldrich 
L-alanine L-arginine L-lysine 4-
aminobenzoic 
acid 
Isoleucine 
L-aspartic acid Ascorbic acid  L(-)- Proline L-tryptophan 
L-glutamic acid L-asparagine    
Pyridoxine Folic acid    
Riboflavin Glutamine    
L-serine D(+) Biotin    
L-threonine L-histidine    
L-valine L-leucine    
 Niacinamide    
 Nicotinic acid    
 L-
phenylalanine 
   
 L-tyrosine    
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Crystallisation chemicals: 
Ammonium acetate- Fisher chemicals 
Ammonium chloride- Fisher 
Tri ammonium citrate- Fisher 
Ammonium citrate dibasic- Sigma 
Ammonium formate- Acros 
Ammonium fluoride- Sigma 
Ammonium dihydrogen orthophosphate- Fisher 
Ammonium nitrate- Fisher 
Ammonium sulphate- Sigma 
Ammonium tartrate dibasic- Sigma 
Bicine- Acros 
Bis-Tris- Melford 
Bis-Tris propane- Sigma 
1, 4- Butanediol- Acros 
Caesium chloride- Fisher  
Calcium acetate (dried) - Fisher 
Calcium chloride hexahydrate- Fisher 
CAPS free acid- Melford 
CHES- Melford 
Citric acid- Fisher 
Cobalt (II) chloride- Fisher 
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1, 4- Dioxane- Fisher 
Diammonium hydrogen citrate- Fisher 
HEPES, free acid- Melford 
Hexadecyl trimethyl ammonium bromide- Sigma 
1, 6- Hexanediol- Acros, Fisher 
Jeffamine- Fluka 
Imidazole (GPG) – Fisher 
Iron (II) chloride- Fisher 
DL-Malic acid- Fisher 
Tertiary butyl alcohol- Fisher 
Barbitone sodium- BDH 
Barium chloride- Sigma 
Calcium sulphate- Fisher 
Cadmium chloride- Acros 
Ethylene glycol- Fisher 
Formaldehyde (40%) – BDH 
Formamide- BDH 
Lithium acetate dehydrate- Acros 
Lithium chloride anhydrous- Fisher 
Lithium sulphate- Fisher 
Magnesium acetate- Sigma 
Magnesium chloride- Fisher 
Magnesium formate dehydrate- Fluka 
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Magnesium nitrate- Fisher 
Magnesium sulphate- Fisher 
MES- Fisher 
2-methyl-1, 2- pentanediol- Acros 
Nickel (II) chloride- Fisone 
Nickel chloride hexahydrate- sigma 
Nickel sulphate- BDH 
Nickel (II) sulphate hexahydrate- Sigma 
Pentaerythritol ethoxylate- Aldrich 
Phenylmethyl sulfonyl fluoride- Sigma 
Poly (acrylic acid) – Acros 
Polyethylene glycol- Fluka 
Polyethylene glycol 4000 grade- Fisher 
Polyethylene glycol 6000 grade- Fisher 
Potassium dichromate-Melford 
Potassium hydrogen tartrate- Fisher 
Potassium iodide- Fisone 
Sodium cacodylate trihydrate- Fisher 
Sodium cyanoborohydride- Sigma 
Thiomersal- BDH 
Tri-lithium citrate tetrahydrate- Fluka 
Sodium chloride- Fisher 
Potassium thiocyanate- Fisher 
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Sodium acetate trihydrate- Fisher 
Potassium-dihydrogen orthophosphate- Fisher 
Potassium nitrate- Fisher 
Sodium formate- Fisher 
Potassium chloride- Fisher 
Potassium iodide- Fisher 
Sodium sulphate anhydrous- Fisher 
Zinc acetate- Fisher 
Sodium thiocyanate dehydrate- Fisher 
Tri-sodium citrate- Fisher 
Potassium sulphate- Fisher 
Sodium selenite- Sigma 
Polyethylenimine- Sigma 
Zinc sulphate- Fisher 
di- sodium tetraborate- Fisher 
Succinic acid- Fisher 
Potassium bromide- Fisher 
Di-sodium hydrogen orthophosphate dodecahydrate- Fisher 
Sodium nitrate- Fisher 
Sodium bromide- Fisher 
Sodium fluoride- Fisher 
Zinc chloride- Fisher 
Sodium succinate- Fisher 
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Tri-sodium citrate- Fisher 
Potassium sodium tartrate- Fisher 
Trimethylamine N-oxide dehydrate- Acros 
Tri potassium citrate- Fisher 
Tris Base Ultrapure- Melford 
Sodium propionate- Fisher 
Polyvinyl pyrrolidone K15- Fluka 
Sodium dihydrogen orthophosphate dehydrate- Fisher 
Sodium tartrate- Fisher 
Potassium formate- Fluka 
Potassium fluoride anhydrous- Fluka 
Potassium acetate- Fisher 
Sodium selenite- Fisher 
Sodium acetate trihydrate- Fisher 
Di-potassium hydrogen orthophosphate- Fisher 
Polyethylene glycol 20000- Fluka 
Polyethylene glycol 5000 monomethyl ether- Fluka 
Propan-2-ol- BDH 
Polypropylene glycol 2000 grade- Fisher 
Porpane-1, 2- diol- Fisher 
Propylene glycol 400- Fluka 
Pentaerythritol propoxylate- Aldrich 
Polyethylene glycol 8000- Fisher 
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Polyethylene glycol 400 grade- Fisher 
Polyethylene glycol 600 grade- Fisher 
Polyethylene glycol 1000 grade- Fisher 
Polyethylene glycol- Sigma 
Polyethylene glycol 3000- Fluka 
2-Ethoxyethanol- Fisher 
Polyethylene glycol 200 grade- Fisher 
Polyethylene glycol 300- Sigma 
Glycerol- Fisher 
Polyethylene glycol 2000 monomethyl ether- Fluka. 
 
A2  Recipe for buffers used in the cloning experiment 
Taq reaction buffer (10 X) 
Tris pH 8.4   200 mM 
KCl    500 mM 
MgCl2    50 mM 
 
T4 DNA polymerase reaction buffer (10 X) 
Tris- HCl pH 8.8  67 mM 
MgCl2    6.7 mM 
(NH4)2SO4   16.6 mM 
β mercaptoethanol  10 mM 
EDTA    6.7 µM 
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BSA    170 µg/mL 
 
KOD polymerase reaction buffer (10 X) 
Tris HCl pH 7.5 at 25°C  20 mM 
MgCl2     8 mM 
DTT     7.5 mM 
BSA      50 µg/mL 
 
NE Buffer 2 (1 X) 
NaCl     50 mM 
Tris-HCl pH 7.9 at 25°C  10 mM 
MgCl2     10 mM 
DTT     1 mM 
The buffer is supplied at a 10 X concentration. 
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Appendix B  
Lab Equipment 
 
Autoclaving 
A benchtop Prestige® Medical 2100 Classic autoclave was used to sterilise solutions 
at 121°C, 32 lb/inch2 pressure for 20 min. 
 
pH meter 
pH of solutions were adjusted to the required values using a Jenway Ion Meter 3340 
calibrated with the standard buffer values of pH 4.0, 7.0 and 9.2. 
 
Spectrophotometer 
The Cecil 2000 Series Spectrophotometer was used to determine the cell density of 
cultures of bacteria at various stages of growth. The wavelength was set to 660 nm 
for bacterial cultures and 420 nm for determining the optical density of Bradford 
assay reaction mixtures.  
The Hitach Fluorescence Spectrophotometer was used to determine the enzyme 
activity against methylumbelliferone substrates. The excitation wavelength was set at 
360 nm and the emission wavelength was set at 460 nm. 
 
Incubators 
A Gallenkamp orbital shaker was used to grow liquid bacterial cultures and a 
Gallenkamp static incubator was used to grow bacteria on solid media. The...... 
anaerobic chamber was used to grow bacteria anaerobically at 37°C. The static 
incubator maintained a stable anaerobic environment by being flushed with a mixture 
of 10% carbon-di-oxide gas, 80% nitrogen gas and 10% hydrogen gas.  
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Freeze drier 
The trypsinised protein samples containing digested peptides were lyophilised using 
the Christ® Alpha 1-2 freeze drier. 
 
Centrifugation 
The Sigma* 1-15 bench top microcentrifuge was used to centrifuge samples of upto 
1.5 ml in volume. The Sigma 3K18C refrigerated bench top centrifuge was used to 
centrifuge larger volumes of cultures or solutions (>1.5 ml). The rotors used have 
been detailed as follows: 
 The rotor number 11133 was used to harvest cells at 4000 xg in clay universal 
holders (part No. 17049, 25 ml plastic universals were used), concentrate proteins at 
4000 xg in 30 kDa cut off protein concentrators which were inserted into clay 
universal holders (part No. 17049). The rotor number 12158 was used to separate 
soluble cell extract from lysed cells at 14000 xg in 30 ml plastic centrifuge tubes (part 
No. 31190030). The rotor number 12131 was used to isolate DNA from the Qiagen 
kit and to extract proteins from lysed cells by centrifuging at 14000 xg in 1.5 ml 
microcentrifuge tubes. 
 
Sonication 
The MSE Soniprep 150-ultrasonication machine was used to lyse cells. 
 
Protein purification 
Large scale purification of proteins was carried out using an AKTA prime and the 
FPLC system which was controlled by Prime View Software. 
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PCR machine 
Eppendorf MasterCyclerTM PCR machine was used to perform all the PCR reactions. 
 
Electroporator 
A Bio-Rad Gene Pulser XcellTM with an attached Bio-Rad Pc and CE module was 
used for the transformation of electrocompetent cells. The Bio-Rad ShockPodTM was 
used to place the cuvettes. 
 
Agarose gel kits 
Owl Scientific EASY-CAST electrophoresis system was used for the electrophoresis 
of DNA and the power supply was an E-C 570-90 E-C Apparatus Corporation power 
pack. 
 
2D Clean up kit from Amersham Biosciences 
The solutions used in the Clean up kit include the precipitant solution which was 
used to in solubilise proteins, the co-precipitant solution which worked with the 
precipitant solution in enhancing the precipitation of proteins, the wash buffer to get 
rid of non protein contaminants and the wash additive to facilitate rapid and complete 
resuspension of the proteins in the solution. Due to trade reasons, the company 
have not revealed the exact composition of these solutions. 
 
SDS-PAGE gel kits for small gels 
A Bio-Rad Mini-PROTEAN 3 Cell kit was used for the electrophoresis of proteins and 
the same E-C 570-90 E-C Apparatus corporation power pack was used. 
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SDS-PAGE kit for 2D analysis of large gels 
Protean II XL 2-D cells and accessories were used to perform the electrophoresis.  
The kit included a tank and a lid, a central cooling core unit, casting stand, sandwich 
clamps, alignment card and combs. The accessories provided include a 4 mm xi 
clamp notch vs. 13 mm XL clamp notch, 19 mm xi spacer vs. 8 mm XL spacer, 181 
mm xi core gasket vs. 198 mm XL core gasket and a 153 mm xi comb vs. 184 mm 
XL comb. 
The molecular biology kits used in the study include the Qiagen Miniprep kit for the 
purification of recombinant plasmids, the Qiagen Maxiprep kit for the large scale 
preparation of cloning vectors, the Qiagen Qiaquick gel extraction kit for the 
purification of DNA from agarose gels and the Qiagen DNeasy kit for the purification 
of genomic DNA. 
 
Immobiline DryStrip Kit 
ImmobilineTM DryStrip gels of pH range 4-7 and 3-10 were ordered as a part of the 
electrophoresis kit. The other parts include the electrodes (anode and cathode), try 
and electrode holder, DryStrip aligners, IEF electrode strips and the Bio-Rad power 
pack 200 and Universal power supply pack for protein and nucleic acid 
electrophoresis. 
 
Gel Documentation 
The Quantity OneTM software in the Bio-Rad Gel Doc 2000 system was used to 
visualise the agarose gels. The Bio-Rad GS-800 densitometer was used to visualise 
SDS-PAGE gels.  Hard copies of the gel were obtained using the Mitsubishi Video 
Copy Processor (Model P91) with Mitsubishi thermal paper (K65HM-CE/High density 
type, 110 mm X 21 m). 
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Gel spot analysis 
The spots on the gels were compared and analysed using the Advanced PDQuestTM 
8.0 software in the Bio-Rad Gel Doc 2000 system. 
 
LC-MS analysis 
The Ultimate 3000 Dionex LC system was used to separate the peptide fragments 
before Mass spectrometric analysis. The LC system was equipped with a vaccum 
degasser, a UV cell compartment, flow manager, column compartment fitted with an 
oven maintained at 60°C and the autosampler system with a multiwell sample 
microtitre plate. 
 
Mass spectrometric analysis 
The peptides of interest were identified using the Bruker Daltonics ESI-ion trap Mass 
spectrometer equipped with the Esquire series, Hystar sample processing, 
Chromeleon LC system and the Biotools software for Mascot database searches.  
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Appendix C 
Vectors used in the cloning experiment 
The vector used in cloning was pET-YSBLIC  
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Appendix D 
Protein and DNA size standards 
Proteins Molecular 
weight 
High range 
(S8320) 
Wide 
range 
(S8445) 
Low range 
(M3913) 
Myosin from rabbit 
muscle 
200000  X X  
Β-galactosidase from E. 
coli 
116000 X X  
Phosphorylase b from 
rabbit muscle 
97000 X X  
Albumin, bovine serum 66000 X X X 
Glutamic 
dehydrogenase from 
bovine liver 
55000 X X  
Ovalbumin from chicken 
egg 
45000 X X X 
Glyceraldehyde-3-
phosphate 
dehydrogenase from 
rabbit muscle 
36000 X X X 
Carbonic anhydrase 
from bovine 
erythrocytes 
29000  X X 
Trypsinogen from 
bovine pancreas 
24000  X X 
Trypsin inhibitor from 
soyabean 
20000  X X 
α-lactalbumin from 
bovine milk  
14200  X X 
Aprotinin from bovine 
lung 
6500  X X 
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High and low molecular weight markers for SDS PAGE gels 
 
NEB 1 kb Ladder used to determine the mass of the DNA fragments. 
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Bioline hyperladder I used as a size standard for agarose gel electrophoresis. 
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Table 5: Growth of E. cancerogenus in control media without mucin 
 
 
 
 
 
Time in 
h 
Absorbance 
at 600 nm- 
Experiment 1 
Absorbance 
at 600 nm- 
Experiment 2 
Absorbance 
at 600 nm- 
Experiment 3 
Average 
absorbance 
at 600 nm 
0 0 0 0 0 
2 0.081 0.083 0.087 0.083667 
3 0.416 0.58 0.55 0.515333 
4 0.789 0.882 0.831 0.834 
5 1.156 1.288 1.186 1.21 
6 1.386 1.415 1.306 1.369 
7 1.412 1.426 1.364 1.400667 
8 1.434 1.445 1.474 1.451 
 Appendix E 
 Growth curve data for E. cancerogenus and B. fragilis 
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Time 
in h 
Absorbance 
at 600 nm- 
Experiment 4 
Absorbance 
at 600 nm- 
Experiment 5 
Absorbance at 
600 nm- 
Experiment 6 
Average 
absorbance at 
600 nm 
0 0 0 0 0 
2 0.053 0.076 0.108 0.079 
3 0.21 0.256 0.257 0.241 
4 0.931 0.794 0.786 0.837 
5 1.264 1.132 1.188 1.194667 
6 1.38 1.31 1.256 1.315333 
7 1.392 1.370 1.376 1.379333 
8 1.396 1.350 1.386 1.377333 
Table 6: Growth of E. cancerogenus in media enriched with mucin Type II 
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Time 
in h 
Absorbance at 
600 nm- 
Experiment 7 
Absorbance 
at 600 nm- 
Experiment 8 
Absorbance 
at 600 nm- 
Experiment 9 
Average 
absorbance 
at 600 nm 
0 0 0 0 0 
2 0.104 0.107 0.072 0.094333 
3 0.31 0.292 0.280 0.294 
4 0.901 0.897 0.807 0.868333 
5 1.106 1.116 1.152 1.124667 
6 1.186 1.242 1.264 1.230667 
7 1.208 1.144 1.2 1.184 
8 1.188 1.156 1.204 1.182667 
Table 7: Growth of E. cancerogenus in media with mucin Type III 
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Time 
in h 
Absorbance at 
600 nm- 
Experiment 10 
Absorbance at 
600 nm- 
Experiment 11 
Absorbance at 
600 nm- 
Experiment 12 
Average 
absorbance at 
600 nm 
0 0 0 0 0 
4 0.067 
 
0.087 
 
0.059 
 
0.071 
 
6 0.112 0.1 0.158 0.123333 
21 0.313 0.286 0.307 0.302 
22 0.439 0.383 0.426 0.416 
23 0.748 0.596 0.619 0.654333 
24 1.004 0.909 0.93 0.947667 
25 1.018 1.052 1.069 1.046333 
26 1.394 1.298 1.243 1.311667 
27 1.526 1.483 1.418 1.475667 
28 1.556 1.552 1.512 1.54 
29 1.488 1.418 1.385 1.430333 
30 1.452 1.448 1.422 1.440667 
31 1.475 1.466 1.486 1.475667 
46 1.402 1.412 1.423 1.412333 
47 1.328 1.396 1.404 1.376 
Table 8: Growth of B. fragilis in control media without mucin 
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Time 
in h 
Absorbance at 
600 nm- 
Experiment 13 
Absorbance at 
600 nm- 
Experiment 14 
Absorbance at 
600 nm- 
Experiment 15 
Average 
absorbance 
at 600 nm 
0 0 
 
 
0 
 
 
0 
 
0 
 
4 0.012 0.018 0.015 0.015 
6 0.05 0.041 0.045 0.045333 
21 0.098 0.106 0.102 0.102 
22 0.206 0.236 0.226 0.222667 
23 0.34 0.358 0.36 0.352667 
24 0.397 0.412 0.422 0.410333 
25 0.532 0.622 0.603 0.585667 
26 0.718 0.814 0.798 0.776667 
27 0.922 1.039 0.956 0.972333 
28 1.294 1.334 1.306 1.311333 
29 1.433 1.461 1.457 1.450333 
30 1.359 1.398 1.405 1.387333 
31 1.382 1.368 1.393 1.381 
46 1.401 1.387 1.384 1.390667 
47 1.385 1.355 1.376 1.372 
Table 9: Growth of B. fragilis in media with mucin Type II 
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Time 
in h 
Absorbance at 
600 nm- 
Experiment 16 
Absorbance at 
600 nm- 
Experiment 17 
Absorbance at 
600 nm- 
Experiment 18 
Average 
absorbance 
at 600 nm 
0 0 
 
0 0 0 
4 0.029 0.023 0.019 0.023667 
6 0.063 0.052 0.058 0.057667 
21 0.165 0.158 0.162 0.161667 
22 0.384 0.4 0.391 0.391667 
23 0.598 0.675 0.656 0.643 
24 0.738 0.842 0.823 0.801 
25 1.012 1.058 1.035 1.035 
26 1.328 1.338 1.332 1.332667 
27 1.438 1.463 1.457 1.452667 
28 1.402 1.417 1.423 1.414 
29 1.334 1.393 1.404 1.377 
30 1.374 1.355 1.369 1.366 
31 1.348 1.382 1.375 1.368333 
46 1.368 1.376 1.36 1.368 
47 1.284 1.318 1.307 1.303 
Table 10: Growth of B. fragilis in media with mucin Type III 
 
 
E1  Resazurin test method  
A 0.001% resazurin solution was prepared by dissolving 1 mg of resazurin and 2 g of 
cysteine-HCl in sterile 18.2 MΩ/cm making it up to 100 ml. The solution was 
aliquoted into 5 ml quantities and used as indicators. The resazurin strips or 
solutions were pink to purple in the presence of oxygen and gradually turn colourless 
when left in an environment lacking oxygen. This was normally used as a test to 
confirm the absence of oxygen in the bacterial growth environment. 
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Appendix F- Analysis data for 2DE gels 
 
F1 Gel analysis data for E. cancerogenus and B. fragilis using Bio-Rad 
PDQuest software  
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„Protbf 1‟ Average quantities of differentially expressed spots in three different 
growth conditions. Red bars indicate non-mucin media, Green bars- mucin Type II 
enriched media, Brown bars- mucin Type III enriched media. 
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„Protbf 1‟ Protein quantities in individual gels of differentially expressed spots in 
three different growth conditions. Red bars indicate non-mucin media, Green 
bars- mucin Type II enriched media, Brown bars- mucin Type III enriched media. 
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„Proteomics 3‟ Average quantities of differentially expressed spots in three different 
growth conditions. Red bars indicate non-mucin media, Green bars- mucin Type II 
enriched media, Brown bars- mucin Type III enriched media. 
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„Proteomics 3‟  Protein quantities in individual gels of differentially expressed 
spots in three different growth conditions. Red bars indicate non-mucin 
media, Green bars- mucin Type II enriched media, Brown bars- mucin Type 
III enriched media. 
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F2 Gel analysis data for E. cancerogenus and B. fragilis using Ludesi Redfin 
software  
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F3 Gel analysis data for E. cancerogenus and B. fragilis using NonLinear 
Dynamics SameSpots software 
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Appendix G 
G1  Details on MS analysis 
 Bruker Daltonics Mass spectrometer that worked based on the principle of 
electrospray ionisation was used for fragmenting, ionising and identifying peptides 
from the protein spots of interest. The liquid sample which passed through an emitter 
was ionised to form a liquid jet under high voltage electricity. The liquid then radially 
dispersed to form small and highly charged liquid droplets due to Coulomb repulsion. 
Following nebulisation, the ions were dried and desorbed under the influence of the 
same high potential electrostatic field. 
 
The generation of ions 
The three important steps in the generation of ions were nebulisation, desolvation 
and ion evaporation. The sample containing the trypsinised proteins was first 
separated using the LC column in the Dionex Ultimate 3000 system and the droplets 
were fed into the mass spectrometer through the needle at a flow rate of 3 µL/min. 
The droplets enter the spray chamber from the tip of the needle where the force of 
Coulomb repulsion exceeds the surface tension causing the droplets to explode into 
smaller droplets that undergo evaporation. During the process of evaporation, the 
droplets become highly charged and get ionised. When the surface tension on the 
surface of the droplets is exceeded by the ionic field, ions are emitted into the gas 
phase. Peptides containing amino acids either accept or donate protons based on 
their charge. A similar effect can be observed in the buffers and solvents that also 
ionise in the presence of an electric field. pH of the buffers and solvents can have a 
great effect on the peptide signals detected.  The ionisation process can also be 
affected by the conductivity of solutions and their flow rate.  
 
Parts of the Ion trap mass spectrometer 
The spray shield forms a protective covering that prevents the deposition of 
contaminants, buffer salts and other impurities. The transfer capillary plays an 
important role in the declustering and desolvation of ions. It acts as the first barrier in 
the vaccum system. The skimmer forms the main part of the next vaccum stage 
where it helps to remove dried gas and other solvent molecules. The ions that pass 
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through the transfer capillary and the skimmer enter the dual octopoles that focus, 
slow down or accelerate them for efficient ion trapping.  
 
Ion trap system 
The first step in the trapping of ions involves the generation of a potential well which 
acts as the site for accumulation of ions. The end cap generates a repelling potential 
that enhances the trapping efficiency. The ions collide with helium thereby slowing 
them down and oscillating around the centre of the trap. The ions focussed in the 
centre of the trap are ejected by applying an increased RF amplitude and auxillary 
RF which cause each m/z to come into resonance. The ions accumulated in the 3D 
multipolar field were ejected by increasing the RF amplitudes and the response was 
measured at the detector. 
The conversion dynode emitted electrons when hit by ions. These electrons were 
accelerated onto an electron multiplier that converted the electrons into a resulting 
current that was measured as the MS spectrum. 
 
Gases used in Ion traps 
One rough pump and two turbomolecular pumps were used to create four stages of 
vaccum within the system (Refer to drawing). Helium gas was used for cooling the 
ions during trapping and also as a collision gas for fragmentation. Nitrogen gas was 
used generally for keeping the system clean, nebulising samples and drying liquid 
droplets. 
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G2 Mass spectrometric analysis data for differentially expressed spots E. 
cancerogenus 
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G3 Mass spectrometric analysis data for differentially expressed spots B. 
fragilis 
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G4 Blast analysis results for hypothetical proteins BF2494, BF1203 and 
BF0301 in B. fragilis 
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H Crystal screen compositions
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1 50% (w/v) PEG 400 0.2 M Lithium Sulphate 0.1 M Sodium acetate pH 5.1  
2 20% (w/v) PEG 3000 0.1 M Sodium citrate 
pH 5.5 
  
3 20% (w/v) PEG 3350 0.2 M Diammonium 
hydrogen citrate pH 
5.0 
  
4 30% (v/v) MPD 0.08 M Calcium 
chloride 
0.1 M Sodium acetate pH 4.6  
5 20% (w/v) PEG 3350 0.2 M Magnesium 
formate pH 5.9 
  
6 20% (w/v) PEG 1000 0.2 M lithium sulphate 0.25 M Sodiumcitrate pH 4.2 0.25 M sodium dihydrogen phosphate 
pH 5.2 
7 20% (w/v) PEG 8000 0.1M CHES pH 9.5   
8 20% (w/v) PEG 3350 0.2 M Ammonium 
formate pH6.6 
  
9 20% (w/v) PEG 3350 0.2 M Ammonium 
chloride pH 6.3 
  
10 20% (w/v) PEG 3350 0.2 M Potassium 
formate pH 7.3 
  
11 50% (v/v) MPD 0.2 M Ammonium 
dihydrogen phosphate 
0.1M Tris pH 8.5  
12 20% (w/v) PEG 3350 0.2 M Potassium 
nitrate pH 6.9 
  
13 0.8 M Ammonium 
sulphate 
0.1M Citric acid pH 4.0   
14 20% (w/v) PEG 3350 0.2 M Sodium   
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thiocyanate pH 6.9 
15 20% (w/v) PEG 6000 0.1M Bicine pH 9.0   
16 10% (w/v) PEG 8000 8% (v/v) Ethylene 
glycol 
0.1 M HEPES pH 7.5  
17 40% (v/v) MPD 5% (w/v) PEG 8000 0.1M Sodium cacodylate pH 7.0  
18 40% (v/v) Ethanol 5% (w/v) PEG 1000 0.25 M Sodium citrate pH 5.2 0.25 M Sodium dihydrogen phosphate 
pH 5.2 
19 8% (w/v) PEG 4000 0.1M Sodium acetate 
pH 4.6 
  
20 10% (w/v) PEG 8000 0.2 M Magnesium 
chloride 
0.1 M Tris pH 7.0  
21 20% (w/v) PEG 6000 0.1M Citric acid pH 5.0   
22 50% (w/v) PEG 200 0.2 M Magnesium 
chloride 
0.1 M Sodium cacodylate pH 6.6  
23 1.6 M Sodium citrate 
pH 6.5 
   
24 20% (w/v) PEG 3350 0.2 M Potassium 
citrate pH 8.3 
  
25 30% (v/v) MPD 0.02 M Calcium 
chloride  
0.1M Sodium acetate pH 4.6  
26 20% (w/v) PEG 8000 0.2 M Sodium chloride 0.25 M Sodium citrate pH 4.2 0.25 M Sodium dihydrogen phosphate 
pH 4.2 
27 20% (w/v) PEG 6000 1.0 M Lithium chloride 0.1 M Citric acid pH 4.0  
28 20% (w/v) PEG 3350 0.2 M Ammonium 
nitrate pH 6.3 
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29 10% (w/v) PEG 6000 0.1M HEPES pH 7.0   
30 0.8 M Ammonium 
dihydrogen 
phosphate 
0.8 M Potassium 
dihydrogen phosphate 
0.1M HEPES pH 7.5  
31 40% (w/v) PEG 300 0.25 M Sodium citrate 
pH 5.2 
0.25 M Sodium dihydrogen 
phosphate pH 5.2 
 
32 10% (w/v) PEG 3000 0.2 M Zinc acetate 0.1 M Sodium acetate pH 4.5  
33 20% (v/v) Ethanol 0.1 M Tris pH 8.5   
34 25% (v/v)1-2-
Propanediol 
0.1M Sodium 
potassium phosphate 
pH 6.8  
10% (v/v) glycerol  
35 10% (w/v) PEG 
20000 
2% (v/v) Dioxane 0.1M Bicine pH 9.0  
36 2.0 M Ammonium 
sulphate 
0.1M Sodium acetate 
pH 4.6 
  
37 10% (w/v) PEG 1000 10% (w/v) PEG 8000   
38 24% (w/v) PEG 1000 20% (v/v) Glycerol   
39 30% (v/v) PEG 400 0.2 M Magnesium 
chloride 
0.1M HEPES pH 7.5  
40 50% (w/v) PEG 200 0.2 M Sodium chloride 0.1 M Sodium potassium 
phosphate pH 7.2 
 
41 30% (w/v) PEG 8000 0.2 M Lithium sulphate 0.1M Sodium acetate pH 4.5  
42 70% (v/v) MPD 0.2 M Magnesium 
chloride 
0.1 M HEPES pH 7.5  
43 20% (w/v) PEG 8000 0.1M Tris pH 8.5   
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44 40% (v/v) PEG 400 0.2 M Lithium sulphate 0.1 M Tris pH 8.4  
45 40%(v/v) MPD 0.1M Tris pH 8.0   
46 25.5% (w/v) PEG 
4000 
0.17 M Ammonium 
sulphate 
15% (v/v) Glycerol  
47 40% (w/v) PEG 300 0.2 M Calcium acetate 0.1M Sodium cacodylate pH 7.0  
48 14% (v/v) 
Isopropanol 
0.14 M Calcium 
chloride 
0.07M Sodium acetate pH 4.6 30% (v/v) glycerol 
49 16% (w/v)PEG 8000 0.04 M Potassium 
dihydrogen phosphate 
20% (v/v) Glycerol  
50 1.0 M Sodium citrate 0.1 M sodium 
cacodylate pH 6.5 
  
51 2.0 M Ammonium 
sulphate 
0.2 M Sodium chloride 0.1 M Sodium cacodylate pH 6.5  
52 10% (v/v) 
Isopropanol 
0.2 M Sodium chloride 0.1 M HEPES pH 7.5  
53 1.26 M Ammonium 
sulphate 
0.2 M Lithium sulphate 0.1M Tris pH 8.5  
54 40% (v/v) MPD 0.1M CAPS pH 10.1   
55 20% (w/v)PEG 3000 0.2 M Zinc acetate 0.1M Imidazole pH 8.0  
56 10% (v/v) 
Isopropanol 
0.2 M Zinc acetate 0.1M Sodium cacodylate pH 6.5  
57 1.0M Diammonium 
hydrogen phosphate 
0.1 M Sodium acetate 
pH 4.5 
  
58 1.6 M Magnesium 
sulphate 
0.1M MES pH 6.5   
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59 10% (w/v)PEG 6000 0.1 M Bicine pH 9.0   
60 14.4% (w/v)PEG 
8000 
0.16 M Calcium 
acetate  
0.08 M Sodium cacodylate pH 
6.5  
20% (v/v) glycerol 
61 10% (w/v)PEG 8000 0.1 M Imidazol pH 8.0   
62 30% (v/v) Jeffamine 0.05 M 
Caesiumchloride 
0.1 M MES pH 6.5   
63 3.2 M Ammonium 
sulphate 
0.1 M Citric acid pH 
5.0 
  
64 20% (v/v) MPD 0.1 M Tris pH 8.0   
65 20% (v/v) Jeffamine 0.1M HEPES pH 6.5   
66 50% (v/v) Ethylene 
glycol 
0.2 M Magnesium 
chloride 
0.1 M Tris pH 8.5   
67 10% (v/v) MPD 0.1 M Bicine pH 9.0   
68 0.2 M Ammonium 
sulphate 
0.1 M Sodium acetate 
pH 4.6 
30% (w/v) PEG MME 2000  
69 0.2 M Ammonium 
sulphate 
0.1 M MES pH 6.5 30% (w/v) PEG MME 5000  
70 0.01 M Zinc sulphate 0.1 M MES pH 6.5 25% (w/v) PEG MME 550  
71 0.01 M Nickel 
chloride 
0.1 M Tris pH 8.5 20% (w/v) PEG MME 2000  
72 0.1 M Sodium 
chloride 
0.1 M Bicine pH 9.0 20% (w/v) PEG MME 550  
73 0.005 M Magnesium 
chloride 
0.05 M HEPES pH 7.0 25% (w/v) PEG MME 550  
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74 0.1 M Potassium 
chloride 
0.015 M Magnesium 
chloride 
0.05 M Tris pH 7.5 10% PEG MME 550 
75 20% (v/v)1-4- 
Butandiol 
0.1 M MES pH 6.0 0.2 M Lithium sulphate  
76 1 M Sodium 
potassium tartrate 
0.1 M Imidazole pH 
8.0 
0.2 M Sodium chloride  
77 20% (v/v)1-4-
Butandiol 
0.1M Sodium acetate 
pH 4.5 
  
78 1M Sodium 
potassium tartrate 
0.1 M CHES pH 9.5 0.2 M Lithium sulphate  
79 35% (v/v) Propanol 0.1 M Sodium 
cacodylate pH6.5 
  
80 35% (v/v) Propanol 0.1 M Tris pH 8.5   
81 3.5 M Sodium 
formate 
   
82 0.8M Succinic acid 
pH 7.0 
   
83 2.1 M Malic acid pH 
7.0 
   
84 2.4 M Sodium 
malonate pH 7.0   
   
85 0.2 M Potassium 
chloride 
0.05 M HEPES pH 7.5 35% (v/v) Pentaerythritol 
propoxylate 
 
86 0.005 M Ammonium 
sulphate 
0.05 M Tris pH 6.5 30% (v/v) Pentaerythritol 
ethoxylate 
 
87 0.2 M Potassium 25% (w/v) PEG MME 0.1 M HEPES pH 7.5  
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bromide 2000 
88 0.2M Potassium 
bromide 
8% (w/v)PEG 20000 8% (w/v) PEG MME 550 0.1 M Tris pH 8.5 
89 1.0 M Potassium 
dihydrogen 
phosphate 
0.1 M Sodium citrate 
pH 4.6 
  
90 0.5 M Potassium 
dihydrogen 
phosphate 
0.1M HEPES pH 7.0   
91 20% (w/v)PEG 4000 0.005 M Cadmium 
chloride 
0.1 M Tris pH 8.0  
92 20% (w/v)PEG 4000 0.005 M Nickel 
chloride 
0.1 M MED pH 6.5  
93 0.8 M Sodium 
formate 
10% (w/v) PEG 8000 10% PEG 1000 0.1 M imidazol pH 8.0 
94 15% (w/v)PEG 4000 0.005 M Cadmium 
sulphate 
0.1 M Sodium cacodylate pH 6.5   
95 20% (w/v) PEG 600 0.005 M Cobalt 
chloride 
0.1 M HEPES pH 7.5  
96 2 M Ammonium 
sulphate  
10% (v/v) Jeffamine 0.1 M Tris pH 8.0  
Newcastle Crystal screen formulation 
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PACT crystal screen formulations 
PEG/Anion Screens 
Well 
number 
Salt Buffer PEG 
1 0.2 M Sodium fluoride  20% (w/v) PEG 3350 
2 0.2 M Sodium bromide  20% (w/v) PEG 3350 
3 0.2 M Sodium iodide  20% (w/v) PEG 3350 
4  0.2 M Potassium thiocyanate  20% (w/v) PEG 3350 
5 0.2 M Sodium nitrate  20% (w/v) PEG 3350 
6  0.2 M Sodium formate  20% (w/v) PEG 3350 
7 0.2 M Sodium acetate  20% (w/v) PEG 3350 
8 0.2 M Sodium sulphate  20% (w/v) PEG 3350 
9 0.2 M Sodium potassium tartrate  20% (w/v) PEG 3350 
10 0.2 M Sodium potassium phosphate  20% (w/v) PEG 3350 
11 0.2 M Sodium citrate  20%(w/v)  PEG 3350 
12 0.2 M Sodium malonate  20% (w/v) PEG 3350 
13 0.2 M Sodium fluoride 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
14 0.2 M Sodium bromide 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
15 0.2 M Sodium iodide 0.1 M Bis-tris propane pH 6.5 20% (w/v)  PEG 3350 
16 0.2 M Potassium thiocyanate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
17 0.2 M Sodium nitrate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
18 0.2 M Sodium formate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
19 0.2 M Sodium acetate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
20 0.2 M Sodium sulphate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
21 0.2 M Sodium potassium tartrate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
22 0.2 M Sodium potassium phosphate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
23 0.2 M Sodium citrate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
24 0.2 M Sodium malonate 0.1 M Bis-tris propane pH 6.5 20% (w/v) PEG 3350 
25 0.2 M Sodium fluoride 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
26 0.2 M Sodium bromide 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
27 0.2 M Sodium iodide 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
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28 0.2 M Potassium thiocyanate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
29 0.2 M Sodium nitrate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
30 0.2 M Sodium formate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
31 0.2 M Sodium acetate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
32 0.2 M Sodium sulphate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
33 0.2 M Sodium potassium tartrate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
34 0.2 M Sodium potassium phosphate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
35 0.2 M Sodium citrate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
36 0.2 M Sodium malonate 0.1 M Bis-tris propane pH 7.5 20% (w/v) PEG 3350 
37 0.2 M Sodium fluoride 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
38 0.2 M Sodium bromide 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
39 0.2 M Sodium iodide 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
40 0.2 M Potassium thiocyanate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
41 0.2 M Sodium nitrate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
42 0.2 M Sodium formate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
43 0.2 M Sodium acetate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
44 0.2 M Sodium sulphate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
45 0.2 M Sodium potassium tartrate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
46 0.2 M Sodium potassium phosphate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
47 0.2 M Sodium citrate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
48 0.2 M Sodium malonate 0.1 M Bis-tris propane pH 8.5 20% (w/v) PEG 3350 
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PEG/Cation Screens 
Well number  Buffer PEG 
1 0.2 M Sodium chloride Acetate pH 5 20% (w/v) PEG 6000 
2 0.2 M Ammonium chloride Acetate pH 5 20% (w/v) PEG 6000 
3 0.2 M Lithium chloride Acetate pH 5 20% (w/v) PEG 6000 
4 0.2 M Magnesium chloride Acetate pH 5 20% (w/v) PEG 6000 
5  0.2 M Calcium chloride Acetate pH 5 20% (w/v) PEG 6000 
6 0.01 M Zinc chloride Acetate pH 5 20% (w/v) PEG 6000 
7 0.2 M Sodium chloride MES pH 6 20% (w/v) PEG 6000 
8 0.2 M Ammonium chloride MES pH 6 20% (w/v) PEG 6000 
9 0.2 M Lithium chloride MES pH 6 20% (w/v) PEG 6000 
10 0.2 M Magnesium chloride MES pH 6 20% (w/v) PEG 6000 
11 0.2 M Calcium chloride MES pH 6 20%(w/v)  PEG 6000 
12 0.01 M Zinc chloride MES pH 6 20% (w/v) PEG 6000 
13 0.2 M Sodium chloride HEPES pH 7 20% (w/v) PEG 6000 
14 0.2 M Ammonium chloride HEPES pH 7 20% (w/v) PEG 6000 
15 0.2 M Lithium chloride HEPES pH 7 20% (w/v) PEG 6000 
16 0.2 M Magnesium chloride HEPES pH 7 20% (w/v) PEG 6000 
17 0.2 M Calcium chloride HEPES pH 7 20% (w/v) PEG 6000 
18 0.01 M Zinc chloride HEPES pH 7 20% (w/v) PEG 6000 
19 0.2 M Sodium chloride Tris pH 8 20% (w/v) PEG 6000 
20 0.2 M Ammonium chloride Tris pH 8 20% (w/v) PEG 6000 
21 0.2 M Lithium chloride Tris pH 8 20% (w/v) PEG 6000 
22 0.2 M Magnesium chloride Tris pH 8 20% (w/v) PEG 6000 
23 0.2 M Calcium chloride Tris pH 8 20% (w/v) PEG 6000 
24 0.01 M Zinc chloride Tris pH 8 20% (w/v) PEG 6000 
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Well 
number 
Buffer system pH of the 
buffer 
system 
PEG 
1 1 M Sodium malonate, 1 M imidazole, 1 M Boric acid 4 25% (w/v) PEG 1500 
2 1 M Sodium malonate, 1 M imidazole, 1 M Boric acid 5 25% (w/v) PEG 1500 
3 1 M Sodium malonate, 1 M imidazole, 1 M Boric acid 6 25% (w/v) PEG 1500 
4 1 M Sodium malonate, 1 M imidazole, 1 M Boric acid 7 25% (w/v) PEG 1500 
5 1 M Sodium malonate, 1 M imidazole, 1 M Boric acid 8 25% (w/v) PEG 1500 
6 1 M Sodium malonate, 1 M imidazole, 1 M Boric acid 9 25% (w/v) PEG 1500 
7 1 M Sodium propionate, 1 M Sodium cacodylate trihydrate, 
1 M Bis tris propane 
4 25% (w/v) PEG 1500 
8 1 M Sodium propionate, 1 M Sodium cacodylate trihydrate, 
1 M Bis tris propane 
5 25% (w/v) PEG 1500 
9 1 M Sodium propionate, 1 M Sodium cacodylate trihydrate, 
1 M Bis tris propane 
6 25% (w/v) PEG 1500 
10 1 M Sodium propionate, 1 M Sodium cacodylate trihydrate, 
1 M Bis tris propane 
7 25% (w/v) PEG 1500 
11 1 M Sodium propionate, 1 M Sodium cacodylate trihydrate, 
1 M Bis tris propane 
8 25% (w/v) PEG 1500 
12 1 M Sodium propionate, 1 M Sodium cacodylate trihydrate, 
1 M Bis tris propane 
9 25% (w/v) PEG 1500 
13 1 M DL-Malic acid, 1 M MES, 1 M Tris 4 25% (w/v) PEG 1500 
14 1 M DL-Malic acid, 1 M MES, 1 M Tris 5 25% (w/v) PEG 1500 
15 1 M DL-Malic acid, 1 M MES, 1 M Tris 6 25% (w/v) PEG 1500 
PEG/pH Screen compositions 
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16 1 M DL-Malic acid, 1 M MES, 1 M Tris 7 25% (w/v) PEG 1500 
17 1 M DL-Malic acid, 1 M MES, 1 M Tris 8 25% (w/v) PEG 1500 
18 1 M DL-Malic acid, 1 M MES, 1 M Tris 9 25% (w/v) PEG 1500 
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Clear Strategy Screen 1 Conditions (CSS 1) 
1 
0.3 M 
Sodium acetate, 
25% (w/v) PEG 
2000 MME 
2 
0.2 M 
Lithium sulphate, 
25%(w/v)  PEG 
2000 MME  
3 
0.2 M 
Magnesium 
chloride, 
25% (w/v) PEG 
2000 MME 
4 
0.2 M 
Potassium 
bromide, 
25% (w/v) PEG 
2000 MME 
5 
0.2 M 
Potassium 
thiocyanate, 
25% (w/v) PEG 
2000 MME 
6 
0.8 M 
Sodium formate, 
25% (w/v) PEG 
2000 MME 
7 
0.3 M 
Sodium acetate, 
15% (w/v) 
PEG 4000 
8 
0.2 M 
Lithium sulphate, 
15% (w/v) 
PEG 4000  
9 
0.2 M 
Magnesium 
chloride, 
15% (w/v) 
PEG 4000 
10 
0.2 M 
Potassium 
bromide, 
15% (w/v) 
PEG 4000 
11 
0.2 M 
Potassium 
thiocyanate, 
15% (w/v) 
PEG 4000 
12 
0.8 M 
Sodium formate, 
15% (w/v) 
PEG 4000 
13 
0.3 M 
Sodium acetate, 
10% (w/v) PEG 
8000,  
10% (w/v)  PEG 
1000 
14 
0.2 M 
Lithium sulphate, 
10% (w/v) PEG 
8000, 
10% (w/v) PEG 
1000  
15 
0.2 M 
Magnesium 
chloride, 
10% (w/v) PEG 
8000, 
10% (w/v) PEG 
1000 
16 
0.2 M 
Potassium 
bromide, 
10% (w/v) PEG 
8000, 
10% (w/v) PEG 
1000 
17 
0.2 M  
Potassium 
thiocyanate, 
10% (w/v) PEG 
8000, 
10% (w/v) PEG 
1000 
18 
0.8 M 
Sodium formate, 
10% (w/v) PEG 
8000, 
10% (w/v) PEG 
1000 
19 
0.3 M 
Sodium acetate 
8% (w/v) PEG 
20000, 
8% (w/v) 
PEG550 MME 
20 
0.2 M 
Lithium sulphate, 
8% (w/v) PEG 
20000, 
8% (w/v) 
PEG550 MME  
21 
0.2 M 
Magnesium 
chloride, 
8% (w/v) PEG 
20000, 
8% (w/v) 
PEG550 MME 
22 
0.2 M 
Potassium 
bromide, 
8% (w/v) PEG 
20000, 
8% (w/v) 
PEG550 MME 
23 
0.2 M 
Potassium 
thiocyanate, 
8% (w/v) PEG 
20000, 
8% (w/v) 
PEG550 MME 
24 
0.8 M 
Sodium formate, 
8% (w/v) PEG 
20000,  
8% (w/v) 
PEG550 MME 
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Clear Strategy Screen 2 conditions (MDCS2)  
[A1] Tube : 1  
1.5 M Ammonium 
sulphate  
 
[A2] 
Tube : 2  
0.8 M 
Lithium 
sulphate  
 
[A3] 
Tube : 3  
2 M Sodium 
formate  
 
[A4] Tube : 4  
0.5 M 
Potassium 
phosphate  
 
[A5] Tube : 5  
25% (w/v) 
PEG 2000 
MME,  
0.2 M 
Calcium 
acetate  
 
[A6] Tube : 6  
15% (w/v) 
PEG 4000,  
0.2 M 
Calcium 
acetate  
 
[B1] Tube : 7  
2.7 M Ammonium 
sulphate  
 
[B2] 
Tube : 8  
1.8 M 
Lithium 
sulphate  
 
[B3] 
Tube : 9  
4 M Sodium 
formate  
 
[B4] Tube : 10  
1.0 M 
Potassium 
dihydrogen 
phosphate  
 
[B5] 
Tube : 11  
10% (w/v) 
PEG 8000,  
10% (w/v) 
PEG 1000,  
0.2 M 
Calcium 
acetate  
 
[B6] 
Tube : 12  
8% (w/v) PEG 
20000,  
8% (w/v)  
PEG 550 
MME,  
0.2 M 
Calcium 
acetate  
 
[C1] Tube : 13  
40%v/v 
Methanepentanediol  
 
[C2] 
Tube : 14  
40%v/v 
Butanediol  
 
[C3] 
Tube : 15  
20% (w/v) 
PEG 4000,  
0.005 M 
Cadmium 
chloride  
 
[C4] Tube : 16  
20% (w/v) PEG 
550 MME,  
0.15 M 
Potassium 
thiocyanate  
 
[C5] 
Tube : 17  
20% (w/v) 
PEG 600,  
0.15 M 
Potassium 
thiocyanate  
 
[C6] 
Tube : 18  
20% (w/v) 
PEG 15000,  
0.15 M 
Potassium 
thiocyanate  
 
[D1] Tube : 19  
35%v/v Isopropanol  
 
[D2] 
Tube : 20  
30% (v/v) 
Jeffamine 
600M  
 
[D3] 
Tube : 21  
20% (w/v) 
PEG 4000,  
0.005 M 
Nickel 
chloride  
 
[D4] Tube : 22  
18% (w/v) PEG 
3350,  
0.15 M 
Potassium 
thiocyanate  
 
[D5] 
Tube : 23  
18% (w/v) 
PEG 5000 
MME,  
0.15 M 
Potassium 
thiocyanate  
 
[D6] 
Tube : 24  
15% (w/v) 
PEG 6000,  
0.15 M 
Potassium 
thiocyanate  
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Hampton screen 1 formulations (HS 1) 
Tube  SALT BUFFER Precipitant 
1 
0.02 M Calcium 
Chloride 
0.1 M Sodium acetate pH 4.6 30% (w/v) 2-methyl-2,4-pentanediol 
2 None None 
0.4 M Potassium sodium tartrate 
tetrahydrate 
3 None None 0.4 M Ammonium dihydrogen phosphate 
4 None 0.1 M Tris-HCl pH 8.5 2.0 M Ammonium Sulphate 
5 0.2 M tri-sodium citrate 0.1 M sodium HEPES pH 7.5 30% (w/v) 2-methyl-2,4-pentanediol 
6 
0.2 M Magnesium 
chloride 
0.1 M Tris-HCl pH 8.5 30% (w/v) PEG 4000 
7 None 
0.1 M sodium cacodylate pH 
6.5 
1.4 M Sodium acetate trihydrate 
8 0.2 M tri-sodium citrate 
0.1 M sodium cacodylate pH 
6.5 
30% (v/v) 2-propanol 
9 
0.2 M Ammonium 
acetate 
0.1 M sodium citrate pH 5.6 30% (w/v) PEG 4000 
10 
0.2 M Ammonium 
acetate 
0.1 M sodium acetate pH 4.6 30% (w/v) PEG 4000 
11 None 0.1 M sodium citrate pH 5.6 1.0 M Ammonium dihydrogen phosphate 
12 
0.2 M Magnesium 
chloride 
0.1 M sodium HEPES pH 7.5 30% (v/v) 2-propanol 
13 0.2 M tri-sodium citrate 0.1 M Tris-HCl pH 8.5 30% (v/v) PEG 400 
14 0.2 M Calcium Chloride 0.1 M sodium HEPES pH 7.5 28% (v/v) PEG 400 
15 
0.2 M Ammonium 
acetate 
0.1 M sodium cacodylate pH 
6.5 
30% (w/v) PEG 8000 
16 None 0.1 M sodium HEPES pH 7.5 1.5 M Lithium sulphate monohydrate 
17 0.2 M Lithium sulphate 0.1 M Tris-HCl pH 8.5 30% (w/v) PEG 4000 
18 
0.2 M Magnesium 
acetate 
0.1 M sodium cacodylate pH 
6.5 
20% (w/v) PEG 8000 
19 
0.2 M Ammonium 
acetate 
0.1 M Tris-HCl pH 8.5 30% (v/v) 2-propanol 
20 
0.2 M Ammonium 
sulphate 
0.1 M sodium acetate pH 4.6 25% (w/v) PEG 4000 
21 
0.2 M Magnesium 
acetate 
0.1 M sodium cacodylate pH 
6.5 
30% (v/v) 2-methyl-2,4-pentanediol 
22 0.2 M Sodium acetate  0.1 M Tris-HCl pH 8.5 30% (w/v) PEG 4000 
23 
0.2 M Magnesium 
chloride 
0.1 M sodium HEPES pH 7.5 30% (v/v) PEG 400 
24 0.2 M Calcium Chloride 0.1 M sodium acetate pH 4.6 20% (v/v) 2-propanol 
25 None 0.1 M Imidazole pH 6.5 1.0 M Sodium acetate trihydrate 
26 
0.2 M Ammonium 
acetate 
0.1 M sodium citrate pH 5.6 30% (v/v) 2-methyl-2,4-pentanediol 
27 0.2 M tri-sodium citrate 0.1 M sodium HEPES pH 7.5 20% (v/v) 2-propanol 
28 0.2 M Sodium acetate 
0.1 M sodium Cacodylate pH 
6.5 
30% (w/v) PEG 8000 
29 None 0.1 M sodium HEPES pH 7.5 0.8 M Potassium sodium tartrate 
30 
0.2 M Ammonium 
acetate 
None 30% (w/v) PEG 8000 
31 
0.2 M Ammonium 
acetate 
None 30% (w/v) PEG 4000 
32 None None 2.0 M Ammonium Sulphate 
33 None None 4.0 M Sodium formate 
34 None 0.1 M sodium Acetate pH 4.6 2.0 M Sodium formate 
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35 None 0.1 M sodium HEPES pH 7.5 1.6 M Potassium sodium tartrate 
36 None 0.1 M Tris-HCl pH 8.5 8% (w/v) PEG 8000 
37 None 0.1 M sodium acetate pH 4.6 8% (w/v) PEG 4000 
38 None 0.1 M sodium HEPES pH 7.5 1.4 M Sodium citrate dihydrate 
39 None 0.1 M sodium HEPES pH 7.5 
2% (v/v) PEG 400 & 2.0 M Ammonium 
Sulphate 
40 None 0.1 M sodium citrate pH 5.6 20% (v/v) 2-propanol & 20% (w/v) PEG 4000 
41 None 0.1 M sodium HEPES pH 7.5 10% (v/v) 2-propanol & 20% (w/v) PEG 4000 
42 
0.05 M potassium 
phosphate monobasic 
None 20% (w/v) PEG 8000 
43 None None 30% (w/v) PEG 1500 
44 None None 0.2 M Magnesium formate 
45 0.2 M Zinc acetate  
0.1 M sodium cacodylate pH 
6.5 
18% (w/v) PEG 8000 
46 0.2 M Calcium acetate 
0.1 M sodium cacodylate pH 
6.5 
18% (w/v) PEG 8000 
47 None 0.1 M sodium acetate pH 4.6 2.0 M Ammonium Sulphate 
48 None 0.1 M Tris-HCl pH 8.5 2.0 M Ammonium dihydrogen phosphate  
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Hampton Crystal Screen II formulations (HCS2)  
[A1] Tube : 1  
2.0 M sodium chloride,  
10% PEG 6000  
 
[A2] Tube : 2  
0.5 M sodium chloride,  
0.01 M 
hexadecyltrimethylammonium 
bromide,  
0.01 M magnesium chloride 
hexahydrate  
 
[A3] Tube : 3  
 
25% (v/v) ethylene 
glycol  
 
[A4] Tube : 4  
 
35% (v/v) 
dioxane  
 
[A5] Tube : 5  
2.0 M 
ammonium 
sulphate,   
5% (v/v) iso-
propanol  
 
[A6] Tube : 6  
 
pH 7.0 
1 M imidazole  
 
[B1] Tube : 7  
 
10% (w/v) PEG 1000,  
10% (w/v) PEG 8000  
 
[B2] Tube : 8  
1.5 M sodium chloride,  
10% (v/v) ethanol  
 
[B3] Tube : 9  
 
0.1 M sodium acetate 
trihydrate pH 4.6,  
2 M sodium chloride  
 
[B4] Tube : 10  
0.2 M sodium 
chloride,  
0.1 M sodium 
acetate 
trihydrate pH 
4.6, 
30% (v/v) MPD  
 
[B5] Tube : 11  
0.01 M cobalt 
chloride 
hexahydrate, 
0.1 M sodium 
acetate 
trihydrate pH 4.6, 
1 M 1,6 
hexanediol  
 
[B6] Tube : 12  
0.1 M cadmium 
chloride 
dehydrate,  
0.1 M sodium 
acetate 
trihydrate pH 
4.6, 
30% (v/v) PEG 
400  
 
[C1] Tube : 13  
0.2 M ammonium 
sulphate,  
0.1 M sodium acetate 
trihydrate pH 4.6, 
30% (w/v) PEG 
monomethyl ether 2000  
 
[C2] Tube : 14  
0.2 M potassium sodium tartrate 
tetrahydrate, 
0.1 M tri-sodium citrate dihydrate 
pH 5.6, 
2 M ammonium sulfate  
 
[C3] Tube : 15  
0.5 M ammonium 
sulphate,   
0.1 M tri-sodium citrate 
dihydrate pH 5.6, 
1 M lithium sulfate 
monohydrate  
 
[C4] Tube : 16  
0.5 M sodium 
chloride,  
0.1 M tri-sodium 
citrate dihydrate 
pH 5.6, 
2% (v/v) 
ethylene imine 
polymer  
 
[C5] Tube : 17  
 
0.1 M tri-sodium 
citrate dihydrate 
pH 5.6, 
35% (v/v) tert-
butanol  
 
[C6] 
Tube : 18  
0.01 M ferric 
chloride 
hexahydrate
, 
0.1 M tri-
sodium 
citrate 
dihydrate 
pH 5.6, 
10% (v/v) 
jeffamine M-
600  
 
[D1] Tube : 19  
 
0.1 M tri-sodium citrate 
dehydrate, pH 5.6 
2.5 M 1,6 hexanediol  
 
[D2] Tube : 20  
 
0.1 M MES pH 6.5, 
1.6 M magnesium sulfate 
heptahydrate  
 
[D3] Tube : 21  
0.1 M sodium 
dihydrogen phosphate,  
0.1 M MES pH 6.5, 
2 M sodium chloride, 
0.1 M  
potassium dihydrogen 
phosphate  
 
[D4] Tube : 22  
 
0.1 M MES pH 
6.5, 
12% (w/v) PEG 
20,000  
 
[D5] Tube : 23  
1.6 M 
ammonium 
sulphate,  
0.1 M MES pH 
6.5 
10% (v/v) 
dioxane  
 
[D6] Tube : 24  
0.05 M cesium 
chloride,  
0.1 M MES pH 
6.5, 
30% (v/v) 
jeffamine M-
600  
 
 
[E1] Tube : 25  
0.01 M cobaltous chloride 
hexahydrate, 
0.1 M MES pH 6.5, 
1.8 M ammonium sulfate  
 
[E2] Tube : 26  
0.2 M ammonium sulphate,  
0.1 M MES pH 6.5, 
30% (w/v) PEG monomethyl ether 
5000  
 
[E3] Tube : 27  
0.01 M zinc sulfate 
heptahydrate,  
0.1 M MES pH 6.5 
25% (v/v) PEG 
monomethyl ether 550  
 
[E4] Tube : 28  
 
pH 6.5 
1.6 M tri-sodium 
citrate dihydrate  
 
[E5] Tube : 29  
0.5 M 
ammonium 
sulphate,  
0.1 M HEPES 
pH 7.5, 
30% (v/v) MPD  
 
[E6] Tube : 30  
 
0.1 M HEPES 
pH 7.5, 
10% (w/v) PEG 
6000,   
5% (v/v) MPD  
 
[F1] Tube : 31  
 
0.1 M HEPES pH 7.5, 
20% (v/v) jeffamine M-
600  
 
[F2] Tube : 32  
0.1 M sodium chloride,  
0.1 M HEPES pH 7.5, 
1.6 M ammonium sulfate  
 
[F3] Tube : 33  
 
0.1 M HEPES pH 7.5, 
2 M ammonium formate  
 
[F4] Tube : 34  
0.05 M 
cadmium 
sulfate hydrate, 
0.1 M HEPES 
[F5] Tube : 35  
 
0.1 M HEPES 
pH 7.5, 
70% (v/v) MPD  
 
[F6] Tube : 36  
 
0.1 M HEPES 
pH 7.5, 
4.3 M sodium 
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pH 7.5, 
1 M sodium 
acetate 
trihydrate  
 
chloride  
 
[G1] Tube : 37  
 
0.1 M HEPES pH 7.5, 
10% (w/v) PEG 8000  
 
[G2] Tube : 38  
 
0.1 M HEPES pH 7.5, 
20% (w/v) PEG 10000,  
8% (v/v) ethylene glycol  
 
[G3] Tube : 39  
0.2 M magnesium 
chloride hexahydrate, 
0.1 M tris pH 8.5, 
3.4 M 1,6 hexanediol  
 
[G4] Tube : 40  
 
0.1 M tris pH 
8.5,  
25% (v/v)  tert-
butanol  
 
[G5] Tube : 41  
0.01 M nickel (II) 
chloride 
hexahydrate, 
0.1 M tris pH 8.5, 
1 M lithium 
sulfate 
monohydrate  
 
[G6] Tube : 42  
1.5 M 
ammonium 
sulphate,  
0.1 M tris pH 
8.5, 
12% (v/v) 
glycerol 
anhydrous  
 
[H1] Tube : 43  
0.2 M ammonium 
dihydrogen phosphate,  
0.1 M tris pH 8.5, 
50% (v/v) MPD  
 
[H2] Tube : 44  
 
0.1 M tris pH 8.5, 
20% (v/v) ethanol  
 
[H3] Tube : 45  
0.01 M nickel (II) 
chloride hexahydrate, 
0.1 M tris pH 8.5, 
20% (w/v) PEG 
monomethyl ether 2000  
 
[H4] Tube : 46  
0.1 M sodium 
chloride,  
0.1 M bicine pH 
9.0, 
20% (v/v) PEG 
monomethyl 
ether 550  
 
[H5] Tube : 47  
 
0.1 M bicine, pH 
9.0, 
2 M magnesium 
chloride 
hexahydrate  
 
[H6] Tube : 48  
 
0.1 M bicine 
pH 9.0, 
2% (v/v) 
dioxane,  
10% (w/v) PEG 
20,000  
 
Recipe courtesy of Hampton Research 
Reference website 
http://xray.bmc.uu.se/markh/php/xtalscreens.php?func=lookup&screen_name=Expa
nd+List 
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I Bioinformatics analysis of GH95 and GH97 proteins, gel filtration graphs for 
CAH06598 and CAH09443 and PCR amplification conditions used in the cloning of 
BF3763 and BF0855 genes. 
 
CAH06598 
CAH06598 
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CAH09443  
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CAH06598 gel filtration graph 
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CAH06598 gel filtration graph 
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CAH09443 gel filtration graph 
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CAH09443 gel filtration graph- selenomethionine derivative 
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Step Temperature Time 
 
Denature 94°C 2 min 
Denature 94°C 15 s 
Annealing 60.27°C 30 s 
Extension 68°C 2 min 39 s 
Repeated 4 more times 
Denature 94°C  15 s 
Annealing 70.03°C 30 s 
Extension 68°C 2 min 39 s 
 
Repeated 24 more times 
Extension 68°C  10 min 
Hold at 10°C  
PCR conditions for the amplification of the BF3763 gene from B. fragilis 
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Step Temperature Time 
Denature 94°C 2 min 
Denature 94°C 15 s 
Annealing 60.27°C 30 s 
Extension 68°C 2 min 39 s 
Denature 94°C  15 s 
Annealing 70.03°C 30 s 
 
Extension 68°C 2 min 39 s 
Extension 68°C 10 min 
Hold at 10°C 
KOD polymerase based PCR amplification of BF3763 gene in B. fragilis 
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Step Temperature Time 
 
Denature 94°C 2 min 
Denature 94°C 15 s 
 61 °C 30 s 
Extension 72°C  1 min 53 s 
 94°C 15 s 
 80°C 30 s 
Annealing 72°C 1 min 53 s 
Denature 94°C  15 s 
Annealing 73°C 30 s 
Extension 72°C 1 min 53 s 
Extension 72°C 10 min 
 
Hold at 10°C  
PCR conditions for the amplification of the BF0855 gene from B. fragilis 
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Step Temperature Time 
Denature 94°C  2 min 
Denature 94°C 15 s 
Annealing 61 °C 30 s 
Extension 72°C 1 min 53 s 
Denature 94°C 15 s 
 80°C 30 s 
Annealing 72°C 1 min 53 s 
Denature 94°C 15 s 
Annealing 73°C 30 s 
Extension 72°C 1 min 53 s 
Extension 72°C 10 min 
Hold at 10°C 
Amplification of the BF3763 gene from transformed E. coli to screen for colonies 
containing successful inserts 
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Appendix J 
Figure represents the standard curve for the Bradford assay 
 
 
 
 
 
 
